NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
Note A - Business and Summary of Significant Accounting Policies
The following describes the business and significant accounting policies of F&G Annuities & Life, Inc. (“FGAL”) and its subsidiaries (collectively, “we”, “us”, “our”, the “Company” or “F&G”), which have been followed in preparing the accompanying Consolidated Financial Statements.
Description of the Business
We provide insurance solutions and market a broad portfolio of annuity and life insurance products, including deferred annuities (fixed indexed annuities (“FIA”) and fixed rate annuities including multi-year guarantee annuities (“MYGA”)), immediate annuities, indexed universal life (“IUL”) insurance and, beginning in early 2024, registered index-linked annuities (“RILA”), through our retail distribution channels. We also provide funding agreements and pension risk transfer (“PRT”) solutions through our institutional channels. F&G has one reporting segment, which is consistent with and reflects the manner by which our chief operating decision maker views and manages the business. For certain disclosures within this Report, we have elected to aggregate business based on the applicable product type, the manner in which information is regularly reviewed by management and the nature of disclosures that exist outside the Company’s GAAP financial statements.
FNF acquired 100% of the outstanding equity of FGL Holdings, the prior parent company, on June 1, 2020. FGAL, a Delaware corporation, was formed on August 7, 2020, and following a series of reorganizations, became the parent company for the consolidated financial statements via a contribution agreement between Fidelity National Financial, Inc. (NYSE: FNF)(“FNF”) and FGAL on November 26, 2020. On December 1, 2022, FNF distributed, on a pro rata basis, approximately 15% of the common stock of F&G. FNF retained control of F&G through ownership of approximately 85% of F&G common stock. Effective December 1, 2022, F&G commenced “regular-way” trading of its common stock on the New York Stock Exchange (“NYSE”) under the symbol “FG”.
Discontinued Operations
In connection with the FNF acquisition, certain third party offshore reinsurance businesses were deemed discontinued operations and are presented as such within our consolidated financial statements for all periods presented through the date of their disposition, in accordance with GAAP. On May 31, 2021, we sold third party reinsurance business held within Front Street Re Cayman Ltd (“FSRC”) to Archipelago Lexa (C) Limited. The transaction and the results of discontinued operations for the year ended December 31, 2021 did not have a material impact to our GAAP financial results.
Recent Developments
Adoption of Accounting Standards Update (“ASU”) 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts (“ASU 2018-12”)
F&G adopted ASU 2018-12 on January 1, 2023, with a transition date of January 1, 2021, which is the earliest period presented in the annual December 31, 2023 Consolidated Financial Statements. We elected to adopt ASU 2018-12 using the full retrospective transition method and balances for liability for future policy benefits (“FPB”), deferred acquisition costs (“DAC”) and balances amortized on a basis consistent with DAC (value of business acquired (“VOBA”), deferred sales inducements (“DSI”), and unearned revenue liabilities (“URL”)), and market risk benefits (“MRB”) were adjusted to conform to ASU 2018-12 starting as of the FNF acquisition date, June 1, 2020 (the “FNF Acquisition Date”). The 2022 and 2021 financial information contained herein have been adjusted for our full retrospective adoption of this update. For more information, refer to Principles of Consolidation and Basis of Presentation below, Note F - Intangibles, Note G - Market Risk Benefits, Note H - Income Taxes, Note I - Contractholder Funds, Note J - Future Policy Benefits, Note K - Accounts Payable and Accrued Liabilities, Note P - ASU 2018-12 Transition and Note T - Recent Accounting Pronouncements.
Revolving Credit Facility
On February 16, 2024, F&G entered into an amendment and extension of its existing senior unsecured revolving credit agreement (the “Credit Agreement”). The maturity date of the Credit Agreement has been extended by approximately two years from November 22, 2025 to November 22, 2027. Total commitments will increase from $665 million to $750 million. Pricing and advance rates remain unchanged. Financial covenants also remain essentially the same. As noted below, we used $150 million of net proceeds from our 7.95% F&G Notes to pay down the Credit Agreement to a balance of approximately $365 million as of December 31, 2023.
Dividends
On February 14, 2024, our Board of Directors declared a quarterly cash dividend of $0.21 per share, payable on March 29, 2024, to F&G common shareholders of record as of March 15, 2024. Generally, no dividends will be declared or paid on F&G common stock and no common stock can be acquired by F&G unless all preferred dividends are declared and paid on the F&G 6.875% Series A Mandatory Convertible Preferred Stock, par value $.001 per share, liquidation preference of $50.00 per share (the “FNF Preferred Stock”) discussed below. On February 14, 2024, our Board of Directors also declared a quarterly cash dividend of $0.8976 per share on the FNF Preferred Stock for the period from January 12, 2024 to and excluding April 15, 2024, to be paid on April 15, 2024, to FNF Preferred Stock record holders as of April 1, 2024.
FNF $250 million Preferred Stock Investment
On January 12, 2024 we completed a $250 million preferred stock investment from FNF. F&G will use net proceeds from the investment to support the growth of its assets under management. Under the terms of the agreement, FNF agreed to invest $250 million in exchange for 5,000,000 shares of FNF Preferred Stock. Unless earlier converted at the option of the holder, each outstanding share of the FNF Preferred Stock will automatically convert into shares of F&G common stock on January 15, 2027. For further information related to this preferred stock issuance, refer to Note Q -Related Party Transactions.
7.95% F&G Senior Notes
On December 6, 2023, F&G completed the public offering of $345 million aggregate principal amount of its 7.95% Senior Notes due 2053 (the “7.95% F&G Notes”). F&G intends to use the net proceeds from the offering to repay borrowings under its revolving credit facility and for general corporate purposes, including the support of organic growth opportunities. As of December 31, 2023, we used approximately $150 million of net proceeds to repay borrowings under our revolving credit facility. The Senior notes were registered under the Securities Act of 1933 (as amended) (the “Securities Act”).
7.40% F&G Senior Notes
On January 13, 2023, F&G completed its issuance and sale of $500 million aggregate principal amount of its 7.40% Senior Notes due 2028 (the “7.40% F&G Notes”). F&G is using the net proceeds from the offering for general corporate purposes, including to support the growth of assets under management and for F&G's future liquidity requirements. The Senior notes were registered under the Securities Act.
Refer to Note L - Notes Payable, for further information related to financing facilities..
Share Repurchase Program
On March 21, 2023, F&G’s Board of Directors approved a new three-year stock repurchase program, effective March 21, 2023, under which the Company may repurchase up to $25 million of F&G common stock. On November 7, 2023, the Board of Directors increased the share repurchase authorization to $50 million. The Company believes the share repurchase program is an efficient means of returning cash to shareholders when we consider the shares to be undervalued. Purchases may be made from time to time by the Company in the open market at prevailing market prices or through privately negotiated transactions or accelerated share repurchase
transactions through November 6, 2026. All purchases are held as treasury stock. The timing and extent of share repurchases will depend on a variety of factors, including, market conditions, regulatory requirements, and considerations as determined by management.
During the year ended December 31, 2023, the Company purchased approximately 869,000 shares pursuant to the program, for a total cost of approximately $18 million with an average cost per share of $21.07. At December 31, 2023, the total remaining authorization of F&G common stock that may be repurchased was approximately $32 million.
Owned Distribution Investments
On January 2, 2024, F&G acquired a 70% majority ownership stake in the equity of Roar Joint Venture, LLC (“Roar”). Roar wholesales life insurance and annuity products to banks and broker dealers through a network of agents. Total initial consideration is comprised of cash of approximately $269 million and contingent consideration. Under the terms of the purchase agreement, the Company has agreed to make cash payments of up to approximately $90 million over a three year period upon the achievement of certain earnings before interest, taxes, depreciation and amortization (“EBITDA”) milestones of Roar.
On August 4, 2023, F&G purchased a 30% minority ownership stake in Quility Holdings, LLC (“Quility”). Quility is a leading insurtech company that offers a frictionless experience for insurance agents, insurance distribution companies and the clients they serve. On June 20, 2023, F&G purchased a 40% minority ownership stake in DCMT Worldwide, LLC (“DCMT”). DCMT distributes life insurance and annuity products through a network of over 1,000 agents. On January 30, 2023, F&G purchased a 49% minority ownership stake in Syncis Holdings, LLC (“Syncis”). Syncis is an approximately 1,200 agent Network Marketing Group (“NMG”). We have elected the fair value option to account for these investments and have included them in Investments in unconsolidated affiliates on the accompanying Consolidated Balance Sheets.
Reclassifications
In addition to the adjustments made related to the implementation of ASU 2018-12, we also reclassified approximately $28 million and $21 million from Other long-term investments to Investments in unconsolidated affiliates on the Consolidated Balance Sheets for consistency as of December 31, 2022 and 2021, respectively. These reclassifications had no impact on Net earnings or Equity.
Principles of Consolidation and Basis of Presentation
The accompanying Consolidated Financial Statements are prepared in accordance with GAAP and include our accounts as well as our wholly owned subsidiaries. All intercompany profits, transactions and balances have been eliminated.
Refer to Note T - Recent Accounting Pronouncements for information on recent accounting pronouncements that may have an impact on our Consolidated Financial Statements.
We are involved in certain entities that are considered variable interest entities (“VIEs”) as defined under GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. We assess our relationships with VIEs to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our Consolidated Financial Statements. See Note C - Investments for additional information on our investments in VIEs.
Investments
Fixed Maturity Securities Available-for-Sale
Fixed maturity securities are purchased to support our investment strategies, which are developed based on factors including rate of return, maturity, credit risk, duration, tax considerations and regulatory requirements. Our investments in fixed maturity securities have been designated as available-for-sale (“AFS”) and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included within accumulated other comprehensive earnings (loss) (“AOCI”), net of deferred income taxes. Fair values for fixed maturity securities are principally a function of current market conditions and are primarily valued based on quoted prices in markets that are not active or model inputs that are observable or unobservable. We recognize investment income on fixed maturities based on the effective interest method, which results in the recognition of a constant rate of return on the investment equal to the prevailing rate at the time of purchase or at the time of subsequent adjustments of book value. Realized gains and losses on sales of our fixed maturity securities are determined on the first-in first-out cost basis. We generally record security transactions on a trade date basis except for private placements, which are recorded on a settlement date basis. Realized gains and losses on sales of fixed maturity securities are reported within Recognized gains and (losses), net in the accompanying Consolidated Statements of Operations. Fixed maturity securities AFS are subject to an allowance for credit loss and changes in the allowance are reported in net earnings as a component of Recognized gains and (losses), net. For details on our policy around allowance for expected credit losses on available-for-sale securities, refer to Note C - Investments.
Preferred and Equity Securities
Preferred and equity securities held are carried at fair value as of the balance sheet dates. The fair values of our preferred and equity securities are based on quoted prices in active markets or are valued based on quoted prices in markets that are not active, model inputs that are observable or unobservable or based on net asset value (“NAV”). Changes in fair value and realized gains and losses on sales of our preferred and equity securities are reported within Recognized gains and losses, net in the accompanying Consolidated Statements of Operations. Realized gains and losses on sales of our preferred and equity securities are determined on the first-in first-out cost basis and are credited or charged to earnings on a trade date basis, unless the security is a private placement in which case settlement date basis is used. Interest and dividend income from these investments is reported in Interest and investment income in the accompanying Consolidated Statements of Operations.
Derivative Financial Instruments
We hedge certain portions of our exposure to product related equity market risk by entering into derivative transactions (primarily call options). We utilize interest rate swaps to reduce market risks from interest rate changes on our earnings associated with our floating rate investments. All such derivative instruments are recognized as either assets or liabilities in the accompanying Consolidated Balance Sheets at fair value. The changes in fair value are reported within Recognized gains and losses, net in the accompanying Consolidated Statements of Operations.
We purchase financial instruments and issue products that may contain embedded derivative instruments. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract for measurement purposes. The Company’s embedded derivative associated to our FIA crediting rates policies is carried at fair value, which is determined through a combination of market observable inputs such as market value of option and interest swap rates and unobservable inputs such as the mortality multiplier, surrender and withdrawal rates and non-performance spread. The changes in fair value of the FIA embedded derivative are reported within Benefits and other changes in policy reserves in the accompanying Consolidated Statements of Operations. See a description of the fair value methodology used in Note B - Fair Value of Financial Instruments.
Reinsurance Related Embedded Derivatives
F&G cedes certain business on a coinsurance funds withheld basis. Investment results for the assets that support the coinsurance that are segregated within the funds withheld account are passed directly to the reinsurer pursuant to
the contractual terms of the reinsurance agreement, which creates embedded derivatives considered to be total return swaps. These total return swaps are not clearly and closely related to the underlying reinsurance contract and thus require bifurcation. The fair value of the total return swaps is based on the change in fair value of the underlying assets held in the funds withheld account. These embedded derivatives are reported in Prepaid expenses and other assets if in a net gain position, or Accounts payable and accrued liabilities, if in a net loss position on the Consolidated Balance Sheets and the related gains or losses are reported in Recognized gains and (losses), net, on the Consolidated Statements of Operations.
Mortgage Loans
Our investment in mortgage loans consists of commercial and residential mortgage loans on real estate, which are reported at amortized cost, less allowance for expected credit losses. For details on our policy around allowance for expected credit losses on mortgage loans, refer to Note C - Investments.
Commercial mortgage loans are continuously monitored by reviewing appraisals, operating statements, rent revenues, annual inspection reports, loan specific credit quality, property characteristics, market trends and other factors.
Commercial mortgage loans are rated for the purpose of quantifying the level of risk. Loans are placed on a watch list when the debt service coverage (“DSC”) ratio falls below certain thresholds and the loan-to-value (“LTV”) ratios exceeds certain thresholds. Loans on the watchlist are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. We define delinquent mortgage loans as 30 days past due, consistent with industry practice.
Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. We define nonperforming residential mortgage loans as those that are 90 or more days past due and/or in nonaccrual status, which is assessed monthly. Generally, nonperforming residential mortgage loans have a higher risk of experiencing a credit loss. We consider residential mortgage loans that are 90 or more days past due and have an LTV greater than 90% to be foreclosure probable.
Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan. Interest income, amortization of premiums and discounts, prepayment fees, and loan commitment fees are reported in Interest and investment income in the accompanying Consolidated Statements of Operations.
Short-term investments
Short-term investments consist of financial instruments with an original maturity of one year or less when purchased and include short-term fixed maturity securities and money market instruments, which are carried at fair value, and short-term loans, which are carried at amortized cost, which approximates fair value.
Investments in Unconsolidated Affiliates
We account for our investments in unconsolidated affiliates using the equity method or by electing the fair value option. Initial investments are recorded at cost. For investments subsequently measured using the equity method (primarily limited partnerships), adjustments to the carrying amount reflect our pro rata ownership percentage of the operating results as indicated by net asset value (“NAV”) in the unconsolidated affiliates’ financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. Distributions received from investments measured using the equity method are recorded as a decrease in the investment balance. For investments subsequently measured using the fair value option, adjustments to the carrying amount reflecting the change in fair value of the investment are reported along with realized gains and losses on sales of investments in unconsolidated affiliates in Recognized gains and (losses), net in the accompanying Consolidated Statements of Operations. Distributions received from investments measured using the fair value option are reported within Interest and investment income in the accompanying Consolidated Statements of
Operations. Recognition of income and adjustments to the carrying amount can be delayed due to the availability of the related financial statements, which are obtained from the general partner or managing member generally on a one to three-month delay. For investments using the equity method, management inquires quarterly with the general partner or managing member to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter valuation and investment income.
Interest and investment income
Dividends and interest income are recorded in Interest and investment income and recognized when earned. Income or losses upon call or prepayment of fixed maturity securities are recognized in Interest and investment income. Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in Interest and investment income over the contractual terms of the investments, and for callable investments at a premium, based on the earliest call date of the investments, in a manner that produces a constant effective yield.
For mortgage-backed and asset-backed securities, included in the fixed maturity securities portfolios, one of two models may be used to recognize interest income. For higher rated securities, interest income will be estimated based on an effective yield that considers cash flows received to date plus current expectations of future cash flows. For all other securities, interest income will be estimated based upon an effective yield that considers current expectations of future cash flows. For both interest income models, the estimated future cash flows include assumptions regarding the performance of the underlying collateral pool.
Interest and investment income is presented net of investment expenses and the effects of certain reinsurance contracts.
Cash and Cash Equivalents
Highly liquid instruments purchased as part of cash management with original maturities of three months or less are considered cash equivalents. The carrying amounts reported in the Consolidated Balance Sheets for these instruments approximate fair value.
Fair Value of Financial Instruments
The fair values of financial instruments presented in the Consolidated Financial Statements are estimates of the fair values at the balance sheet date using available market information and appropriate valuation methodologies. These estimates are subjective in nature and involve uncertainties and significant judgment in the interpretation of current market data. See a description of the fair value methodology used in Note B - Fair Value of Financial Instruments.
Fair Value of Assets Acquired and Liabilities Assumed in Business Combinations
FASB Accounting Standards Codification (“ASC”) Topic 805, Business Combinations, requires an acquirer to recognize, separately from goodwill, the identifiable assets acquired, liabilities assumed, and any noncontrolling interest in the acquiree, and to measure these items generally at their acquisition date fair values. Goodwill is recorded as the residual amount by which the purchase price exceeds the fair value of the net assets acquired. If the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, we are required to report provisional amounts in the financial statements for the items for which the accounting is incomplete. Adjustments to provisional amounts initially recorded that are identified during the measurement period are recognized in the reporting period in which the adjustment amounts are determined. This includes any effect on earnings of changes in depreciation, amortization, or other income effects as a result of the change to the provisional amounts, calculated as if the accounting had been completed at the acquisition date. During the measurement period, we are also required to recognize additional assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets and liabilities as of that date. The measurement period ends the sooner of one year from the acquisition date or when we receive the information we were seeking about facts and circumstances that
existed as of the acquisition date or learn that more information is not obtainable. Contingent consideration liabilities or receivables recorded in connection with business acquisitions must also be adjusted for changes in fair value until settled.
Goodwill
Goodwill represents the excess of cost over fair value of identifiable net assets acquired and assumed in a business combination. Goodwill and other intangible assets with indefinite useful lives are reviewed for impairment at the reporting unit level on an annual basis or more frequently if circumstances indicate potential impairment, through a comparison of fair value to the carrying amount. In evaluating the recoverability of goodwill, we first determined that based on the level at which the operating results are shared with and regularly reviewed by the Company’s Chief Operating Decision Maker, the Company is a single reporting unit. Next, we perform a qualitative analysis at the reporting unit level to determine whether there are any events or circumstances that would indicate it is more likely than not that the fair value of our recorded goodwill exceeds its carrying value, prior to performing a full fair-value assessment.
We complete annual goodwill impairment analyses in the fourth quarter of each period presented using a September 30 measurement date. For the years ended December 31, 2023 and 2022, we determined there were no events or circumstances which indicated that the carrying value of a reporting unit exceeded the fair value.
VOBA, DAC, DSI and URL
Our intangible assets include the value of insurance and reinsurance contracts acquired (hereafter referred to as VOBA), DAC and DSI.
VOBA is an intangible asset that reflects the amount recorded as insurance contract liabilities less the estimated fair value of in-force contracts (“VIF”) in a life insurance company acquisition. It represents the portion of the purchase price that is allocated to the value of the rights to receive future cash flows from the business in force at the acquisition date. VOBA is a function of the VIF, current GAAP reserves, GAAP assets, and deferred tax liability. The VIF is determined by the present value of statutory distributable earnings less opening required capital. DAC consists principally of commissions and other acquisition costs that are related directly to the successful sale of new or renewal insurance contracts. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. DSI represents up front bonus credits and persistency or vesting bonuses credited to contractholder fund balances.
VOBA, DAC, and DSI are amortized on a constant level basis for the grouped contracts over the expected term of the related contracts to approximate straight-line amortization. Contracts are grouped by product type, feature and issue year into cohorts consistent with the grouping used in estimating the associated liability, where applicable. The constant level amortization bases of VOBA, DAC and DSI varies by product type. For universal life and IUL insurance products, the constant level basis used is face amount in force. For deferred annuities (FIA and fixed rate annuities), the constant level basis used is initial premium deposit for DAC and DSI and vested account value as of the acquisition date for VOBA. For immediate annuity contracts, the VOBA balance is amortized in alignment with the Company’s accounting policy of amortizing the deferred profit liability (“DPL”). All amortization bases are adjusted by full lapses, which includes deaths, full surrenders, annuitizations and maturities, where applicable.
The constant level basis used for amortization are projected using mortality and lapse assumptions that are based on Company’s experience, industry data, and other factors and are consistent with those used for the FPB, where applicable. If those projected assumptions change in future periods, they will be reflected in the cohort level amortization basis at that time. Unexpected contract terminations, due to higher mortality and/or lapse experience than expected, are recognized in the current period as a reduction of the capitalized balances. All balances are reduced for actual experience in excess of expected experience with changes in future estimates recognized prospectively over the remaining expected grouped contract term. The impact of changes in projected assumptions and the impact of actual experience that is different from expectations both impact the amortization of these intangible assets, which is reported within Depreciation and amortization in the accompanying Consolidated Statements of Operations.
Some of our IUL policies require payment of fees or other policyholder assessments in advance for services that will be rendered over the estimated lives of the policies or contracts. These payments are established as URL upon receipt and included in Accounts payable and other accrued liabilities in the Consolidated Balance Sheets. URL is amortized like DAC over the estimated lives of these policies.
Other Intangible Assets
We have other intangible assets, not including goodwill, VOBA, DAC or DSI, which consist primarily of customer relationships and contracts, the value of distribution network acquired (“VODA”), trademarks and tradenames, state licenses and computer software, which are generally recorded in connection with business combinations at their fair value. Intangible assets with estimable lives are amortized over their respective estimated useful lives to their estimated residual values and reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. In general, customer relationships are amortized over their estimated useful lives, generally ten years, using an accelerated method, which takes into consideration expected customer attrition rates. VODA is an intangible asset that represents the value of an acquired distribution network and is amortized using the sum of years digits method. Contractual relationships are generally amortized over their contractual life. Trademarks and tradenames are generally amortized over ten years. Capitalized computer software includes the fair value of software acquired in business combinations, purchased software and capitalized software development costs. Purchased software is recorded at cost and amortized using the straight-line method over its estimated useful life. Software acquired in business combinations is recorded at its fair value and amortized using straight-line or accelerated methods over its estimated useful life. For internal-use computer software products, internal and external costs incurred during the preliminary project stage are expensed as they are incurred. Internal and external costs incurred during the application development stage are capitalized and amortized on a product by product basis commencing on the date the software is ready for its intended use. We do not capitalize any costs once the software is ready for its intended use.
We review VOBA, DSI and other intangible assets for impairment annually or when events or circumstances occur that indicate a potential change in the underlying basis. Refer to Note F - Intangibles for details of impairment expense.
Property and Equipment
Property and equipment are recorded at cost, less accumulated depreciation in Prepaid expenses and other assets on the Consolidated Balance Sheets. Depreciation is computed primarily using the straight-line method based on the estimated useful lives of the related assets: twenty to thirty years for buildings and zero to twenty-five years for furniture, fixtures and equipment. Leasehold improvements are amortized on a straight-line basis over the lesser of the term of the applicable lease or the estimated useful lives of such assets. Property and equipment are reviewed for impairment whenever events or circumstances indicate that the carrying amounts may not be recoverable.
Contractholder Funds
Contractholder funds include deferred annuities (FIAs and fixed rate annuities), IULs, funding agreements and non-life contingent (“NLC”) immediate annuities (which includes NLC PRT annuities). The liabilities for contractholder funds for fixed rate annuities, funding agreements and NLC immediate annuities consist of contract account balances that accrue to the benefit of the contractholders. The liabilities for FIA and IUL policies consist of the value of the host contract plus the fair value of the indexed crediting feature of the policy, which is accounted for as an embedded derivative. The embedded derivative liability is carried at fair value in Contractholder funds in the accompanying Consolidated Balance Sheets with changes in fair value reported in Benefits and other changes in policy reserves in the accompanying Consolidated Statements of Operations. See a description of the fair value methodology used in Note B - Fair Value of Financial Instruments.
Future Policy Benefits
The FPB are determined as the present value of future policy benefits and related claims expenses to be paid to or on behalf of the policyholder less the present value of future net premiums to be collected from policyholders. The FPB for traditional life policies and life-contingent immediate annuity policies (which includes life-contingent
PRT annuities) are estimated using current assumptions that include discount rate, mortality and surrender/lapse terminations for traditional life insurance policies only, and expenses. The expense assumption is locked-in at contract issuance and not subsequently reviewed or updated. The initial assumptions are based on generally accepted actuarial methods and a combination of internal and industry experience. Policies are terminated through surrenders, lapses and maturities, where surrenders represent the voluntary terminations of policies by policyholders, lapses represent cancellations by us due to nonpayment of premiums, and maturities are determined by policy contract terms.
For traditional life policies and life-contingent immediate annuity policies, contracts are grouped into cohorts by product type, legal entity, and issue year, or acquisition year for cohorts established as of the FNF Acquisition Date. Life-contingent PRT annuities are grouped into cohorts by deal and legal entity. At contract inception, a net premium ratio (“NPR”) is determined, which is calculated based on discounted future cash flows projected using best estimate assumptions and is capped at 100%, as net premiums cannot exceed gross premiums. Cohorts with NPRs less than 100% are not used to offset cohorts with NPRs greater than 100%.
The NPR is adjusted for changes in cash flow assumptions and for differences between actual and expected experience. We assess the appropriateness of all future cash flow assumptions, excluding the expense assumption, on a quarterly basis and perform an in-depth review of future cash flow assumptions in the third quarter of each year. Updates are made when evidence suggests a revision is necessary. Updates for actual experience, which includes actual cash flows and insurance in-force, are performed on a quarterly basis. These updated cash flows are used to calculate a revised NPR, which is used to derive an updated liability as of the beginning of the current reporting period, discounted at the original contract issuance date. The updated liability is compared with the carrying amount of the liability as of that same date before the revised NPR. The difference between these amounts is the remeasurement gain or loss, presented parenthetically within Benefits and other changes in policy reserves in the accompanying Consolidated Statements of Operations. In subsequent periods, the revised NPR is used to measure the FPB, subject to future revisions. If the NPR is greater than 100%, and therefore capped at 100%, the liability is increased and expensed immediately to reflect the amount necessary for net premiums to equal gross premiums. As the liability assumptions are reviewed and updated, if deemed necessary, at least annually, if conditions improve whereby the contracts are no longer expected to have net premiums in excess of gross premiums, the improvements would be captured in the remeasurement process and reflected in the accompanying Consolidated Statements of Operations in the period of improvement.
For traditional life policies and life-contingent immediate annuity policies (which includes life-contingent PRT annuities), the discount rate assumption is an equivalent single rate that is derived based on A-credit-rated fixed-income instruments with similar duration to the liability. We selected fixed-income instruments that have been A-rated by Bloomberg. In order to reflect the duration characteristics of the liability, we will use an implied forward yield curve and linear interpolation will be used for durations that have limited or no market observable points on the curve. The discount rate assumption is updated quarterly and used to remeasure the liability at the reporting date, with the resulting change reflected in the accompanying Consolidated Statements of Comprehensive Earnings.
Deferred Profit Liability
For life-contingent immediate annuity policies, gross premiums received in excess of net premiums are deferred at initial recognition as a DPL. Gross premiums are measured using assumptions consistent with those used in the measurement of the related liability for FPBs, including discount rate, mortality, and expenses.
The DPL is amortized and recognized as premium revenue with the amount of expected future benefit payments, discounted using the same discount rate determined and locked-in at contract issuance that is used in the measurement of the related FPB. Interest is accreted on the balance of the DPL using this same discount rate. We periodically review and update our estimates using the actual historical experience and updated cash flows for the DPL at the same time as the estimates of cash flows for the FPB. When cash flows are updated, the updated estimates are used to recalculate the initial DPL at contract issuance. The recalculated DPL as of the beginning of the current reporting period is compared to the carrying amount of the DPL as of the beginning of the current reporting period, with any differences recognized as a remeasurement gain or loss, presented parenthetically within Benefits and other changes in policy reserves in the accompanying Consolidated Statements of Operations. The DPL is recorded as a component of the Future policy benefits in the accompanying Consolidated Balance Sheets.
Market Risk Benefits
MRBs are contracts or contract features that both provide protection to the contract holder from other-than-nominal capital market risk (equity, interest rate and foreign exchange risk) and expose the Company to other-than-nominal capital market risk. MRBs include certain contract features primarily on FIA products that provide minimum guarantees to policyholders, such as guaranteed minimum death benefit (“GMDB”), guaranteed minimum withdrawal benefit (“GMWB”) riders and guaranteed minimum accumulation benefit (“GMAB”) riders.
MRBs are measured at fair value using an attributed fee measurement approach where attributed fees are explicit rider charges collectible from the policyholder used to cover the excess benefits, which represent expected benefits in excess of the policyholder’s account value. At contract inception, an attributed fee ratio is calculated equal to rider charges over benefits paid in excess of the account value attributable to the MRBs. The attributed fee ratio remains static over the life of the MRBs and is capped at 100%. Each period subsequent to contract inception, the attributed fee ratio is used to calculate the fair value of the MRBs using a risk neutral valuation method and is based on current net amounts at risk, market data, internal and industry experience, and other factors. The balances are computed using assumptions including mortality, full and partial surrender, GMWB utilization, risk-free rates including non-performance spread and risk margin, market value of options and economic scenarios. Policyholder behavior assumptions are reviewed at least annually, typically in the third quarter, for any revisions. MRBs can either be in an asset or liability position and are presented separately on the Consolidated Balance Sheets as the right of setoff criteria are not met. Changes in fair value are recognized in Market risk benefits gain (losses) in the Consolidated Statements of Operations, except for the change in fair value due to a change in the instrument-specific credit risk, which is recognized in the Consolidated Statements of Comprehensive Earnings. See a description of the fair value methodology used in Note B - Fair Value of Financial Instruments and Note G - Market Risk Benefits.
Income Taxes
We recognize deferred tax assets and liabilities for temporary differences between the financial reporting basis and the tax basis of our assets and liabilities and expected benefits of utilizing net operating loss and credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. We evaluate the likelihood of realizing the benefit of our deferred tax assets and may record a valuation allowance if, based on all available evidence, we determine that it is more likely than not that some portion of the tax benefit will not be realized. We adjust the valuation allowance if, based on our evaluation, there is a change in the amount of deferred income tax assets that are deemed more-likely-than-not to be realized. The impact on deferred taxes of changes in tax rates and laws, if any, is applied to the years during which temporary differences are expected to be settled and reflected in the financial statements in the period enacted.
Reinsurance
Our insurance subsidiaries enter into reinsurance agreements with other companies in the normal course of business. For arrangements that meet the criteria to be accounted for as reinsurance, we present the amounts consistently and on a gross basis in our Consolidated Balance Sheets with the ceded reserves balance presented as a Reinsurance recoverable. Deferred gains will be included within Accounts payable and accrued expenses with the related accretion reflected within Life insurance premiums and other fees on the Consolidated Balance Sheets and Statements of Operations, respectively. Deferred costs will be included within the Prepaid expense and other assets with the related amortization reflected within Other operating expenses in the Consolidated Balance Sheets and Statements of Operations, respectively. Premium and expense are recorded net of reinsurance ceded.
For arrangements in which the underlying contracts do not included insurance risk or do not meet the criteria to be accounted for as reinsurance, the arrangements are accounted for as separate investment contracts or deposit accounting is applied, respectively. In both cases, we calculate a deposit asset based on the actual and expected cash flows associated to each arrangement and use the interest method to accrete the deposit asset using an effective yield based on changes in actual and expected cash flows. The deposit asset is presented within Reinsurance recoverable on the Consolidated Balance Sheets and the accretion of the deposit asset is presented within Benefits and other changes in policy reserves on the accompanying Consolidated Statements of Operations.
For certain arrangements that are not accounted for as reinsurance, the right of offset is applied when there is a right of offset explicit in the reinsurance agreement. This results in the assets and liabilities associated with the arrangement presented on a net basis in the accompanying Consolidated Balance Sheets, and the related net investment income, investment gain/loss, and change in deposit asset are presented net on the accompanying Consolidated Statements of Operations. F&G intends to apply the right of offset where there is a right of offset explicit in the reinsurance agreement.
Revenue Recognition
Life insurance premiums and other fees primarily reflect premiums on life-contingent PRTs and traditional life insurance products, which are recognized as revenue when due from the policyholder, as well as policy rider fees primarily on FIA policies, the cost of insurance on IUL policies and surrender charges assessed against policy withdrawals in excess of the policyholder's allowable penalty-free amounts. We have ceded the majority of our traditional life business to unaffiliated third-party reinsurers. While the base contract has been reinsured, we continue to retain the return of premium rider. Other income related to riders is earned when elected by the policyholder. Surrender charges are earned when a policyholder withdraws funds from the contract early or cancels the contract.
Premium and annuity deposit collections for FIA, fixed rate annuities, immediate annuities and PRT without life contingencies, and amounts received for funding agreements are reported in the financial statements as deposit liabilities (i.e., Contractholder Funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities include net investment income, surrender, cost of insurance and other charges deducted from Contractholder Funds, and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the hedging cost of providing index credits to the policyholder), amortization of VOBA, DAC and DSI, other operating costs and expenses, and income taxes.
Premiums, annuity deposits (net of reinsurance and reinsurance recoverable) and funding agreements, which are not included as revenues in the accompanying Consolidated Statements of Operations, collected by product type were as follows:
| | | | | | | | | | | | | | | | | | | | |
| | Year Ended December 31, |
| | 2023 | | 2022 | | 2021 |
| | | | | | |
Product Type | | | | | | |
Fixed indexed annuities | | $ | 4,738 | | | $ | 4,483 | | | $ | 4,420 | |
Fixed rate annuities | | 1,147 | | | 1,522 | | | 878 | |
Funding agreements (FABN/FHLB) | | 1,256 | | | 1,891 | | | 2,658 | |
Life insurance and other (a) | | 646 | | | 446 | | | 329 | |
Total | | $ | 7,787 | | | $ | 8,342 | | | $ | 8,285 | |
(a)Life insurance and other primarily includes indexed universal life insurance.
Interest and investment income consist primarily of interest payments received on fixed maturity security holdings and dividends received on preferred and equity security holdings along with the investment income of limited partnerships and is recognized when earned.
Benefits and Other Changes in Policy Reserves
Benefit expenses for deferred annuities (FIAs and fixed rate annuities), IUL policies and funding agreements include interest credited, fixed interest, floating interest (specific to funding agreements) and/or index credits (specific to FIA and IUL policies), to contractholder account balances. Benefit claims in excess of contract account balances, net of reinsurance recoveries, are charged to expense in the period that they are earned by the policyholder based on their selected strategy or strategies. Other changes in policy reserves include the change in the fair value of the FIA embedded derivative.
Other changes in policy reserves also include the change in reserves for life insurance products. For traditional life and life-contingent immediate annuities (which includes PRT annuities with life contingencies), policy benefit claims are charged to expense in the period that the claims are incurred, net of reinsurance recoveries. Remeasurement gains or losses on the related FPB and DPL balances are presented parenthetically within Benefits and other changes in policy reserves in the accompanying Consolidated Statements of Operations.
Stock-Based Compensation Plans
We account for stock-based compensation plans using the fair value method. Using the fair value method of accounting, compensation cost is measured based on the fair value of the award at the grant date using quoted market prices and recognized over the service period. Refer to Note R - Employee Benefit Plans for more details regarding our stock compensation plans.
Earnings Per Share
Basic earnings per share (“EPS”), as presented on the Consolidated Statements of Operations, is computed by dividing net earnings from continuing operations and separately from discontinued operations by the weighted average number of common shares outstanding during the period. In periods when earnings are positive, diluted earnings per share is calculated by dividing net earnings from continuing operations and separately from discontinued operations by the weighted average number of common shares outstanding plus the impact of assumed conversions of potentially dilutive securities. For periods when we recognize a net loss, diluted earnings per share is equal to basic earnings per share as the impact of assumed conversions of potentially dilutive securities is considered to be antidilutive.
Refer to Note S - Earnings Per Share for more details over our calculation of EPS.
Comprehensive Earnings (Loss)
We report Comprehensive earnings (loss) in accordance with GAAP on the Consolidated Statements of Comprehensive Earnings (Loss). Total comprehensive earnings are defined as all changes in shareholders' equity during a period, other than those resulting from investments by and distributions to shareholders. While total comprehensive earnings is the activity in a period and is largely driven by net earnings in that period, accumulated other comprehensive earnings or loss represents the cumulative balance of other comprehensive earnings, net of tax, as of the balance sheet date. Amounts reclassified to net earnings relate to the realized gains (losses) on our investments and other financial instruments, excluding investments in unconsolidated affiliates, and are included in Recognized gains and losses, net on the Consolidated Statements of Operations.
Management Estimates
The preparation of these Consolidated Financial Statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the Consolidated Financial Statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Periodically, and at least annually, typically in the third quarter, we review the assumptions associated with reserves for policy benefits and product guarantees. During the third quarter of 2023 and for the year ended December 31, 2023, based on increases in interest rates and pricing changes, we updated certain FIA assumptions to calculate the fair value of the embedded derivative component within the contractholder funds and also aligned reserves to actual policyholder behavior. These changes resulted in an increase in total benefits and other changes in policy reserves of approximately $73 million.
During the fourth quarter of 2022, based on increases in interest rates and pricing changes during 2022, we updated certain FIA assumptions used to calculate the fair value of the embedded derivative component within contractholder funds and the fair value of market risk benefits. These changes, taken together, resulted in an increase in contractholder funds and market risk benefits of $99 million.
During the third quarter of 2021, we implemented a new actuarial valuation system. As a result, our third quarter 2021 assumption updates include model refinements and assumption updates resulting from the
implementation. The system implementation and assumption review process that occurred in the third quarter of 2021, included refinements in the calculation of the fair value of the embedded derivative component of our FIAs within contractholder funds and updates to the surrender rates, GMWB utilization and earned rate assumptions to reflect our current and expected future experience. These changes, taken together, resulted in a decrease in contractholder funds and future policy reserves of $435 million. The majority of the changes represent one-time adjustments in the third quarter of 2021 related to the cumulative impact of the system implementation and are not expected to re-occur in the future.
Note B - Fair Value of Financial Instruments
Our measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include our own credit risk. We estimate an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). We categorize financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows:
Level 1 – Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date.
Level 2 – Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves.
Level 3 – Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances.
NAV - Certain equity investments are measured using NAV as a practical expedient in determining fair value. In addition, our unconsolidated affiliates (primarily limited partnerships) are primarily accounted for using the equity method of accounting with fair value determined using NAV as a practical expedient. Our carrying value reflects our pro rata ownership percentage as indicated by NAV in the unconsolidated affiliate’s financial statements, which we may adjust if we determine NAV is not calculated consistent with investment company fair value principles. The underlying investments of the unconsolidated affiliates may have significant unobservable inputs, which may include, but are not limited to, comparable multiples and weighted average cost of capital rates applied in valuation models or a discounted cash flow model. Additionally, management meets quarterly with the general partner to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter valuation and investment income.
In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. Our assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.
When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources.
The carrying amounts and estimated fair values of our financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, was summarized according to the hierarchy previously described, as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 |
| Level 1 | | Level 2 | | Level 3 | | NAV | | Fair Value | | Carrying Amount |
Assets | | | | | | | | | | | |
Cash and cash equivalents | $ | 1,563 | | | $ | — | | | $ | — | | | $ | — | | | $ | 1,563 | | | $ | 1,563 | |
Fixed maturity securities, available-for-sale: | | | | | | | | | | | |
Asset-backed securities | — | | | 7,212 | | | 7,122 | | | — | | | 14,334 | | | 14,334 | |
Commercial mortgage-backed securities | — | | | 4,392 | | | 18 | | | — | | | 4,410 | | | 4,410 | |
Corporates | — | | | 14,609 | | | 1,970 | | | — | | | 16,579 | | | 16,579 | |
Hybrids | 95 | | | 523 | | | — | | | — | | | 618 | | | 618 | |
Municipals | — | | | 1,518 | | | 49 | | | — | | | 1,567 | | | 1,567 | |
Residential mortgage-backed securities | — | | | 2,421 | | | 3 | | | — | | | 2,424 | | | 2,424 | |
U.S. Government | 261 | | | — | | | — | | | — | | | 261 | | | 261 | |
Foreign Governments | — | | | 210 | | | 16 | | | — | | | 226 | | | 226 | |
Preferred securities | 152 | | | 310 | | | 7 | | | — | | | 469 | | | 469 | |
Equity securities | 78 | | | — | | | — | | | 59 | | | 137 | | | 137 | |
Derivative investments | — | | | 740 | | | 57 | | | — | | | 797 | | | 797 | |
Investment in unconsolidated affiliates | — | | | — | | | 285 | | | — | | | 285 | | | 285 | |
Short term investments | 1,444 | | | 8 | | | — | | | — | | | 1,452 | | | 1,452 | |
Reinsurance related embedded derivative, included in other assets | — | | | 152 | | | — | | | — | | | 152 | | | 152 | |
Other long-term investments | — | | | — | | | 37 | | | | | 37 | | | 37 | |
Market risk benefits asset | — | | | — | | | 88 | | | — | | | 88 | | | 88 | |
Total financial assets at fair value | $ | 3,593 | | | $ | 32,095 | | | $ | 9,652 | | | $ | 59 | | | $ | 45,399 | | | $ | 45,399 | |
Liabilities | | | | | | | | | | | |
| | | | | | | | | | | |
Derivatives: | | | | | | | | | | | |
FIA/ IUL embedded derivatives, included in contractholder funds | $ | — | | | $ | — | | | $ | 4,258 | | | $ | — | | | $ | 4,258 | | | $ | 4,258 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Market risk benefits liability | — | | | — | | | 403 | | | — | | | 403 | | | 403 | |
Total financial liabilities at fair value | $ | — | | | $ | — | | | $ | 4,661 | | | $ | — | | | $ | 4,661 | | | $ | 4,661 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| Level 1 | | Level 2 | | Level 3 | | NAV | | Fair Value | | Carrying Amount |
Assets | | | | | | | | | | | |
Cash and cash equivalents | $ | 960 | | | $ | — | | | $ | — | | | $ | — | | | $ | 960 | | | $ | 960 | |
Fixed maturity securities, available-for-sale: | | | | | | | | | | | |
Asset-backed securities | — | | | 5,204 | | | 6,263 | | | — | | | 11,467 | | | 11,467 | |
Commercial mortgage-backed securities | — | | | 2,999 | | | 37 | | | — | | | 3,036 | | | 3,036 | |
Corporates | — | | | 11,472 | | | 1,427 | | | — | | | 12,899 | | | 12,899 | |
Hybrids | 93 | | | 612 | | | — | | | — | | | 705 | | | 705 | |
Municipals | — | | | 1,381 | | | 29 | | | — | | | 1,410 | | | 1,410 | |
Residential mortgage-backed securities | — | | | 1,219 | | | 302 | | | — | | | 1,521 | | | 1,521 | |
U.S. Government | 32 | | | — | | | — | | | — | | | 32 | | | 32 | |
Foreign Governments | — | | | 132 | | | 16 | | | — | | | 148 | | | 148 | |
Preferred securities | 248 | | | 474 | | | — | | | — | | | 722 | | | 722 | |
Equity securities | 54 | | | — | | | — | | | 47 | | | 101 | | | 101 | |
| | | | | | | | | | | |
Derivative investments | — | | | 244 | | | — | | | — | | | 244 | | | 244 | |
Investment in unconsolidated affiliates | — | | | — | | | 23 | | | — | | | 23 | | | 23 | |
Short-term investments | 1,556 | | | — | | | — | | | — | | | 1,556 | | | 1,556 | |
Reinsurance related embedded derivative, included in other assets | — | | | 279 | | | — | | | — | | | 279 | | | 279 | |
Other long-term investments | — | | | — | | | 48 | | | — | | | 48 | | | 48 | |
Market risk benefits asset | — | | | — | | | 117 | | | — | | | 117 | | | 117 | |
Total financial assets at fair value | $ | 2,943 | | | $ | 24,016 | | | $ | 8,262 | | | $ | 47 | | | $ | 35,268 | | | $ | 35,268 | |
Liabilities | | | | | | | | | | | |
| | | | | | | | | | | |
Derivatives: | | | | | | | | | | | |
FIA/ IUL embedded derivatives, included in contractholder funds | $ | — | | | $ | — | | | $ | 3,115 | | | $ | — | | | $ | 3,115 | | | $ | 3,115 | |
Market risk benefits liability | — | | | — | | | 282 | | | — | | | 282 | | | 282 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Total financial liabilities at fair value | $ | — | | | $ | — | | | $ | 3,397 | | | $ | — | | | $ | 3,397 | | | $ | 3,397 | |
Valuation Methodologies
Cash and Cash Equivalents
The carrying amounts reported in the Consolidated Balance Sheets for these instruments approximate fair value.
Fixed Maturity, Preferred and Equity Securities
We measure the fair value of our securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity, preferred or equity security, and we will then consistently apply the valuation methodology to measure the security’s fair value. Our fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. We use observable and unobservable inputs in our valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data including market research publications. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met.
For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. We believe
the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices.
We analyze the third-party valuation methodologies and related inputs to perform assessments to determine the appropriate level within the fair value hierarchy. However, we did not adjust prices received from third parties as of December 31, 2023 or 2022.
Certain equity investments are measured using NAV as a practical expedient in determining fair value.
Derivative Financial Instruments
Our call options, futures contracts, and interest rate swaps can either be exchange traded or over the counter. Exchange traded derivatives typically fall within Level 1 of the fair value hierarchy if there is active trading activity. Two methods are used to value over-the-counter derivatives. When required inputs are available, certain derivatives are valued using valuation pricing models, which represent what we would expect to receive or pay at the balance sheet date if we cancelled or exercised the derivative, or entered into offsetting positions. Valuation models require a variety of inputs, which include the use of market-observable inputs, including interest rate, yield curve volatilities, and other factors. These over-the-counter derivatives are typically classified within Level 2 of the fair value hierarchy as the majority trade in liquid markets, we can verify model inputs and model selection does not involve significant management judgment. When inputs aren’t available for valuation models, certain over-the-counter derivatives are valued using independent broker quotes, which are based on unobservable market data and classified within Level 3.
The fair value measurement of the FIA/IUL embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs using the option budget method. The market observable inputs are the market value of option and treasury rates. The significant unobservable inputs are the budgeted option cost (i.e., the expected cost to purchase call options in future periods to fund the equity indexed linked feature), surrender rates, mortality multiplier and non-performance spread. The mortality multiplier at December 31, 2023 and 2022 was applied to the 2012 Individual Annuity mortality tables. Increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Increases or decreases in treasury rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input. Also refer to Management's Estimates in Note A - Business and Summary of Significant Accounting Policies regarding certain assumption updates.
The fair value of the reinsurance-related embedded derivatives in our funds withheld reinsurance agreements are estimated based upon the fair value of the assets supporting the funds withheld from reinsurance liabilities. The fair value of the assets is based on a quoted market price of similar assets (Level 2), and therefore the fair value of the embedded derivative is based on market-observable inputs and classified as Level 2.
Investments in Unconsolidated affiliates
We have elected the fair value option for certain investments in unconsolidated affiliates as we believe this better aligns them with other investments in unconsolidated affiliates that are measured using NAV as a practical expedient in determining fair value. Investments measured using the fair value option are included in Level 3 and the fair value of these investments are determined using a multiple of the affiliates’ EBITDA, which is derived from market analysis of transactions involving comparable companies. The EBITDA used in this calculation is based on the affiliates’ financial information. The inputs are usually considered unobservable, as not all market participants have access to this data.
Short-term Investments
The carrying amounts reported in the Consolidated Balance Sheets for these instruments approximate fair value.
Other Long-term Investments
We hold a fund-linked note, which provides for an additional payment at maturity based on the value of an embedded derivative based on the actual return of a dedicated return fund. Fair value of the embedded derivative is based on an unobservable input, the NAV of the fund at the balance sheet date. The embedded derivative is similar to a call option on the net asset value of the fund with a strike price of zero since we will not be required to make any additional payments at maturity of the fund-linked note in order to receive the NAV of the fund on the maturity date. A Black-Scholes model determines the NAV of the fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model. The NAV of the fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the fund. As the value of the fund increases or decreases, the fair value of the embedded derivative will increase or decrease. See further discussion on the available-for-sale embedded derivative in Note D - Derivative Financial Instruments.
The fair value of the credit-linked note is based on a weighted average of a broker quote and a discounted cash flow analysis. The discounted cash flow approach is based on the expected portfolio cash flows and amortization schedule reflecting investment expectations, adjusted for assumptions on the portfolio's default and recovery rates, and the note's discount rate. The fair value of the note is provided by the fund manager at the end of each quarter.
Market Risk Benefits
MRBs are measured at fair value using an attributed fee measurement approach where attributed fees are explicit rider charges collectible from the policyholder used to cover the excess benefits. The fair value is calculated using a risk neutral valuation method and is based on current net amounts at risk, market data, internal and industry experience, and other factors. The balances are computed using assumptions including mortality, full and partial surrender, rider benefit utilization, risk-free rates including non-performance spread and risk margin, market value of options and economic scenarios. Policyholder behavior assumptions are reviewed at least annually, typically in the third quarter, for any revisions. See further discussion on MRBs in Note G - Market Risk Benefits.
Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of December 31, 2023 and 2022, excluding assets and liabilities for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services) are as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Fair Value at | | Valuation Technique | | Unobservable Input(s) | | Range (Weighted average) |
| December 31, 2023 | | | | December 31, 2023 |
Assets | | | | | | | |
| | | | | | | |
| | | | | | | |
Asset-backed securities | 57 | | | Third-Party Valuation | | Discount Rate | | 5.09% - 6.95% (6.00%) |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Corporates | 787 | | | Third-Party Valuation | | Discount Rate | | 0.00% - 12.87% (6.91%) |
Municipals | 32 | | | Third-Party Valuation | | Discount Rate | | 6.25% - 6.25% (6.25%) |
| | | | | | | |
| | | | | | | |
Residential mortgage-backed securities | 3 | | | Third-Party Valuation | | Discount Rate | | 5.46% - 5.46% (5.46%) |
Foreign governments | 16 | | | Third-Party Valuation | | Discount Rate | | 6.94% - 7.68% (7.45%) |
Investment in unconsolidated affiliates | 285 | | | Market Comparable Company Analysis | | EBITDA Multiple | | 4.4x - 31.8x (23.2x) |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Other long-term investments: | | | | | | | |
| | | | | | | |
| | | | | | | |
Available-for-sale embedded derivative | 28 | | | Black Scholes Model | | Market Value of Fund | | 100.00% |
| | | | | | | |
| | | | | | | |
Market risk benefits asset | 88 | | Discounted Cash Flow | | Mortality | | 100.00% - 100.00% (100.00%) |
| | | | | Surrender Rates | | 0.25% - 10.00% (5.22%) |
| | | | | Partial Withdrawal Rates | | 0.00% - 23.26% (2.50%) |
| | | | | Non-Performance Spread | | 0.38% - 1.10% (0.96%) |
| | | | | GMWB Utilization | | 50.00% - 60.00% (50.81%) |
Total financial assets at fair value (a) | $ | 1,296 | | | | | | | |
| | | | | | | |
Liabilities | | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Derivatives: | | | | | | | |
FIA/IUL embedded derivatives, included in contractholder funds | $ | 4,258 | | | Discounted Cash Flow | | Market Value of Option | | 0.00% - 18.93% (2.63%) |
| | | | | Swap Rates | | 3.84% - 5.26% (4.55%) |
| | | | | Mortality Multiplier | | 100.00% - 100.00% (100.00%) |
| | | | | Surrender Rates | | 0.25% - 70.00% (6.83%) |
| | | | | Partial Withdrawals | | 2.00% - 34.48% (2.74%) |
| | | | | Non-Performance Spread | | 0.38% - 1.10% (0.96%) |
| | | | | Option cost | | 0.07% - 5.48% (2.38%) |
Market risk benefits liability | 403 | | | Discounted Cash Flow | | Mortality | | 100.00% - 100.00% (100.00%) |
| | | | | Surrender Rates | | 0.25% - 10.00% (5.22%) |
| | | | | Partial Withdrawal Rates | | 0.00% - 23.26% (2.50%) |
| | | | | Non-Performance Spread | | 0.38% - 1.10% (0.96%) |
| | | | | GMWB Utilization | | 50.00% - 60.00% (50.81%) |
Total financial liabilities at fair value | $ | 4,661 | | | | | | | |
(a) Excludes $8,356 million of assets for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services)
| | | | | | | | | | | | | | | | | | | | | | | |
| Fair Value at | | Valuation Technique | | Unobservable Input(s) | | Range (Weighted average) |
| December 31, 2022 | | | | December 31, 2022 |
Assets | | | | | | | |
| | | | | | | |
Asset-backed securities | 91 | | | Third-Party Valuation | | Discount Rate | | 5.23% - 8.98% (6.07%) |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Corporates | 796 | | | Third-Party Valuation | | Discount Rate | | 4.75% - 12.45% (7.22%) |
| | | | | | | |
Municipals | 29 | | | Third-Party Valuation | | Discount Rate | | 7.62% - 7.62% (7.62%) |
| | | | | | | |
| | | | | | | |
Foreign governments | 16 | | | Third-Party Valuation | | Discount Rate | | 5.99% - 6.28% (6.19%) |
Investment in unconsolidated affiliates | 23 | | | Market Comparable Company Analysis | | EBITDA Multiple | | 5x - 5.5x |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Other long-term investments: | | | | | | | |
Available-for-sale embedded derivative | 23 | | | Black Scholes Model | | Market Value of Fund | | 100.00% |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Market risk benefits asset | 117 | | | Discounted Cash Flow | | Mortality | | 100.00% - 100.00% (100.00%) |
| | | | | Surrender Rates | | 0.25% - 10.00% (4.69%) |
| | | | | Partial Withdrawal Rates | | 2.00% - 21.74% (2.49%) |
| | | | | Non-Performance Spread | | 0.48% - 1.44% (1.30%) |
| | | | | GMWB Utilization | | 50.00% - 60.00% (50.94%) |
Total financial assets at fair value (a) | $ | 1,095 | | | | | | | |
Liabilities | | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
Derivatives: | | | | | | | |
FIA/ IUL embedded derivatives, included in contractholder funds | $ | 3,115 | | | Discounted Cash Flow | | Market Value of Option | | 0.00% - 23.90% (0.87%) |
| | | | | Swap Rates | | 3.88% - 4.73% (4.31%) |
| | | | | Mortality Multiplier | | 100.00% - 100.00% (100.00%) |
| | | | | Surrender Rates | | 0.25% - 70.00% (6.57%) |
| | | | | Partial Withdrawals | | 2.00% - 29.41% (2.73%) |
| | | | | Non-Performance Spread | | 0.48% - 1.44% (1.30%) |
| | | | | Option Cost | | 0.07% - 4.97% (1.89%) |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | |
Market risk benefits liability | 282 | | | Discounted Cash Flow | | Mortality | | 100.00% - 100.00% (100.00%) |
| | | | | Surrender Rates | | 0.25% - 10.00% (4.69%) |
| | | | | Partial Withdrawal Rates | | 2.00% - 21.74% (2.49%) |
| | | | | Non-Performance Spread | | 0.48% - 1.44% (1.30%) |
| | | | | | | |
| | | | | | | |
| | | | | GMWB Utilization | | 50.00% - 60.00% (50.94%) |
Total financial liabilities at fair value | $ | 3,397 | | | | | | | |
(a) Excludes $7,167 million of assets for which significant quantitative unobservable inputs are not developed internally and not readily available to the Company (primarily those valued using broker quotes and certain third-party pricing services)
The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended December 31, 2023 and 2022, respectively (in millions). The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year ended December 31, 2023 |
| Balance at Beginning of Period | | Total Gains (Losses) | | Purchases | | Sales | | Settlements | | Net transfer In (Out) of Level 3 (a) | | Balance at End of Period | | Change in Unrealized Included in OCI |
| | Included in Earnings | | Included in AOCI | | | | | | |
Assets | | | | | | | | | | | | | | | | | |
Fixed maturity securities available-for-sale: | | | | | | | | | | | | | | | | | |
Asset-backed securities | $ | 6,263 | | | $ | (53) | | | $ | 186 | | | $ | 1,830 | | | $ | (125) | | | $ | (738) | | | $ | (241) | | | $ | 7,122 | | | $ | 185 | |
Commercial mortgage-backed securities | 37 | | | — | | | 2 | | | 22 | | | — | | | — | | | (43) | | | 18 | | | 2 | |
Corporates | 1,427 | | | (2) | | | (21) | | | 652 | | | — | | | (94) | | | 8 | | | 1,970 | | | (20) | |
| | | | | | | | | | | | | | | | | |
Municipals | 29 | | | — | | | 20 | | | — | | | — | | | — | | | — | | | 49 | | | 20 | |
Residential mortgage-backed securities | 302 | | | 1 | | | 7 | | | 32 | | | — | | | (9) | | | (330) | | | 3 | | | 7 | |
Foreign Governments | 16 | | | — | | | — | | | — | | | — | | | — | | | — | | | 16 | | | — | |
Short-term | — | | | — | | | — | | | 204 | | | (19) | | | (185) | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Preferred securities | — | | | — | | | 1 | | | — | | | — | | | — | | | 6 | | | 7 | | | 1 | |
Derivative instruments | — | | | 57 | | | — | | | — | | | — | | | — | | | — | | | 57 | | | — | |
Other long-term investments: | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Available-for-sale embedded derivative | 23 | | | — | | | 4 | | | — | | | — | | | — | | | — | | | 27 | | | 4 | |
Investment in affiliate | 23 | | | 13 | | | — | | | 249 | | | — | | | — | | | — | | | 285 | | | — | |
| | | | | | | | | | | | | | | | | |
Credit linked note | 15 | | | — | | | — | | | — | | | — | | | (5) | | | — | | | 10 | | | — | |
Secured borrowing receivable | 10 | | | — | | | — | | | — | | | — | | | (10) | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Subtotal assets at Level 3 fair value | $ | 8,145 | | | $ | 16 | | | $ | 199 | | | $ | 2,989 | | | $ | (144) | | | $ | (1,041) | | | $ | (600) | | | $ | 9,564 | | | $ | 199 | |
Market risk benefits asset (a) | 117 | | | | | | | | | | | | | | | 88 | | 106 | | |
Total assets at Level 3 fair value | $ | 8,262 | | | | | | | | | | | | | | | $ | 9,652 | | | |
Liabilities | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
FIA/IUL embedded derivatives, included in contractholder funds | 3,115 | | | 257 | | | — | | | 1,049 | | | — | | | (163) | | | — | | | 4,258 | | | — | |
| | | | | | | | | | | | | | | | | |
Subtotal liabilities at Level 3 fair value | $ | 3,115 | | | $ | 257 | | | $ | — | | | $ | 1,049 | | | $ | — | | | $ | (163) | | | $ | — | | | $ | 4,258 | | | $ | — | |
Market risk benefits liability (a) | 282 | | | | | | | | | | | | | | | 403 | | | |
Total liabilities at Level 3 fair value | $ | 3,397 | | | | | | | | | | | | | | | $ | 4,661 | | | |
(a)Refer to Note G - Market Risk Benefits for roll forward activity of the net Market Risk Benefits Asset and Liability.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year ended December 31, 2022 |
| Balance at Beginning of Period | | Total Gains (Losses) | | Purchases | | Sales | | Settlements | | Net transfer In (Out) of Level 3 (a) | | Balance at End of Period | | Change in Unrealized Included in OCI |
| | Included in Earnings | | Included in AOCI | | | | | | |
Assets | | | | | | | | | | | | | | | | | |
Fixed maturity securities available-for-sale: | | | | | | | | | | | | | | | | | |
Asset-backed securities | $ | 3,959 | | | $ | (6) | | | $ | (393) | | | $ | 3,269 | | | $ | (39) | | | $ | (541) | | | $ | 14 | | | $ | 6,263 | | | $ | (426) | |
Commercial mortgage-backed securities | 35 | | | — | | | (5) | | | — | | | — | | | — | | | 7 | | | 37 | | (4) | |
Corporates | 1,121 | | | 1 | | | (187) | | | 710 | | | (20) | | | (215) | | | 17 | | | 1,427 | | (188) | |
| | | | | | | | | | | | | | | | | |
Municipals | 43 | | | — | | | (14) | | | — | | | — | | | — | | | — | | | 29 | | (13) | |
Residential mortgage-backed securities | — | | | — | | | — | | | 316 | | | — | | | — | | | (14) | | | 302 | | — | |
Foreign Governments | 18 | | | — | | | (2) | | | — | | | — | | | — | | | — | | | 16 | | (1) | |
Investment in unconsolidated affiliates | 21 | | | — | | | 2 | | | — | | | — | | | — | | | — | | | 23 | | 2 | |
Short-term | 321 | | | — | | | (1) | | | 20 | | | — | | | — | | | (340) | | | — | | | (1) | |
Preferred securities | 1 | | | — | | | (1) | | | — | | | — | | | — | | | — | | | — | | | (1) | |
| | | | | | | | | | | | | | | | | |
Other long-term investments: | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Available-for-sale embedded derivative | 34 | | | (11) | | | — | | | — | | | — | | | — | | | — | | | 23 | | — | |
| | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
Credit linked note | 23 | | | (1) | | | (1) | | | — | | | (2) | | | (4) | | | — | | | 15 | | — | |
Secured borrowing receivable | — | | | — | | | — | | | — | | | — | | | — | | | 10 | | | 10 | | | |
| | | | | | | | | | | | | | | | | |
Subtotal assets at Level 3 fair value | $ | 5,576 | | | $ | (17) | | | $ | (602) | | | $ | 4,315 | | | $ | (61) | | | $ | (760) | | | $ | (306) | | | $ | 8,145 | | | $ | (632) | |
Market risk benefits asset (a) | 41 | | | | | | | | | | | | | | | 117 | | | |
Total assets at Level 3 fair value | $ | 5,617 | | | | | | | | | | | | | | | $ | 8,262 | | | |
Liabilities | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | |
FIA/IUL embedded derivatives, included in contractholder funds | 3,883 | | | (1,382) | | | — | | | 768 | | | — | | | (154) | | | — | | | 3,115 | | | — | |
| | | | | | | | | | | | | | | | | |
Subtotal liabilities at Level 3 fair value | $ | 3,883 | | | $ | (1,382) | | | $ | — | | | $ | 768 | | | $ | — | | | $ | (154) | | | $ | — | | | $ | 3,115 | | | $ | — | |
Market risk benefits liability (a) | 469 | | | | | | | | | | | | | | | 282 | | | |
Total liabilities at Level 3 fair value | $ | 4,352 | | | | | | | | | | | | | | | $ | 3,397 | | | |
(a) Refer to Note G - Market Risk Benefits for roll forward activity of the net Market Risk Benefits Asset and Liability.
Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value
The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments.
Mortgage Loans
The fair value of mortgage loans is established using a discounted cash flow method based on internal credit rating, maturity and future income. This yield-based approach is sourced from our third-party vendor. The internal ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy.
Investments in Unconsolidated affiliates
The fair value of investments in unconsolidated affiliates is primarily determined using NAV as a practical expedient. As discussed in Note A - Business and Summary of Significant Accounting Policies, recognition of income and adjustments to the carrying amount are delayed due to the availability of the related financial statements, which are obtained from the general partner generally on a one to three-month delay.
Policy Loans (included within Other long-term investments)
Fair values for policy loans are estimated from a discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk. Loans with similar characteristics are aggregated for purposes of the calculations, policy loans are classified as Level 3 in the fair value hierarchy.
Company Owned Life Insurance
Company owned life insurance (“COLI”) is a life insurance program used to finance certain employee benefit expenses. The fair value of COLI is based on net realizable value, which is generally cash surrender value. COLI is classified as Level 3 within the fair value hierarchy.
Other Invested Assets (included within Other long-term investments)
The fair value of bank loans is estimated using a discounted cash flow method with the discount rate based on weighted average cost of capital (“WACC”). This yield-based approach is sourced from a third-party vendor and the WACC establishes a market participant discount rate by determining the hypothetical capital structure for the asset should it be underwritten as of each period end. Other invested assets are classified as Level 3 within the fair value hierarchy.
Investment Contracts
Investment contracts include deferred annuities (FIAs and fixed rate annuities), IUL policies, funding agreements and PRT and immediate annuity contracts without life contingencies. The FIA/ IUL embedded derivatives, included in contractholder funds, are excluded as they are carried at fair value. The fair value of the deferred annuities (FIA and fixed rate annuities) and IUL contracts is based on their cash surrender value (i.e., the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of funding agreements and PRT and immediate annuity contracts without life contingencies is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value.
Other
Federal Home Loan Bank of Atlanta (“FHLB”) common stock, Accounts receivable and Notes receivable are carried at cost, which approximates fair value. The carrying amount of FHLB common stock represents the value it can be sold back to the FHLB and is classified as Level 2 within the hierarchy. Accounts receivable and Notes receivable are classified as Level 3 within the fair value hierarchy.
Debt
The fair value of the $345 million aggregate principal amount of its 7.95% F&G Notes, $500 million aggregate principal amount of its 7.40% F&G Notes and the $550 million aggregate principal amount of its 5.50% Senior Notes due 2025 (the “5.50% F&G Notes”) are based on quoted market prices of debt with similar credit risk and tenor. The inputs used to measure the fair value of these debts results in a Level 2 classification within the fair value hierarchy.
The carrying value of the revolving credit facility at December 31, 2023 and 2022 approximates fair value as the rates are comparable to those at which we could currently borrow under similar terms. As such, the fair value of the revolving credit facility was classified as a Level 2 measurement.
The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described (in millions).
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 |
| Level 1 | | Level 2 | | Level 3 | | NAV | | Total Estimated Fair Value | | Carrying Amount |
Assets | | | | | | | | | | | |
FHLB common stock | $ | — | | | $ | 138 | | | $ | — | | | $ | — | | | $ | 138 | | | $ | 138 | |
Commercial mortgage loans | — | | | — | | | 2,253 | | | — | | | 2,253 | | | 2,538 | |
Residential mortgage loans | — | | | — | | | 2,545 | | | — | | | 2,545 | | | 2,798 | |
Investments in unconsolidated affiliates | — | | | — | | | 7 | | | 2,779 | | | 2,786 | | | 2,786 | |
Policy loans | — | | | — | | | 71 | | | — | | | 71 | | | 71 | |
| | | | | | | | | | | |
Company-owned life insurance | — | | | — | | | 362 | | | — | | | 362 | | | 362 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Total | $ | — | | | $ | 138 | | | $ | 5,238 | | | $ | 2,779 | | | $ | 8,155 | | | $ | 8,693 | |
| | | | | | | | | | | |
Liabilities | | | | | | | | | | | |
Investment contracts, included in contractholder funds | — | | | — | | | 40,229 | | | — | | | 40,229 | | | 44,540 | |
Debt | | | 1,777 | | | — | | | — | | | 1,777 | | | 1,754 | |
| | | | | | | | | | | |
Total | $ | — | | | $ | 1,777 | | | $ | 40,229 | | | $ | — | | | $ | 42,006 | | | $ | 46,294 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| Level 1 | | Level 2 | | Level 3 | | NAV | | Total Estimated Fair Value | | Carrying Amount |
Assets | | | | | | | | | | | |
FHLB common stock | $ | — | | | $ | 99 | | | $ | — | | | $ | — | | | $ | 99 | | | $ | 99 | |
Commercial mortgage loans | — | | | — | | | 2,083 | | | — | | | 2,083 | | | 2,406 | |
Residential mortgage loans | — | | | — | | | 1,892 | | | — | | | 1,892 | | | 2,148 | |
Investments in unconsolidated affiliates | — | | | — | | | 5 | | | 2,427 | | | 2,432 | | | 2,432 | |
Policy loans | — | | | — | | | 52 | | | — | | | 52 | | | 52 | |
Other invested assets | — | | | — | | | 10 | | | — | | | 10 | | | 10 | |
Company-owned life insurance | — | | | — | | | 328 | | | — | | | 328 | | | 328 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Total | $ | — | | | $ | 99 | | | $ | 4,370 | | | $ | 2,427 | | | $ | 6,896 | | | $ | 7,475 | |
| | | | | | | | | | | |
Liabilities | | | | | | | | | | | |
Investment contracts, included in contractholder funds | — | | | — | | | 34,464 | | | — | | | 34,464 | | | 38,412 | |
Debt | — | | | 1,092 | | | — | | | — | | | 1,092 | | | 1,114 | |
| | | | | | | | | | | |
Total | $ | — | | | $ | 1,092 | | | $ | 34,464 | | | $ | — | | | $ | 35,556 | | | $ | 39,526 | |
For investments for which NAV is used, we do not have any significant restrictions in our ability to liquidate our positions in these investments, other than obtaining general partner approval, nor do we believe it is probable a price less than NAV would be received in the event of a liquidation.
We review the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. The transfers into and out of Level 3 were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value.
Note C - Investments
Our investments in fixed maturity securities have been designated as AFS and are carried at fair value, net of allowance for expected credit losses, with unrealized gains and losses included within AOCI, net of deferred income taxes. Our preferred and equity securities investments are carried at fair value with unrealized gains and losses included in net earnings. The Company’s consolidated investments are summarized as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 |
| Amortized Cost | | Allowance for Expected Credit Losses | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Carrying Value |
AFS securities | | | | | | | | | | | |
Asset-backed securities | $ | 14,623 | | | $ | (11) | | | $ | 191 | | | $ | (469) | | | $ | 14,334 | | | $ | 14,334 | |
Commercial mortgage-backed securities | 4,732 | | | (22) | | | 23 | | | (323) | | | 4,410 | | | 4,410 | |
Corporates | 18,780 | | | — | | | 178 | | | (2,379) | | | 16,579 | | | 16,579 | |
Hybrids | 668 | | | — | | | 3 | | | (53) | | | 618 | | | 618 | |
Municipals | 1,776 | | | — | | | 14 | | | (223) | | | 1,567 | | | 1,567 | |
Residential mortgage-backed securities | 2,501 | | | (2) | | | 29 | | | (104) | | | 2,424 | | | 2,424 | |
U.S. Government | 258 | | | — | | | 4 | | | (1) | | | 261 | | | 261 | |
Foreign Governments | 263 | | | — | | | 2 | | | (39) | | | 226 | | | 226 | |
Total AFS securities | $ | 43,601 | | | $ | (35) | | | $ | 444 | | | $ | (3,591) | | | $ | 40,419 | | | $ | 40,419 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| Amortized Cost | | Allowance for Expected Credit Losses | | Gross Unrealized Gains | | Gross Unrealized Losses | | Fair Value | | Carrying Value |
AFS securities | | | | | | | | | | | |
Asset-backed securities | $ | 12,209 | | | $ | (8) | | | $ | 36 | | | $ | (770) | | | $ | 11,467 | | | $ | 11,467 | |
Commercial mortgage-backed securities | 3,309 | | | (1) | | | 12 | | | (284) | | | 3,036 | | | 3,036 | |
Corporates | 15,879 | | | (15) | | | 30 | | | (2,995) | | | 12,899 | | | 12,899 | |
Hybrids | 781 | | | — | | | 8 | | | (84) | | | 705 | | | 705 | |
Municipals | 1,695 | | | — | | | 4 | | | (289) | | | 1,410 | | | 1,410 | |
Residential mortgage-backed securities | 1,631 | | | (7) | | | 6 | | | (109) | | | 1,521 | | | 1,521 | |
U.S. Government | 34 | | | — | | | — | | | (2) | | | 32 | | | 32 | |
Foreign Governments | 185 | | | — | | | — | | | (37) | | | 148 | | | 148 | |
Total AFS securities | $ | 35,723 | | | $ | (31) | | | $ | 96 | | | $ | (4,570) | | | $ | 31,218 | | | $ | 31,218 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
As of December 31, 2023 and 2022, the Company held $47 million and $27 million of investments that were non-income producing for a period greater than twelve months, respectively.
As of December 31, 2023 and 2022, the Company's accrued interest receivable balance was $469 million and $358 million, respectively. Accrued interest receivable is classified within Prepaid expenses and other assets within the Consolidated Balance Sheets.
In accordance with our FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to us for general purposes. The collateral investments had a fair value of $4,345 million and $3,387 million as of December 31, 2023 and 2022, respectively.
The amortized cost and fair value of fixed maturity securities by contractual maturities, as applicable, are shown below (in millions). Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations.
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 |
| Amortized Cost | | Fair Value | | Amortized Cost | | Fair Value |
Corporates, Non-structured Hybrids, Municipal and U.S. Government Securities: | | | | | | | |
Due in one year or less | $ | 383 | | | $ | 374 | | | $ | 124 | | | $ | 123 | |
Due after one year through five years | 3,207 | | | 3,129 | | | 2,193 | | | 2,059 | |
Due after five years through ten years | 2,822 | | | 2,680 | | | 1,840 | | | 1,633 | |
Due after ten years | 15,333 | | | 13,068 | | | 14,417 | | | 11,379 | |
Subtotal | 21,745 | | | 19,251 | | | 18,574 | | | 15,194 | |
Other securities, which provide for periodic payments: | | | | | | | |
Asset-backed securities | 14,623 | | | 14,334 | | | 12,209 | | | 11,467 | |
Commercial mortgage-backed securities | 4,732 | | | 4,410 | | | 3,309 | | | 3,036 | |
| | | | | | | |
Residential mortgage-backed securities | 2,501 | | | 2,424 | | | 1,631 | | | 1,521 | |
Subtotal | 21,856 | | | 21,168 | | | 17,149 | | | 16,024 | |
Total fixed maturity AFS securities | $ | 43,601 | | | $ | 40,419 | | | $ | 35,723 | | | $ | 31,218 | |
Allowance for Current Expected Credit Loss
We regularly review AFS securities for declines in fair value that we determine to be credit related. For our fixed maturity securities, we generally consider the following in determining whether our unrealized losses are credit related, and if so, the magnitude of the credit loss:
•The extent to which the fair value is less than the amortized cost basis;
•The reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening);
•The financial condition of and near-term prospects of the issuer (including issuer's current credit rating and the probability of full recovery of principal based upon the issuer's financial strength);
•Current delinquencies and nonperforming assets of underlying collateral;
•Expected future default rates;
•Collateral value by vintage, geographic region, industry concentration or property type;
•Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and
•Contractual and regulatory cash obligations and the issuer's plans to meet such obligations.
We recognize an allowance for current expected credit losses on fixed maturity securities in an unrealized loss position when it is determined, using the factors discussed above, a component of the unrealized loss is related to credit. We measure the credit loss using a discounted cash flow model that utilizes the single best estimate cash flow and the recognized credit loss is limited to the total unrealized loss on the security (i.e., the fair value floor). Cash flows are discounted using the implicit yield of bonds at their time of purchase and the current book yield for asset and mortgage backed securities as well as variable rate securities. We recognize the expected credit losses in Recognized gains and losses, net in the Consolidated Statements of Operations, with an offset for the amount of non-credit impairments recognized in AOCI. We do not measure a credit loss allowance on accrued investment income because we write-off accrued interest through Interest and investment income when collectability concerns arise.
We consider the following in determining whether write-offs of a security’s amortized cost are necessary:
•We believe amounts related to securities have become uncollectible;
•We intend to sell a security; or
•It is more likely than not that we will be required to sell a security prior to recovery.
If we intend to sell a fixed maturity security or it is more likely than not that we will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, we will write down the security to current fair value, with a corresponding charge, net of any amount previously recognized as an allowance for expected credit loss, to Recognized gains and losses, net in the accompanying Consolidated Statements of Operations. If we do not intend to sell a fixed maturity security or it is more likely than not that we will not be required to sell a fixed maturity security before recovery of its amortized cost basis but believe amounts related to a security are uncollectible, an impairment is deemed to have occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge, net of any amount previously recognized as an allowance for expected credit loss, to Recognized gains and losses, net in the accompanying Consolidated Statements of Operations. The remainder of unrealized loss is held in other comprehensive income in the accompanying Consolidated Statements of Equity.
The activity in the allowance for expected credit losses of AFS securities aggregated by investment category was as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year ended December 31, 2023 |
| | | | | | | | | | | | | | | | | | | | | | |
| | | Additions | | | | | Reductions | | | | | | | | | | |
| Balance at Beginning of Period | | For credit losses on securities for which losses were not previously recorded | | For initial credit losses on purchased securities accounted for as PCD financial assets (a) | | (Additions) reductions in allowance recorded on previously impaired securities | | | For securities sold during the period | | For securities intended/required to be sold prior to recovery of amortized cost basis | | Write offs charged against the allowance | | Recoveries of amounts previously written off | | | | | | Balance at End of Period |
AFS securities | | | | | | | | | | | | | | | | | | | | | | |
Asset-backed securities | $ | (8) | | | $ | (18) | | | $ | — | | | $ | 15 | | | | $ | — | | | $ | — | | | $ | — | | | — | | | | | | | $ | (11) | |
Commercial mortgage-backed securities | (1) | | | (22) | | | — | | | 1 | | | | — | | | — | | | — | | | — | | | | | | | (22) | |
Corporates | (15) | | | — | | | — | | | — | | | | 15 | | | — | | | — | | | — | | | | | | | — | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Residential mortgage-backed securities | (7) | | | (7) | | | — | | | 12 | | | | — | | | — | | | — | | | — | | | | | | | (2) | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Total AFS securities | $ | (31) | | | $ | (47) | | | $ | — | | | $ | 28 | | | | $ | 15 | | | $ | — | | | $ | — | | | $ | — | | | | | | | $ | (35) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year ended December 31, 2022 |
| | | | | | | | | | | | | | | | | | | | | | |
| | | Additions | | | | | Reductions | | | | | | | | | | |
| Balance at Beginning of Period | | For credit losses on securities for which losses were not previously recorded | | For initial credit losses on purchased securities accounted for as PCD financial assets (a) | | (Additions) reductions in allowance recorded on previously impaired securities | | | For securities sold during the period | | For securities intended/required to be sold prior to recovery of amortized cost basis | | Write offs charged against the allowance | | Recoveries of amounts previously written off | | | | | | Balance at End of Period |
AFS securities | | | | | | | | | | | | | | | | | | | | | | |
Asset-backed securities | $ | (3) | | | $ | (7) | | | $ | — | | | $ | (1) | | | | $ | 2 | | | $ | — | | | $ | 1 | | | — | | | | | | | $ | (8) | |
Commercial mortgage-backed securities | (2) | | | — | | | — | | | — | | | | 1 | | | — | | | — | | | — | | | | | | | (1) | |
Corporates | — | | | (15) | | | — | | | — | | | | — | | | — | | | — | | | — | | | | | | | (15) | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Residential mortgage-backed securities | (3) | | | (2) | | | — | | | (2) | | | | — | | | — | | | — | | | — | | | | | | | (7) | |
| | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | |
Total AFS securities | $ | (8) | | | $ | (24) | | | $ | — | | | $ | (3) | | | | $ | 3 | | | $ | — | | | $ | 1 | | | $ | — | | | | | | | $ | (31) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year ended December 31, 2021 |
| | | | | | | | | | | | | | | | | | | | |
| | | Additions | | | | | Reductions | | | | | | | | |
| Balance at Beginning of Period | | For credit losses on securities for which losses were not previously recorded | | For initial credit losses on purchased securities accounted for as PCD financial assets (a) | | (Additions) reductions in allowance recorded on previously impaired securities | | | For securities sold during the period | | For securities intended/required to be sold prior to recovery of amortized cost basis | | Write offs charged against the allowance | | Recoveries of amounts previously written off | | | | Balance at End of Period |
AFS securities | | | | | | | | | | | | | | | | | | | | |
Asset-backed securities | $ | — | | | $ | — | | | $ | (1) | | | $ | (2) | | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | | | $ | (3) | |
Commercial mortgage-backed securities | — | | | (2) | | | — | | | — | | | | — | | | — | | | — | | | — | | | | | (2) | |
Corporates | (7) | | | — | | | — | | | 6 | | | | — | | | — | | | — | | | 1 | | | | | — | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Residential mortgage-backed securities | (3) | | | — | | | — | | | — | | | | — | | | — | | | — | | | — | | | | | (3) | |
| | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | |
Total AFS securities | $ | (10) | | | $ | (2) | | | $ | (1) | | | $ | 4 | | | | $ | — | | | $ | — | | | $ | — | | | $ | 1 | | | | | $ | (8) | |
(a) Purchased credit deteriorated financial assets (“PCD”).
PCDs are AFS securities purchased at a discount, where part of that discount is attributable to credit. Credit loss allowances are calculated for these securities as of the date of their acquisition, with the initial allowance serving to increase amortized cost. There were no purchases of PCD AFS securities during the years ended December 31, 2023 and 2022.
The fair value and gross unrealized losses of AFS securities, excluding securities in an unrealized loss position with an allowance for expected credit loss, aggregated by investment category and duration of fair value below amortized cost as of December 31, 2023 and 2022 were as follows (dollars in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 |
| Less Than 12 Months | | 12 Months or Longer | | Total |
| Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses |
AFS securities | | | | | | | | | | | |
Asset-backed securities | $ | 1,707 | | | $ | (56) | | | $ | 5,835 | | | $ | (404) | | | $ | 7,542 | | | $ | (460) | |
Commercial mortgage-backed securities | 798 | | | (53) | | | 1,916 | | | (234) | | | 2,714 | | | (287) | |
Corporates | 2,273 | | | (128) | | | 9,779 | | | (2,251) | | | 12,052 | | | (2,379) | |
Hybrids | 60 | | | (2) | | | 483 | | | (51) | | | 543 | | | (53) | |
Municipals | 392 | | | (48) | | | 884 | | | (174) | | | 1,276 | | | (222) | |
Residential mortgage-backed securities | 334 | | | (5) | | | 660 | | | (89) | | | 994 | | | (94) | |
U.S. Government | 5 | | | — | | | 9 | | | (1) | | | 14 | | | (1) | |
Foreign Government | 25 | | | (1) | | | 145 | | | (38) | | | 170 | | | (39) | |
Total AFS securities | $ | 5,594 | | | $ | (293) | | | $ | 19,711 | | | $ | (3,242) | | | $ | 25,305 | | | $ | (3,535) | |
Total number of available-for-sale securities in an unrealized loss position less than twelve months | | | | | | | | | | | 927 | |
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | | | | | | | | | | | 2,602 |
Total number of AFS securities in an unrealized loss position | | | | | | | | | | | 3,529 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| Less Than 12 Months | | 12 Months or Longer | | Total |
| Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses | | Fair Value | | Gross Unrealized Losses |
AFS securities | | | | | | | | | | | |
Asset-backed securities | $ | 7,001 | | | $ | (410) | | | $ | 3,727 | | | $ | (360) | | | $ | 10,728 | | | $ | (770) | |
Commercial mortgage-backed securities | 2,065 | | | (168) | | | 475 | | | (116) | | | 2,540 | | | (284) | |
Corporates | 8,780 | | | (1,679) | | | 3,231 | | | (1,312) | | | 12,011 | | | (2,991) | |
Hybrids | 619 | | | (83) | | | 3 | | | (1) | | | 622 | | | (84) | |
Municipals | 948 | | | (176) | | | 352 | | | (113) | | | 1,300 | | | (289) | |
Residential mortgage-backed securities | 990 | | | (51) | | | 184 | | | (22) | | | 1,174 | | | (73) | |
U.S. Government | 11 | | | (1) | | | 21 | | | (1) | | | 32 | | | (2) | |
Foreign Government | 119 | | | (32) | | | 14 | | | (5) | | | 133 | | | (37) | |
Total AFS securities | $ | 20,533 | | | $ | (2,600) | | | $ | 8,007 | | | $ | (1,930) | | | $ | 28,540 | | | $ | (4,530) | |
Total number of available-for-sale securities in an unrealized loss position less than twelve months | | | | | | | | | | | 2,774 |
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | | | | | | | | | | | 1,212 |
Total number of AFS securities in an unrealized loss position | | | | | | | | | | | 3,986 | |
We determined the unrealized losses were caused by higher treasury rates compared to those at the time of the FNF acquisition or the purchase of the security if later. For securities in an unrealized loss position as of December 31, 2023, our allowance for expected credit loss was $35 million. We believe that the unrealized loss position for which we have not recorded an allowance for expected credit loss as of December 31, 2023 was primarily attributable to interest rate increases, near-term illiquidity, and other macroeconomic uncertainties as opposed to issuer specific credit concerns.
Mortgage Loans
Our mortgage loans are collateralized by commercial and residential properties.
Commercial Mortgage Loans
Commercial mortgage loans (“CMLs”) represented approximately 5% and 6% of our total investments as of December 31, 2023 and 2022, respectively. The mortgage loans in our investment portfolio, are generally comprised of high quality commercial first lien and mezzanine real estate loans. Mortgage loans are primarily on income producing properties including industrial properties, retail buildings, multifamily properties and office buildings. We diversify our CML portfolio by geographic region and property type to attempt to reduce concentration risk. We continuously evaluate CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables (dollars in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 |
| Gross Carrying Value | | % of Total | | Gross Carrying Value | | % of Total |
Property Type: | | | | | | | |
Hotel | $ | 18 | | | 1 | % | | $ | 18 | | | 1 | % |
Industrial | 616 | | | 24 | % | | 520 | | | 22 | % |
Mixed Use | 11 | | | — | % | | 12 | | | 1 | % |
Multifamily | 1,012 | | | 40 | % | | 1,013 | | | 42 | % |
Office | 316 | | | 13 | % | | 330 | | | 14 | % |
Retail | 102 | | | 4 | % | | 105 | | | 4 | % |
Student Housing | 83 | | | 3 | % | | 83 | | | 3 | % |
Other | 392 | | | 15 | % | | 335 | | | 13 | % |
Total CMLs, gross of valuation allowance | $ | 2,550 | | | 100 | % | | $ | 2,416 | | | 100 | % |
Allowance for expected credit loss | (12) | | | | | (10) | | | |
Total CMLs, net of valuation allowance | $ | 2,538 | | | | | $ | 2,406 | | | |
| | | | | | | |
U.S. Region: | | | | | | | |
East North Central | $ | 151 | | | 6 | % | | $ | 151 | | | 6 | % |
East South Central | 75 | | | 3 | % | | 76 | | | 3 | % |
Middle Atlantic | 354 | | | 14 | % | | 326 | | | 13 | % |
Mountain | 352 | | | 14 | % | | 355 | | | 15 | % |
New England | 168 | | | 6 | % | | 158 | | | 7 | % |
Pacific | 766 | | | 30 | % | | 708 | | | 28 | % |
South Atlantic | 563 | | | 22 | % | | 521 | | | 22 | % |
West North Central | 4 | | | — | % | | 4 | | | 1 | % |
West South Central | 117 | | | 5 | % | | 117 | | | 5 | % |
Total CMLs, gross of valuation allowance | $ | 2,550 | | | 100 | % | | $ | 2,416 | | | 100 | % |
Allowance for expected credit loss | (12) | | | | | (10) | | | |
Total CMLs, net of valuation allowance | $ | 2,538 | | | | | $ | 2,406 | | | |
CMLs segregated by aging of the loans and charge offs (by year of origination) were as follows for the year ended December 31, 2023 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 |
| |
| Amortized Cost by Origination Year |
| 2023 | | 2022 | | 2021 | | 2020 | | 2019 | | Prior | | Total |
Current (less than 30 days past due) | $ | 213 | | | $ | 288 | | | $ | 1,256 | | | $ | 512 | | | $ | — | | | $ | 259 | | | $ | 2,528 | |
30-89 days past due | — | | | — | | | — | | | — | | | — | | | — | | | — | |
90 days or more past due | — | | | — | | | — | | | — | | | — | | | — | | | — | |
Total CMLs (a) | $ | 213 | | | $ | 288 | | | $ | 1,256 | | | $ | 512 | | | $ | — | | | $ | 259 | | | $ | 2,528 | |
| | | | | | | | | | | | | |
Charge offs | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | — | | | $ | 3 | | | $ | 3 | |
(a) Excludes loans under development with an amortized cost and estimated fair value of $22 million at December 31, 2023.
CMLs segregated by aging of the loans (by year of origination) were as follows for the year ended December 31, 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| |
| Amortized Cost by Origination Year |
| 2022 | | 2021 | | 2020 | | 2019 | | 2018 | | Prior | | Total |
Current (less than 30 days past due) | $ | 341 | | | $ | 1,300 | | | $ | 488 | | | $ | — | | | $ | — | | | $ | 269 | | | $ | 2,398 | |
30-89 days past due | — | | | — | | | — | | | — | | | — | | | — | | | — | |
90 days or more past due | — | | | — | | | — | | | — | | | — | | | 9 | | | 9 | |
Total CMLs (a) | $ | 341 | | | $ | 1,300 | | | $ | 488 | | | $ | — | | | $ | — | | | $ | 278 | | | $ | 2,407 | |
(a) Excludes loans under development with an amortized cost and estimated fair value of $9 million at December 31, 2022.
Loan-to-value (“LTV”) and debt service coverage (“DSC”) ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation.
The following tables present the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios, gross of valuation allowances at December 31, 2023 and 2022 (dollars in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Debt-Service Coverage Ratios | | | | Total Amount | | % of Total | | Estimated Fair Value | | % of Total |
| >1.25 | | 1.00 - 1.25 | | <1.00 | | | | | | |
December 31, 2023 | | | | | | | | | | | | | | | |
LTV Ratios: | | | | | | | | | | | | | | | |
Less than 50.00% | $ | 519 | | | $ | 4 | | | $ | 10 | | | | | $ | 533 | | | 21 | % | | $ | 510 | | | 23 | % |
50.00% to 59.99% | 764 | | | — | | | — | | | | | 764 | | | 30 | % | | 679 | | | 30 | % |
60.00% to 74.99% | 1,160 | | | 56 | | | — | | | | | 1,216 | | | 48 | % | | 1,028 | | | 46 | % |
75.00% to 84.99% | — | | | 6 | | | 9 | | | | | 15 | | | 1 | % | | 14 | | | 1 | % |
| | | | | | | | | | | | | | | |
CMLs (a) | $ | 2,443 | | | $ | 66 | | | $ | 19 | | | | | $ | 2,528 | | | 100 | % | | $ | 2,231 | | | 100 | % |
| | | | | | | | | | | | | | | |
December 31, 2022 | | | | | | | | | | | | | | | |
LTV Ratios: | | | | | | | | | | | | | | | |
Less than 50.00% | $ | 511 | | | $ | 4 | | | $ | 11 | | | | | $ | 526 | | | 22 | % | | $ | 490 | | | 24 | % |
50.00% to 59.99% | 706 | | | — | | | — | | | | | 706 | | | 29 | % | | 615 | | | 30 | % |
60.00% to 74.99% | 1,154 | | | 3 | | | — | | | | | 1,157 | | | 48 | % | | 955 | | | 45 | % |
75.00% to 84.99% | — | | | — | | | 18 | | | | | 18 | | | 1 | % | | 14 | | | 1 | % |
CMLs (a) | $ | 2,371 | | | $ | 7 | | | $ | 29 | | | | | $ | 2,407 | | | 100 | % | | $ | 2,074 | | | 100 | % |
(a) Excludes loans under development with an amortized cost and estimated fair value of $22 million and $9 million at December 31, 2023 and 2022, respectively. | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 |
| |
| Amortized Cost by Origination Year |
| 2023 | | 2022 | | 2021 | | 2020 | | 2019 | | Prior | | Total |
LTV | | | | | | | | | | | | | |
Less than 50.00% | $ | 85 | | | $ | 17 | | | $ | 77 | | | $ | 232 | | | $ | — | | | $ | 122 | | | $ | 533 | |
50.00% to 59.99% | 53 | | | 149 | | | 267 | | | 158 | | | — | | | 137 | | | 764 | |
60.00% to 74.99% | 69 | | | 113 | | | 912 | | | 122 | | | — | | | — | | | 1,216 | |
75.00% to 84.99% | 6 | | | 9 | | | — | | | — | | | — | | | — | | | 15 | |
| | | | | | | | | | | | | |
Total CMLs (a) | $ | 213 | | | $ | 288 | | | $ | 1,256 | | | $ | 512 | | | $ | — | | | $ | 259 | | | 2,528 | |
DSCR | | | | | | | | | | | | | |
Greater than 1.25x | $ | 154 | | | $ | 276 | | | $ | 1,256 | | | $ | 512 | | | $ | — | | | $ | 245 | | | $ | 2,443 | |
1.00x - 1.25x | 59 | | | 3 | | | — | | | — | | | — | | | 4 | | | 66 | |
Less than 1.00x | — | | | 9 | | | — | | | — | | | — | | | 10 | | | 19 | |
Total CMLs(a) | $ | 213 | | | $ | 288 | | | $ | 1,256 | | | $ | 512 | | | $ | — | | | $ | 259 | | | $ | 2,528 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| |
| Amortized Cost by Origination Year |
| 2022 | | 2021 | | 2020 | | 2019 | | 2018 | | Prior | | Total |
LTV | | | | | | | | | | | | | |
Less than 50.00% | $ | 70 | | | $ | 120 | | | $ | 207 | | | $ | — | | | $ | — | | | $ | 129 | | | $ | 526 | |
50.00% to 59.99% | 149 | | | 268 | | | 158 | | | — | | | — | | | 131 | | | 706 | |
60.00% to 74.99% | 113 | | | 912 | | | 123 | | | — | | | — | | | 9 | | | 1,157 | |
75.00% to 84.99% | 9 | | | — | | | — | | | — | | | — | | | 9 | | | 18 | |
Total CMLs (a) | $ | 341 | | | $ | 1,300 | | | $ | 488 | | | $ | — | | | $ | — | | | $ | 278 | | | $ | 2,407 | |
DSCR | | | | | | | | | | | | | |
Greater than 1.25x | $ | 329 | | | $ | 1,300 | | | $ | 488 | | | $ | — | | | $ | — | | | $ | 254 | | | $ | 2,371 | |
1.00x - 1.25x | 3 | | | — | | | — | | | — | | | — | | | 4 | | | 7 | |
Less than 1.00x | 9 | | | — | | | — | | | — | | | — | | | 20 | | | 29 | |
Total CMLs (a) | $ | 341 | | | $ | 1,300 | | | $ | 488 | | | $ | — | | | $ | — | | | $ | 278 | | | $ | 2,407 | |
(a) Excludes loans under development with an amortized cost and estimated fair value of $22 million and $9 million at December 31, 2023 and 2022, respectively.
We recognize a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At December 31, 2023 and 2022, we had no CMLs that were delinquent in principal or interest payments as shown in the risk rating exposure table.
Residential Mortgage Loans
Residential mortgage loans (“RMLs”) represented approximately 5% and 5% of our total investments as of December 31, 2023 and 2022, respectively. Our RMLs are closed end, amortizing loans and 100% of the properties are located in the United States. We diversify our RML portfolio by state to attempt to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration are reflected in the following tables, gross of valuation allowances (dollars in millions):
| | | | | | | | | | | |
| December 31, 2023 |
U.S. State: | Amortized Cost | | % of Total |
Florida | $ | 163 | | | 6 | % |
New York | 129 | | | 5 | % |
Texas | 129 | | | 5 | % |
| | | |
| | | |
| | | |
| | | |
All other states (a) | 2,431 | | | 84 | % |
Total RMLs, gross of valuation allowance | $ | 2,852 | | | 100 | % |
Allowance for expected credit loss | (54) | | | |
Total RMLs, net of valuation allowance | $ | 2,798 | | | |
(a) The individual concentration of each state is equal to or less than 5% as of December 31, 2023.
| | | | | | | | | | | |
| December 31, 2022 |
U.S. State: | Amortized Cost | | % of Total |
Florida | $ | 324 | | | 15 | % |
Texas | 215 | | | 10 | % |
New Jersey | 172 | | | 8 | % |
Pennsylvania | 153 | | | 7 | % |
California | 139 | | | 6 | % |
New York | 138 | | | 6 | % |
Georgia | 125 | | | 6 | % |
All other states (a) | 914 | | | 42 | % |
Total RMLs, gross of valuation allowance | $ | 2,180 | | | 100 | % |
Allowance for expected credit loss | (32) | | | |
Total RMLs, net of valuation allowance | $ | 2,148 | | | |
(a) The individual concentration of each state is equal to or less than 5% as of December 31, 2022.
RMLs have a primary credit quality indicator of either a performing or nonperforming loan. We define non-performing residential mortgage loans as those that are 90 or more days past due or in nonaccrual status, which is assessed monthly. The credit quality of RMLs was as follows (dollars in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 |
Performance indicators: | Amortized Cost | | % of Total | | Amortized Cost | | % of Total |
Performing | $ | 2,795 | | | 98 | % | | $ | 2,118 | | | 97 | % |
Non-performing | 57 | | | 2 | % | | 62 | | | 3 | % |
Total RMLs, gross of valuation allowance | $ | 2,852 | | | 100 | % | | $ | 2,180 | | | 100 | % |
Allowance for expected loan loss | (54) | | | — | | | (32) | | | — | |
Total RMLs, net of valuation allowance | $ | 2,798 | | | 100 | % | | $ | 2,148 | | | 100 | % |
There were no charge offs recorded on RMLs during the year ended December 31, 2023. RMLs segregated by aging of the loans (by year of origination) as of December 31, 2023 and 2022 were as follows, gross of valuation allowances (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 |
| |
| Amortized Cost by Origination Year |
| 2023 | | 2022 | | 2021 | | 2020 | | 2019 | | Prior | | Total |
Current (less than 30 days past due) | $ | 373 | | | $ | 985 | | | $ | 854 | | | $ | 192 | | | $ | 183 | | | $ | 192 | | | $ | 2,779 | |
30-89 days past due | — | | | 4 | | | 7 | | | 3 | | | — | | | 2 | | | 16 | |
Over 90 days past due | — | | | 6 | | | 16 | | | 13 | | | 21 | | | 1 | | | 57 | |
Total RMLs | $ | 373 | | | $ | 995 | | | $ | 877 | | | $ | 208 | | | $ | 204 | | | $ | 195 | | | $ | 2,852 | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| |
| Amortized Cost by Origination Year |
| 2022 | | 2021 | | 2020 | | 2019 | | 2018 | | Prior | | Total |
Current (less than 30 days past due) | $ | 766 | | | $ | 884 | | | $ | 214 | | | $ | 185 | | | $ | 23 | | | $ | 33 | | | $ | 2,105 | |
30-89 days past due | 2 | | | 7 | | | — | | | 4 | | | — | | | — | | | 13 | |
Over 90 days past due | 3 | | | 9 | | | 15 | | | 34 | | | 1 | | | — | | | 62 | |
Total RMLs | $ | 771 | | | $ | 900 | | | $ | 229 | | | $ | 223 | | | $ | 24 | | | $ | 33 | | | $ | 2,180 | |
Non-accrual loans by amortized cost as of December 31, 2023 and 2022, were as follows (in millions):
| | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 | | | |
Residential mortgage | $ | 57 | | | $ | 62 | | | | |
Commercial mortgage | — | | | 9 | | | | |
Total non-accrual mortgages | $ | 57 | | | $ | 71 | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
| | | | | | |
Immaterial interest income was recognized on non-accrual financing receivables for the years ended December 31, 2023 and 2022.
It is our policy to cease to accrue interest on loans that are delinquent for 90 days or more. For loans less than 90 days delinquent, interest is accrued unless it is determined that the accrued interest is not collectible. If a loan becomes 90 days or more delinquent, it is our general policy to initiate foreclosure proceedings unless a workout arrangement to bring the loan current is in place. As of December 31, 2023 and 2022, we had $57 million and $71 million, respectively, of mortgage loans that were over 90 days past due, of which $41 million and $38 million were in the process of foreclosure as of December 31, 2023 and 2022, respectively.
Allowance for Expected Credit Loss
We estimate expected credit losses for our commercial and residential mortgage loan portfolios using a probability of default/loss given default model. Significant inputs to this model include, where applicable, the loans' current performance, underlying collateral type, location, contractual life, LTV, DSC and Debt to Income or FICO. The model projects losses using a two year reasonable and supportable forecast and then reverts over a three year period to market-wide historical loss experience. Changes in our allowance for expected credit losses on mortgage loans are recognized in Recognized gains and losses, net in the accompanying Consolidated Statements of Operations.
The allowances for our mortgage loan portfolio are summarized as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | Year Ended December 31, |
| | | | | 2023 | | 2022 | | 2021 |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | Residential Mortgages | | Commercial Mortgages | | Total | | Residential Mortgages | | Commercial Mortgages | | Total | | Residential Mortgages | | Commercial Mortgages | | Total |
Beginning Balance | | | | | | | | | | | | | $ | 32 | | | $ | 10 | | | $ | 42 | | | $ | 25 | | | $ | 6 | | | $ | 31 | | | $ | 37 | | | $ | 2 | | | $ | 39 | |
Provision for loan losses | | | | | | | | | | | | | 22 | | | 5 | | | 27 | | | 7 | | | 4 | | | 11 | | | (12) | | | 4 | | | (8) | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Loans charged off | | | | | | | | | | | | | — | | | (3) | | | (3) | | | — | | | — | | | — | | | — | | | — | | | — | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Ending Balance | | | | | | | | | | | | | $ | 54 | | | $ | 12 | | | $ | 66 | | | $ | 32 | | | $ | 10 | | | $ | 42 | | | $ | 25 | | | $ | 6 | | | $ | 31 | |
An allowance for expected credit loss is not measured on accrued interest income for commercial mortgage loans as we have a process to write-off interest on loans that enter into non-accrual status (90 days or more past due). Allowances for expected credit losses are measured on accrued interest income for residential mortgage loans and were immaterial as of December 31, 2023 and 2022.
Interest and Investment Income
The major sources of Interest and investment income reported on the accompanying Consolidated Statements of Operations were as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| | | Year ended December 31, |
| | | | | 2023 | | 2022 | | 2021 |
| | | | | | | | | |
Fixed maturity securities, available-for-sale | | | | | $ | 1,843 | | | $ | 1,431 | | | $ | 1,213 | |
Equity securities | | | | | 20 | | | 17 | | | 11 | |
Preferred securities | | | | | 41 | | | 49 | | | 47 | |
| | | | | | | | | |
Mortgage loans | | | | | 229 | | | 186 | | | 131 | |
Invested cash and short-term investments | | | | | 76 | | | 33 | | | 7 | |
| | | | | | | | | |
Limited partnerships | | | | | 229 | | | 110 | | | 589 | |
Other investments | | | | | 27 | | | 20 | | | 17 | |
Gross investment income | | | | | 2,465 | | | 1,846 | | | 2,015 | |
Investment expense | | | | | (254) | | | (191) | | | (163) | |
| | | | | | | | | |
Interest and investment income | | | | | $ | 2,211 | | | $ | 1,655 | | | $ | 1,852 | |
Interest and investment income is shown net of amounts attributable to certain funds withheld reinsurance agreements which is passed along to the reinsurer in accordance with the terms of these agreements. Interest and investment income attributable to these agreements, and thus excluded from the totals in the table above, was $339 million, $109 million and $53 million, for the years ended December 31, 2023, 2022 and 2021, respectively.
Recognized Gains and Losses, net
Details underlying Recognized gains and losses, net reported on the accompanying Consolidated Statements of Operations were as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| | | Year ended December 31, |
| | | | | 2023 | | 2022 | | 2021 |
| | | | | | | | | |
Net realized (losses) gains on fixed maturity available-for-sale securities | | | | | $ | (155) | | | $ | (241) | | | $ | 102 | |
Net realized/unrealized (losses) gains on equity securities (a) | | | | | 18 | | | (40) | | | (37) | |
Net realized/unrealized (losses) gains on preferred securities (b) | | | | | 2 | | | (167) | | | (14) | |
Realized (losses) gains on other invested assets | | | | | 24 | | | (13) | | | 6 | |
Change in allowance for expected credit losses | | | | | (37) | | | (34) | | | 4 | |
Derivatives and embedded derivatives: | | | | | | | | | |
Realized (losses) gains on certain derivative instruments | | | | | (211) | | | (164) | | | 455 | |
Unrealized (losses) gains on certain derivative instruments | | | | | 358 | | | (693) | | | 160 | |
Change in fair value of reinsurance related embedded derivatives | | | | | (128) | | | 352 | | | 34 | |
Change in fair value of other derivatives and embedded derivatives | | | | | 5 | | | (10) | | | 5 | |
Realized (losses) gains on derivatives and embedded derivatives | | | | | 24 | | | (515) | | | 654 | |
Recognized gains and losses, net | | | | | $ | (124) | | | $ | (1,010) | | | $ | 715 | |
(a)Includes net valuation (losses) gains of $18 million, $(40) million, and $(37) million for the years ended December 31, 2023, 2022 and 2021, respectively.
(b)Includes net valuation (losses) gains of $73 million, $(159) million, and $(14) million for the years ended December 31, 2023, 2022 and 2021, respectively.
Recognized gains and losses is shown net of amounts attributable to certain funds withheld reinsurance agreements which is passed along to the reinsurer in accordance with the terms of these agreements. Recognized gains and losses attributable to these agreements, and thus excluded from the totals in the table above, was $(123) million, $381 million and $15 million for the years ended December 31, 2023, 2022 and 2021, respectively.
The proceeds from the sale of fixed-maturity securities and the gross gains and losses associated with those transactions were as follows (in millions):
| | | | | | | | | | | | | | | | | |
| Year ended December 31, |
| 2023 | | 2022 | | 2021 |
| | | | | |
Proceeds | $ | 2,590 | | | $ | 3,097 | | | $ | 4,555 | |
Gross gains | 8 | | | 13 | | | 142 | |
Gross losses | (134) | | | (239) | | | (42) | |
Unconsolidated Variable Interest Entities
We own investments in VIEs that are not consolidated within our financial statements. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support, where investors lack certain characteristics of a controlling financial interest, or where the entity is structured with non-substantive voting rights. VIEs are consolidated by their ‘primary beneficiary’, a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While we participate in the benefits from VIEs in which we invest, but do not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under our common control. It is for this reason that we are not considered the primary beneficiary for the VIE investments that are not consolidated.
We invest in various limited partnerships and limited liability companies primarily as a passive investor. These investments are primarily in credit funds with a bias towards current income, real assets, or private equity. Limited partnership and limited liability company interests are accounted for under the equity method and are included in Investments in unconsolidated affiliates on our Consolidated Balance Sheets. In addition, we invest in structured investments, which may be VIEs, but for which we are not the primary beneficiary. These structured investments typically invest in fixed income investments and are managed by third parties and include asset-backed securities,
commercial mortgage-backed securities and residential mortgage-backed securities included in fixed maturity securities available for sale on our Consolidated Balance Sheets.
Our maximum loss exposure with respect to these VIEs is limited to the investment carrying amounts reported in our Consolidated Balance Sheets for limited partnerships and the amortized costs of certain of our fixed maturity securities, in addition to any required unfunded commitments (also refer to Note N - Commitments and Contingencies).
The following table summarizes the carrying value and the maximum loss exposure of our unconsolidated VIEs as of December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 |
| Carrying Value | | Maximum Loss Exposure | | Carrying Value | | Maximum Loss Exposure |
Investment in unconsolidated affiliates | $ | 3,071 | | | $ | 4,806 | | | $ | 2,427 | | | $ | 4,030 | |
Fixed maturity securities | 20,837 | | | 22,346 | | | 15,680 | | | 17,404 | |
Total unconsolidated VIE investments | $ | 23,908 | | | $ | 27,152 | | | $ | 18,107 | | | $ | 21,434 | |
Concentrations
Our underlying investment concentrations that exceed 10% of shareholders equity as of December 31, 2023 and 2022 are as follows (in millions):
| | | | | | | | |
| December 31, 2023 | December 31, 2022 |
Blackstone Wave Asset Holdco (a) | $ | 725 | | $ | 741 | |
ELBA (b) | 463 | | 470 | |
COLI | 324 | | 308 | |
Verus Securitization Trust (c)(e) | — | | 302 | |
Jade 1 (d)(e) | — | | 271 | |
Jade 2 (d)(e) | — | | 271 | |
Jade 3 (d)(e) | — | | 271 | |
Jade 4 (d)(e) | — | | 271 | |
(a)Represents a special purpose vehicle that holds investments in numerous limited partnership investments whose underlying investments are further diversified by holding interest in multiple individual investments and industries.
(b)Represents special purpose vehicles that hold an underlying minority ownership interest in a single operating liquified natural gas export facility.
(c)Represents special purpose vehicles that hold investments backed by the interest paid on loans for residencies.
(d)Represents special purpose vehicles that hold numerous underlying corporate loans across various industries.
(e)Investments did not exceed 10% of shareholder’s equity as of December 31, 2023.
Note D - Derivative Financial Instruments
The carrying amounts of derivative instruments, including derivative instruments embedded in FIA and IUL contracts, and reinsurance is as follows (in millions):
| | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 |
Assets: | | | |
Derivative investments: | | | |
Call options | $ | 739 | | | $ | 244 | |
Interest rate swaps | 57 | | | — | |
| | | |
Foreign currency forward | 1 | | | — | |
Other long-term investments: | | | |
Other embedded derivatives | 28 | | | 23 | |
Prepaid expenses and other assets: | | | |
Reinsurance related embedded derivatives | 152 | | | 279 | |
Total | $ | 977 | | | $ | 546 | |
| | | | | | | | | | | |
Liabilities | | | |
Contractholder funds: | | | |
FIA/IUL embedded derivatives | $ | 4,258 | | | $ | 3,115 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
Total | $ | 4,258 | | | $ | 3,115 | |
The change in fair value of derivative instruments included within Recognized gains and losses, net, in the accompanying Consolidated Statements of Operations is as follows (in millions):
| | | | | | | | | | | | | | | | | | | | |
| | Year ended December 31, |
| | 2023 | | 2022 | | 2021 |
Net investment gains (losses): | | | | | | |
Call options | | $ | 92 | | | $ | (862) | | | $ | 597 | |
Interest rate swaps | | 48 | | | — | | | — | |
Futures contracts | | 9 | | | (7) | | | 8 | |
Foreign currency forwards | | (2) | | | 12 | | | 10 | |
Other derivatives and embedded derivatives | | 5 | | | (10) | | | 5 | |
Reinsurance related embedded derivatives | | (128) | | | 352 | | | 34 | |
Total net investment gains (losses) | | $ | 24 | | | $ | (515) | | | $ | 654 | |
| | | | | | |
Benefits and other changes in policy reserves: | | | | | | |
FIA/ IUL embedded derivatives (decrease) increase | | $ | 1,143 | | | $ | (768) | | | $ | 479 | |
Additional Disclosures
See descriptions of the fair value methodologies used for derivative financial instruments in Note B - Fair Value of Financial Instruments.
FIA/IUL Embedded Derivative, Call Options and Futures
We have FIA and IUL contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, primarily the S&P 500 Index. This feature represents an embedded derivative under GAAP. The FIA/IUL embedded derivatives are valued at fair value and included in the liability for contractholder funds in the accompanying Consolidated Balance Sheets with changes in fair value included as a component of Benefits and other changes in policy reserves in the Consolidated Statements of Operations.
We purchase derivatives consisting of a combination of call options and futures contracts (specifically for FIA contracts) on the applicable market indices to fund the index credits due to FIA/IUL contractholders. The call
options are one, two, three, and five year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the indexed policies, the index used to compute the interest credit is reset and we purchase new call options to fund the next index credit. We manage the cost of these purchases through the terms of our FIA/IUL contracts, which permit us to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the portion of the change in the fair value of the FIA/IUL embedded derivatives related to index performance through the current credit period. The call options and futures contracts are marked to fair value with the change in fair value included as a component of Recognized gains and (losses), net, in the accompanying Consolidated Statements of Operations. The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instrument term or upon early termination and the changes in fair value of open positions.
Other market exposures are hedged periodically depending on market conditions and our risk tolerance. Our FIA/IUL hedging strategy economically hedges the equity returns and exposes us to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. We use a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. We intend to continue to adjust the hedging strategy as market conditions and our risk tolerance changes.
Interest Rate Swaps
We utilize interest rate swaps to reduce market risks from interest rate changes on our earnings associated with our floating rate investments. With an interest rate swap, we agree with another party to exchange the difference between fixed-rate and floating-rate interest amounts tied to an agreed upon notional principal at specified intervals. The interest rate swaps are marked to fair value with the change in fair value, including accrued interest and related periodic cash flows received or paid, included as a component of Recognized gains and losses, net, in the accompanying Consolidated Statements of Operations.
Reinsurance Related Embedded Derivatives
F&G cedes certain business on a coinsurance funds withheld basis. Investment results for the assets that support the coinsurance that are segregated within the funds withheld account are passed directly to the reinsurer pursuant to the contractual terms of the reinsurance agreement, which creates embedded derivatives considered to be total return swaps. These total return swaps are not clearly and closely related to the underlying reinsurance contract and thus require bifurcation. The fair value of the total return swaps is based on the change in fair value of the underlying assets held in the funds withheld account. These embedded derivatives are reported in Prepaid expenses and other assets if in a net gain position, or Accounts payable and accrued liabilities, if in a net loss position on the Consolidated Balance Sheets and the related gains or losses are reported in Recognized gains and losses, net, on the Consolidated Statements of Operations.
Credit Risk
We are exposed to credit loss in the event of non-performance by our counterparties on the call options and interest rate swaps and reflect assumptions regarding this non-performance risk in the fair value of these derivatives. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. We maintain a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement.
Information regarding our exposure to credit loss on the call options and interest rate swaps we hold is presented in the following table (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | December 31, 2023 |
Counterparty | | Credit Rating (Fitch/Moody's/S&P) (a) | | Notional Amount | | Fair Value | | Collateral | | Net Credit Risk |
Merrill Lynch | | AA/*/A+ | | $ | 4,408 | | | $ | 96 | | | $ | 59 | | | $ | 37 | |
Morgan Stanley | | AA-/Aa3/A+ | | 3,466 | | | 102 | | | 116 | | | — | |
Barclay's Bank | | A+/A1/A+ | | 6,236 | | | 102 | | | 100 | | | 2 | |
Canadian Imperial Bank of Commerce | | AA-/A2/A- | | 5,983 | | | 147 | | | 148 | | | — | |
Wells Fargo | | AA-/Aa2/A+ | | 1,443 | | | 58 | | | 60 | | | — | |
Goldman Sachs | | A+/A1/A+ | | 1,919 | | | 45 | | | 45 | | | — | |
Credit Suisse | | A+/A3/A+ | | 92 | | | 4 | | | 4 | | | — | |
Truist | | A+/A2/A | | 2,759 | | | 124 | | | 124 | | | — | |
Citibank | | A+/Aa3/A+ | | 1,073 | | | 27 | | | 28 | | | — | |
JP Morgan | | AA/Aa2/A+ | | 2,589 | | | 91 | | | 91 | | | — | |
Total | | | | $ | 29,968 | | | $ | 796 | | | $ | 775 | | | $ | 39 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | December 31, 2022 |
Counterparty | | Credit Rating (Fitch/Moody's/S&P) (a) | | Notional Amount | | Fair Value | | Collateral | | Net Credit Risk |
Merrill Lynch | | AA/*/A+ | | $ | 3,563 | | | $ | 23 | | | $ | — | | | $ | 23 | |
Morgan Stanley | | */Aa3/A+ | | 1,699 | | | 14 | | | 19 | | | — | |
Barclay's Bank | | A+/A1/A | | 6,049 | | | 65 | | | 59 | | | 6 | |
Canadian Imperial Bank of Commerce | | AA/Aa2/A+ | | 5,169 | | | 68 | | | 64 | | | 4 | |
Wells Fargo | | A+/A1/BBB+ | | 1,361 | | | 17 | | | 17 | | | — | |
Goldman Sachs | | A/A2/BBB+ | | 1,133 | | | 9 | | | 10 | | | — | |
Credit Suisse | | BBB+/A3/A- | | 1,039 | | | 5 | | | 5 | | | — | |
Truist | | A+/A2/A | | 2,489 | | | 35 | | | 36 | | | — | |
Citibank | | A+/Aa3/A+ | | 795 | | | 8 | | | 9 | | | — | |
Total | | | | $ | 23,297 | | | $ | 244 | | | $ | 219 | | | $ | 33 | |
(a)An * represents credit ratings that were not available.
Collateral Agreements
We are required to maintain minimum ratings as a matter of routine practice as part of our over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, we have agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open derivative contracts between the parties, at which time any amounts payable by us or the counterparty would be dependent on the market value of the underlying contracts. Our current rating does not allow any counterparty the right to terminate ISDA agreements. In certain transactions, both us and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except Merrill Lynch, this threshold is set to zero. As of December 31, 2023 and 2022 counterparties posted $775 million and $219 million, respectively, of collateral of which $588 million and $178 million, respectively, is included in Cash and cash equivalents with an associated payable for this collateral included in Accounts payable and accrued liabilities on the Consolidated Balance Sheets. Accordingly, the maximum amount of loss due to credit risk that we would incur if parties to the derivatives failed completely to perform according to the terms of the contracts was $39 million at December 31, 2023 and $33 million at December 31, 2022.
We are required to pay counterparties the effective federal funds rate each day for cash collateral posted to F&G for daily mark to market margin changes. We reinvest derivative cash collateral to reduce the interest cost. Cash
collateral is invested in overnight investment sweep products, which are included in cash and cash equivalents in the accompanying Consolidated Balance Sheets.
We held 439 and 409 futures contracts at December 31, 2023 and 2022, respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). We provide cash collateral to the counterparties for the initial and variation margin on the futures contracts, which is included in Cash and cash equivalents in the accompanying Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $4 million and $3 million at December 31, 2023 and 2022, respectively.
Note E - Reinsurance
F&G reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding F&G's retention limit is reinsured. F&G primarily seeks reinsurance coverage in order to manage loss exposures, to enhance our capital position, to diversify risks and earnings, and to manage new business volume. F&G follows reinsurance accounting when the treaty adequately transfers insurance risk. Otherwise, F&G follows deposit accounting if there is inadequate transfer of insurance risk or if the underlying policy for which risk is being transferred is an investment contract that does not contain insurance risk. Refer to Note A - Business and Summary of Significant Accounting Policies for more information over our accounting policy for reinsurance agreements.
The effects of reinsurance on net premiums earned and net benefits incurred (benefits paid and reserve changes) for the years ended December 31, 2023, 2022, and 2021 respectively, were as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
| Net Premiums Earned | | Net Benefits Incurred | | Net Premiums Earned | | Net Benefits Incurred | | Net Premiums Earned | | Net Benefits Incurred |
Direct | $ | 2,112 | | | $ | 3,728 | | | $ | 1,522 | | | $ | 3,640 | | | $ | 1,314 | | | $ | 3,070 | |
| | | | | | | | | | | |
Ceded | (105) | | | (175) | | | (128) | | | (2,514) | | | (137) | | | (1,138) | |
Net | $ | 2,007 | | | $ | 3,553 | | | $ | 1,394 | | | $ | 1,126 | | | $ | 1,177 | | | $ | 1,932 | |
Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. No policies issued by F&G have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance. F&G has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues.
The following summarizes our reinsurance recoverable (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Parent Company/ Principal Reinsurers | | Reinsurance Recoverable (a) | | Agreement Type | | Products Covered | | Accounting |
| | December 31, 2023 | | December 31, 2022 | | | | | | |
| | | | | | | | |
Aspida Life Re Ltd | | $ | 6,128 | | | $ | 3,121 | | | Coinsurance Funds Withheld | | Certain MYGA (b) | | Deposit |
Wilton Reassurance Company | | 1,092 | | | 1,231 | | | Coinsurance | | Block of traditional, IUL and UL (c) | | Reinsurance |
Somerset Reinsurance Ltd | | 716 | | | 570 | | | Coinsurance Funds Withheld | | Certain MYGA (b) and DA | | Deposit |
Everlake Life Insurance Company | | 509 | | | — | | | Coinsurance (d) | | Certain MYGA (b) (d) | | Deposit |
Other (e) | | 536 | | | 505 | | | | | | | |
Reinsurance recoverable, gross of allowance for credit losses | | 8,981 | | | 5,427 | | | | | | | |
Allowance for expected credit loss | | (21) | | | (10) | | | | | | | |
Reinsurance recoverable, net of allowance for credit losses | | $ | 8,960 | | | $ | 5,417 | | | | | | | |
| | | | | | | | | | |
(a) Reinsurance recoverables do not include unearned ceded premiums that would be recovered in the event of early termination of certain traditional life policies. |
(b) As of the years ended December 31, 2023 and 2022, the combined quota share flow reinsurance amongst all reinsurers was 90% and 75%, respectively. |
(c) Also includes certain FGL Insurance life insurance policies that are subject to redundant reserves, reported on a statutory basis, under Regulation XXX and Guideline AXXX. |
(d) Reinsurance recoverable is collateralized by assets placed in a statutory comfort trust by the reinsurer and maintained for our sole benefit. |
(e) Represents all other reinsurers, with no single reinsurer having a carrying value in excess of 5% of total reinsurance recoverable. |
F&G incurred risk charge fees of $39 million, $36 million, and $28 million during the years ended December 31, 2023, 2022, and 2021, respectively, in relation to reinsurance agreements.
Credit Losses
F&G estimates expected credit losses on reinsurance recoverables using a probability of default/loss given default model. Significant inputs to the model include the reinsurer's credit risk, expected timing of recovery, industry-wide historical default experience, senior unsecured bond recovery rates, and credit enhancement features.
The expected credit loss reserves were as follows (in millions):
| | | | | | | | | | | | | |
| Year Ended |
| December 31, 2023 | | December 31, 2022 | | |
Balance at Beginning of Period | $ | (10) | | | $ | (20) | | | |
Provision for losses | (11) | | | 10 | | | |
Charge offs | — | | | — | | | |
Balance at End of Period | $ | (21) | | | $ | (10) | | | |
Concentration of Reinsurance Risk
As indicated above, the Company has a significant concentration of reinsurance risk with third party reinsurers, ASPIDA Life Re Ltd. (“Aspida Re”), Wilton Reinsurance (“Wilton Re”), Somerset Reinsurance Ltd. (“Somerset”) and Everlake Life Insurance Company (“Everlake”) that could have a material impact on our financial position in the event that any of these reinsurers fails to perform its obligations under the various reinsurance treaties. We monitor the financial condition and financial strength of individual reinsurers using public ratings (refer to table below) and ratings reports of individual reinsurers to attempt to reduce the risk of default by such reinsurers. In addition, the risk of non-performance is further mitigated with various forms of collateral or collateral arrangements, including secured trusts, funds withheld accounts and irrevocable letters of credit. We believe that all amounts due from Aspida Re, Wilton Re, Somerset and Everlake for periodic treaty settlements, net of any applicable credit loss
reserves, are collectible as of December 31, 2023. The following table presents financial strength ratings as of December 31, 2023:
| | | | | | | | | | | | | | | | | | | | | | | | | | |
Parent Company/Principal Reinsurers | | Financial Strength Rating |
| | AM Best | | S&P | | Fitch | | Moody's |
Aspida Life Re Ltd | | A- | | not rated | | not rated | | not rated |
Wilton Re | | A+ | | not rated | | A | | not rated |
Somerset Reinsurance Ltd | | A- | | BBB+ | | not rated | | not rated |
Everlake | | A+ | | not rated | | not rated | | not rated |
|
|
Reinsurance Transactions
The following summarizes significant changes to third-party reinsurance agreements for the year ended December 31, 2023:
Everlake and Somerset: F&G executed flow reinsurance agreements with Everlake and Somerset, third-party reinsurers, to cede certain MYGA business written effective September 1, 2023, and December 1, 2023, respectively, on a coinsurance quota share basis.
Canada Life: Effective May 1, 2020, F&G entered into an indemnity reinsurance agreement with Canada Life Assurance Company (“Canada Life”) United States Branch, a third-party reinsurer, to reinsure FIA policies with GMWB Riders. In accordance with the terms of this agreement, F&G cedes a quota share percentage of the net retention of guaranteed payments in excess of account value for GMWB. Effective December 31, 2023, we entered a Recapture and Termination Agreement with Canada Life whereby 100% of the liabilities and obligations were recaptured.
There were no significant changes to third party reinsurance agreements for the year ended December 31, 2022.
Intercompany Reinsurance Agreements
The Company executes various intercompany reinsurance agreements between its insurance subsidiaries, including off shore entities, for purposes of managing regulatory statutory capital and risk. Since these agreements are intercompany, the financial impacts are eliminated in the preparation of the Consolidated Financial Statements included within this Annual Report on Form 10-K.
Some of these intercompany transactions are executed with wholly owned reinsurance subsidiaries, Corbeau Re, Inc. (“Corbeau Re”), Raven Reinsurance Company (“Raven Re”) and F&G Cayman Re (“Cayman Re”), to finance the portion of statutory reserves considered to be non-economic. The financing arrangements involve Fidelity & Guaranty Life Insurance Company reinsuring certain annuity products and their related rider benefits to the captives and the captives executing third-party financing facilities that are classified as capital for statutory purposes.
The transaction with Raven Re and Cayman Re included the execution of letter of credits with Nomura Bank International plc (“NBI”) and Deutsche Bank AG (“DB”), respectively, that are undrawn and have maximum borrowing capacities of $200 million and $200 million, respectively, as of December 31, 2023. The transaction with Corbeau Re included the execution of an excess of loss agreement (“XOL”) with Canada Life Barbados Branch that matures on December 31, 2043, and provides for coverage on losses up to $1,500 million as of December 31, 2023. With Corbeau Re, non-economic reserves were financed through the maturity date of the XOL and statutory reserves are recorded for all risks expected to be incurred after the maturity date of the XOL. The XOL is not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP; therefore, deposit accounting is applied.
Note F - Intangibles
The following table reconciles to Other intangible assets, net, on the Consolidated Balance Sheets as of December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 |
VOBA | | $ | 1,446 | | | $ | 1,615 | |
DAC | | 2,215 | | | 1,411 | |
DSI | | 346 | | | 200 | |
Value of distribution asset | | 86 | | | 100 | |
Computer software | | 65 | | | 61 | |
Definite lived trademarks, tradenames, and other | | 41 | | | 34 | |
Indefinite lived tradenames and other | | 8 | | | 8 | |
Total Other intangible assets, net | | $ | 4,207 | | | $ | 3,429 | |
The following tables roll forward VOBA by product for the years ended December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| FIA | | Fixed Rate Annuities | | Immediate Annuities | | Universal Life | | Traditional Life | | | | | | | Total |
Balance at January 1, 2023 | $ | 1,166 | | | $ | 32 | | | $ | 201 | | | $ | 143 | | | $ | 73 | | | | | | | | $ | 1,615 | |
| | | | | | | | | | | | | | | | |
Amortization | (141) | | | (5) | | | (10) | | | (9) | | | (4) | | | | | | | | (169) | |
| | | | | | | | | | | | | | | | |
Balance at December 31, 2023 | $ | 1,025 | | | $ | 27 | | | $ | 191 | | | $ | 134 | | | $ | 69 | | | | | | | | $ | 1,446 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| FIA | | Fixed Rate Annuities | | Immediate Annuities | | Universal Life | | Traditional Life | | | | | | | Total |
Balance at January 1, 2022 | $ | 1,314 | | | $ | 39 | | | $ | 212 | | | $ | 153 | | | $ | 25 | | | | | | | | $ | 1,743 | |
| | | | | | | | | | | | | | | | |
Amortization | (148) | | | (7) | | | (11) | | | (10) | | | (4) | | | | | | | | (180) | |
Shadow Premium Deficiency Testing (“PDT”) | — | | | — | | | — | | | — | | | 52 | | | | | | | | 52 | |
Balance at December 31, 2022 | $ | 1,166 | | | $ | 32 | | | $ | 201 | | | $ | 143 | | | $ | 73 | | | | | | | | $ | 1,615 | |
VOBA amortization expense of $169 million, $180 million, and $195 million, was recorded in Depreciation and amortization on the Consolidated Statements of Operations for the years ended December 31, 2023, 2022, and 2021 respectively.
The following table presents a reconciliation of VOBA to the table above which is reconciled to the Consolidated Balance Sheets as of December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 |
FIA | | $ | 1,025 | | | $ | 1,166 | |
Fixed Rate Annuities | | 27 | | | 32 | |
Immediate Annuities | | 191 | | | 201 | |
Universal Life | | 134 | | | 143 | |
Traditional Life | | 69 | | | 73 | |
| | | | |
Total | | $ | 1,446 | | | $ | 1,615 | |
The following tables roll forward DAC by product for the years ended December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| FIA | | Fixed Rate Annuities | | Universal Life | | Total (a) |
Balance at January 1, 2023 | $ | 971 | | | $ | 83 | | | $ | 348 | | | $ | 1,402 | |
Capitalization | 510 | | | 177 | | | 229 | | | 916 | |
Amortization | (103) | | | (51) | | | (32) | | | (186) | |
Reinsurance related adjustments | — | | | 79 | | | — | | | 79 | |
Balance at December 31, 2023 | $ | 1,378 | | | $ | 288 | | | $ | 545 | | | $ | 2,211 | |
| | | | | | | |
| FIA | | Fixed Rate Annuities | | Universal Life | | Total (a) |
Balance at January 1, 2022 | $ | 564 | | | $ | 38 | | | $ | 173 | | | $ | 775 | |
Capitalization | 474 | | | 56 | | | 196 | | | 726 | |
Amortization | (67) | | | (11) | | | (21) | | | (99) | |
Balance at December 31, 2022 | $ | 971 | | | $ | 83 | | | $ | 348 | | | $ | 1,402 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
(a) Excludes insignificant amounts of DAC related to Funding Agreement Backed Note (“FABN”).DAC amortization expense of $186 million, $99 million, and $46 million, was recorded in Depreciation and amortization on the Consolidated Statements of Operations for the years ended December 31, 2023, 2022, and 2021, respectively, excluding insignificant amounts related to FABN.
The following table presents a reconciliation of DAC to the table above which is reconciled to the Consolidated Balance Sheets as of December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 |
FIA | | $ | 1,378 | | | $ | 971 | |
Fixed Rate Annuities | | 288 | | | 83 | |
| | | | |
Universal Life | | 545 | | | 348 | |
| | | | |
Funding Agreements | | 4 | | | 9 | |
Total | | $ | 2,215 | | | $ | 1,411 | |
The following tables roll forward DSI for the years ended December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | |
| FIA | | Total |
Balance at January 1, 2023 | $ | 200 | | | $ | 200 | |
Capitalization | 168 | | | 168 | |
Amortization | (22) | | | (22) | |
Balance at December 31, 2023 | $ | 346 | | | $ | 346 | |
| | | |
| FIA | | Total |
Balance at January 1, 2022 | $ | 127 | | | $ | 127 | |
Capitalization | 87 | | | 87 | |
Amortization | (14) | | | (14) | |
Balance at December 31, 2022 | $ | 200 | | | $ | 200 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
DSI amortization expense of $22 million, $14 million, and $7 million, was recorded in Depreciation and amortization on the Consolidated Statements of Operations for the years ended December 31, 2023, 2022, and 2021, respectively.
The following table presents a reconciliation of DSI to the table above which is reconciled to the Consolidated Balance Sheets as of December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 |
FIA | | $ | 346 | | | $ | 200 | |
| | | | |
| | | | |
| | | | |
| | | | |
| | | | |
Total | | $ | 346 | | | $ | 200 | |
The cash flow assumptions used to amortize VOBA and DAC were consistent with the assumptions used to estimate the FPB for life contingent immediate annuities, and will be reviewed and unlocked, if applicable, in the same period as those balances. For nonparticipating traditional life contracts, the VOBA amortization is straight-line, without the use of cash flow assumptions. For FIA contracts, the cash flow assumptions used to amortize VOBA, DAC, and DSI were consistent with the assumptions used to estimate the value of the embedded derivative and MRBs, and will be reviewed and unlocked, if applicable, in the same period as those balances. For fixed rate annuities and IUL the cash flow assumptions used to amortize VOBA, DAC and DSI reflect the Company’s best estimates for policyholder behavior, consistent with the development of assumptions for FIA and immediate annuity. Refer to Note A - Business and Summary of Significant Accounting Policies for further information about accounting policies for amortization of VOBA, DAC and DSI.
We review cash flow assumptions annually, generally in the third quarter. In 2023, F&G undertook a review of all significant assumptions and revised several assumptions relating to our deferred annuity (FIA and fixed rate annuity) and IUL products, including surrender rates, partial withdrawal rates, mortality improvement, premium persistency, and option budgets. All updates to these assumptions brought us more in line with our company and overall industry experience since the prior assumption update. In 2022, F&G undertook a review of all significant assumptions and revised GMWB utilization for our deferred annuity contracts (FIA and fixed rate annuities) to reflect internal and industry experience in the first several contract years.
For the in-force liabilities as of December 31, 2023, the estimated amortization expense for VOBA in future fiscal periods is as follows (in millions):
| | | | | |
| Estimated Amortization Expense |
Fiscal Year | |
| |
2024 | $ | 149 | |
2025 | 139 | |
2026 | 127 | |
2027 | 116 | |
2028 | 105 | |
Thereafter | 810 | |
Total | $ | 1,446 | |
Definite and Indefinite Lived Other Intangible Assets
Other intangible assets as of December 31, 2023 consist of the following (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Cost | | Accumulated amortization | | Net carrying amount | | Weighted average useful life (years) |
| | | | | | | |
Value of distribution asset (VODA) | $ | 140 | | | $ | (54) | | | $ | 86 | | | 15 |
Computer software | 94 | | | (29) | | | 65 | | | 2 to 10 |
Definite lived trademarks, tradenames, and other | 54 | | | (13) | | | 41 | | | 10 |
Indefinite lived tradenames and other | 8 | | | N/A | | 8 | | | Indefinite |
Total | | | | | $ | 200 | | | |
Other intangible assets as of December 31, 2022 consist of the following (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Cost | | Accumulated amortization | | Net carrying amount | | Weighted average useful life (years) |
Value of distribution asset (VODA) | $ | 140 | | | $ | (40) | | | $ | 100 | | | 15 |
Computer software | 82 | | | (21) | | | 61 | | | 2 to 10 |
Definite lived trademarks, tradenames and other | 43 | | | (9) | | | 34 | | | 10 |
Indefinite lived tradenames and other | 8 | | | N/A | | 8 | | | Indefinite |
Total | | | | | $ | 203 | | | |
Amortization expense for amortizable intangible assets, which consist primarily of VODA, computer software, and definite lived trademarks, tradenames and other was $26 million, $25 million and $28 million for the years ended December 31, 2023, 2022 and 2021, respectively. We recorded $13 million, $14 million and $0 of impairment expense related to computer software during the years ended December 31, 2023, 2022 and 2021, respectively. Estimated amortization expense for the next five years for assets owned at December 31, 2023, is $31 million in 2024, $26 million in 2025, $23 million in 2026, $22 million in 2027, $19 million in 2028 and $71 million thereafter.
Note G - Market Risk Benefits
The following table presents the balances of and changes in MRBs associated with FIAs and fixed rate annuities for the years ended December 31, 2023, 2022 and 2021 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
| FIA | | Fixed rate annuities | | FIA | | Fixed rate annuities | | FIA | | Fixed rate annuities |
Balance, beginning of period, net liability | $ | 164 | | | $ | 1 | | | $ | 426 | | | $ | 2 | | | $ | 478 | | | $ | 1 | |
| | | | | | | | | | | |
Balance, beginning of period, before effect of changes in the instrument-specific credit risk | $ | 102 | | | $ | 1 | | | $ | 280 | | | $ | 1 | | | $ | 320 | | | $ | 1 | |
Issuances and benefit payments | (10) | | | — | | | (21) | | | — | | | (9) | | | — | |
Attributed fees collected and interest accrual | 131 | | | — | | | 107 | | | 1 | | | 99 | | | 1 | |
Actual policyholder behavior different from expected | 27 | | | — | | | 43 | | | — | | | (22) | | | — | |
Changes in assumptions and other | 29 | | | — | | | (76) | | | — | | | — | | | — | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Effects of market related movements | (70) | | | — | | | (231) | | | (1) | | | (108) | | | (1) | |
Balance, end of period, before effect of changes in the instrument-specific credit risk | $ | 209 | | | $ | 1 | | | $ | 102 | | | $ | 1 | | | $ | 280 | | | $ | 1 | |
Effect of changes in the instrument-specific credit risk | 105 | | | — | | | 62 | | | — | | | 146 | | | 1 | |
Balance, end of period, net liability | $ | 314 | | | $ | 1 | | | $ | 164 | | | $ | 1 | | | $ | 426 | | | $ | 2 | |
| | | | | | | | | | | |
| | | | | | | | | | | |
| | | | | | | | | | | |
Weighted-average attained age of policyholders weighted by total AV (years) | 68.28 | | 72.59 | | 68.59 | | 72.88 | | 68.95 | | 73.10 |
Net amount at risk | $ | 1,059 | | | $ | 2 | | | $ | 952 | | | $ | 3 | | | $ | 1,304 | | | $ | 4 | |
The following table reconciles MRBs by amounts in an asset position and amounts in a liability position to the MRBs amounts in the Consolidated Balance Sheets (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
| Asset | | Liability | | Net | | Asset | | Liability | | Net | | Asset | | Liability | | Net |
FIA | 88 | | | 402 | | | 314 | | | 117 | | | 281 | | | 164 | | | 41 | | | 467 | | | 426 | |
Fixed rate annuities | — | | | 1 | | | 1 | | | — | | | 1 | | | 1 | | | — | | | 2 | | | 2 | |
Total | $ | 88 | | | $ | 403 | | | $ | 315 | | | $ | 117 | | | $ | 282 | | | $ | 165 | | | $ | 41 | | | $ | 469 | | | $ | 428 | |
2023. The net MRB liability increased for the year ended December 31, 2023, primarily as a result of attributed fees collected, increases as a result of actual policyholder behavior different than expected and changes in assumptions and other as discussed below. These increases were partially offset by the effects of market related movements, including the impacts of higher risk-free rates and increases in the equity market related projections.
For the year ended December 31, 2023, notable changes made to the inputs to the fair value estimates of MRBs calculations included a significant increase in risk-free rates leading to a favorable change in the MRBs associated with FIA and fixed rate annuities; increases in the equity market related projections resulted in a decrease in the net amount at risk associated with FIAs, lead to a favorable change in the value of the associated MRBs; and F&G’s credit spread decreased, leading to a corresponding unfavorable change in the MRBs associated with both FIA and fixed rate annuities.
In addition, the cash flow assumptions used to calculate MRBs reflect the company’s best estimates for policyholder behavior. We review cash flow assumptions annually, generally in the third quarter. In 2023, F&G undertook a review of all significant assumptions and revised several assumptions relating to our deferred annuities (FIA and fixed rate annuities) with MRBs including surrender rates, partial withdrawal rates, mortality improvement, and option budgets. All updates to these assumptions brought us more in line with our Company and overall industry experience since the prior assumption update. These updates, in total, led to an unfavorable change in the MRB balance during the third quarter of 2023. Additionally, in the fourth quarter of 2023, an update to the industry future mortality improvement table led to a corresponding update in our future mortality improvement assumption, which led to an unfavorable change in the MRB balance during the fourth quarter of 2023.
2022. The net MRB liability decreased for the year ended December 31, 2022, primarily as a result of the effects of market related movements, including the impact of higher risk-free rates, and changes in assumptions and other as discussed below, partially offset by attributed fees collected and increases as a result of actual policyholder behavior different than expected.
For the year ended December 31, 2022, notable changes made to the inputs to the fair value estimates of MRBs calculations included a significant increase to risk-free rates leading to a favorable change in the MRBs associated with both FIA and fixed rate annuities; decreases in the equity markets resulting in an increase in the net amount at risk associated with FIAs, leading to an unfavorable change in the value of the associated MRBs; and volatility indices increased, leading to an unfavorable change in the MRBs associated with FIAs.
Cash flow assumptions for mortality and full and partial surrenders were unchanged during the annual third quarter review in 2022. The GMWB utilization assumption was revised in the second quarter of 2022 to reflect additional internal and industry experience for the first several contract years. This assumption update led to a decrease in the net MRB liability. In addition, F&G’s credit spread increased during 2022, leading to a corresponding decrease in the net MRB liability. Credit spreads on the block of business remain lower than the at-issue or at-purchase credit spreads, but the level has decreased since the beginning of 2022.
2021. The net MRB liability decreased for the year ended December 31, 2021, primarily as a result of the effects of market related movements, including the impact of higher risk-free rates, and decreases as a result of actual policyholder behavior different than expected, partially offset by attributed fees collected.
For the year ended December 31, 2021, notable changes made to the inputs to the fair value estimates of MRBs calculations included a moderate increase to risk-free rates leading to a favorable change in the MRBs associated with both FIA and fixed rate annuities and increases in the equity markets resulting in a decrease in the net amount at risk associated with FIAs, leading to a favorable change in the value of the associated MRBs.
Note H - Income Taxes
Income tax expense (benefit) on continuing operations consists of the following (in millions):
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
| | | | | |
Current | $ | 27 | | | $ | (31) | | | $ | 27 | |
Deferred | (4) | | | 189 | | | 293 | |
Total | $ | 23 | | | $ | 158 | | | $ | 320 | |
Total income tax expense (benefit) was allocated as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
| | | | | |
Taxes on net earnings (loss) from continuing operations | $ | 23 | | | $ | 158 | | | $ | 320 | |
| | | | | |
Other comprehensive (loss) earnings: | | | | | |
Changes in current discount rate - future policy benefits | (50) | | | 203 | | | 33 | |
Changes in instrument-specific credit risk-market benefits | (9) | | | 18 | | | 3 | |
Unrealized (loss) gain on investments and other financial instruments | 275 | | | (1,186) | | | (141) | |
Unrealized gain on foreign currency translation and cash flow hedging | 1 | | | (1) | | | (1) | |
Total income tax (benefit) expense allocated to other comprehensive earnings | 217 | | | (966) | | | (106) | |
Total income taxes | $ | 240 | | | $ | (808) | | | $ | 214 | |
A reconciliation of the federal statutory rate to our effective tax rate is as follows:
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
| | | | | |
Federal statutory rate | 21.0 | % | | 21.0 | % | | 21.0 | % |
State income taxes, net of federal benefit | (12.7) | | | 0.1 | | | 0.3 | |
Benefit for Capital Loss Carryback | — | | | (3.0) | | | — | |
| | | | | |
| | | | | |
| | | | | |
Stock compensation | (8.5) | | | 0.3 | | | (0.1) | |
Tax credits | 16.2 | | | (1.1) | | | (0.3) | |
Dividends received deduction | 7.9 | | | (0.4) | | | (0.2) | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Valuation allowance for deferred tax assets | (100.1) | | | 3.4 | | | (1.2) | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Adjustment of DTAs on sale of subsidiary | — | | | — | | | 1.2 | |
| | | | | |
COLI | 13.2 | | | (0.4) | | | (0.2) | |
Non-deductible expenses and other, net | (3.2) | | | — | | | 0.1 | |
Effective tax rate | (66.2) | % | | 19.9 | % | | 20.6 | % |
| | | | | |
| | | | | |
For the year ended December 31, 2023, the Company’s effective tax rate was (66.2)%. The effective tax rate was negatively impacted by the valuation allowance expense recorded on unrealized losses and capital loss carryforwards.
For the year ended December 31, 2022, the Company’s effective tax rate was 19.9%. The effective tax rate was positively impacted by favorable permanent adjustments, including low income housing tax credits (“LIHTC”), the dividends received deduction (“DRD”), and COLI. The effective tax rate was also impacted by the benefit of the capital loss carryback. This benefit is offset by the valuation allowance expense recorded on unrealized losses and capital loss carryforwards.
For the year ended December 31, 2021, the Company’s effective tax rate was 20.6%. The effective tax rate was positively impacted by favorable permanent adjustments, including LIHTC, DRD, and COLI.
The significant components of deferred tax assets and liabilities consist of the following:
| | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
| (In millions) |
Deferred Tax Assets: | | | |
Employee benefit accruals | $ | 25 | | | $ | 21 | |
| | | |
Net operating loss carryforwards | 75 | | | 28 | |
| | | |
Accrued liabilities | — | | | 1 | |
| | | |
| | | |
General Business Tax credits | 43 | | | 30 | |
| | | |
CAMT Credit Carryforwards | 36 | | | — | |
Bermuda CIT NOL Carryforward | 24 | | | — | |
| | | |
Investment securities | 597 | | | 853 | |
Capital loss carryover | 38 | | | 8 | |
Market Risk Benefit | 61 | | | 32 | |
Derivatives | — | | | 67 | |
Life insurance and claim related adjustments | 547 | | | 433 | |
Funds held under reinsurance agreements | 500 | | | 37 | |
Other | 5 | | | 19 | |
Total gross deferred tax asset | 1,951 | | | 1,529 | |
Less: valuation allowance | 85 | | | 30 | |
Total deferred tax asset | $ | 1,866 | | | $ | 1,499 | |
Deferred Tax Liabilities: | | | |
| | | |
Amortization of goodwill and intangible assets | (25) | | | (29) | |
| | | |
Other | (5) | | | (2) | |
| | | |
Depreciation | (15) | | | (14) | |
Partnerships | (127) | | | (93) | |
Value of business acquired | (304) | | | (339) | |
| | | |
Derivatives | (3) | | | — | |
Deferred acquisition costs | (361) | | | (210) | |
Transition reserve on new reserve method | (17) | | | (25) | |
Funds held under reinsurance agreements | (621) | | | (187) | |
| | | |
| | | |
| | | |
Total deferred tax liability | $ | (1,478) | | | $ | (899) | |
Net deferred tax asset (liability) | $ | 388 | | | $ | 600 | |
Our net deferred tax asset (liability) was $388 million as of December 31, 2023 and a net deferred tax asset (liability) of $600 million as of December 31, 2022. The significant changes in the deferred taxes are as follows: the deferred tax asset for investment securities decreased by $256 million primarily due to unrealized capital gains on fixed maturities. The deferred tax liability related to deferred acquisition costs increased by $151 million, which is consistent with the growth in sales in our U.S. life group. The deferred tax relating to derivatives decreased by $70 million due to unrealized gains on call options, interest rate swaps, and embedded derivatives. The life insurance reserves and claim related adjustments deferred tax asset increased by $114 million primarily due to the GAAP reserves for the year increasing by more than the tax reserves. The reinsurance receivable deferred tax asset increased by $463 million, and the reinsurance receivable deferred tax liability increased by $434 million, both due to the Modco reinsurance treatment of GAAP and tax reserves.
As of December 31, 2023, we have net operating losses (“NOLs”) on a pretax basis of $355 million, which are available to carryforward and offset future federal taxable income subject to the 80% taxable income limitation. The life losses are U.S. federal net operating losses and consist of $68 million of Internal Revenue Code Section 382 limited net operating losses, and $287 million of Internal Revenue Code Section 382 non-limited net operating losses. These losses do not expire.
As of December 31, 2023 and 2022, we had $43 million and $30 million of general business tax credits, respectively, which expire between 2040 and 2043. The tax credits consist of $43 million of tax credits with no IRC
Section 382 limitation. We also had $36 million of corporate alternative minimum tax (“CAMT”) credits. The CAMT credits are not limited by IRC Section 382, and have no expiration date.
As of December 31, 2023, the valuation allowance of $85 million consisted of a full valuation allowance of $4 million on the unrealized capital loss deferred tax assets for F&G Life Re, F&G Cayman Re, and the US Non-life Companies, a full valuation allowance of $24 million on the foreign deferred tax assets of F&G Life Re, a full valuation allowance of $4 million on the remaining capital loss carryforwards for the US Non-life Companies, and a partial valuation allowance of $53 million on the US Life Companies’ capital loss deferred tax assets.
The U.S. Life insurance group is subject to a Tax Sharing Agreement within the members of the life insurance tax return group. The agreement provides for an allocation based on separate return calculations and allows for reimbursement of company tax benefits absorbed by other members of the group. The U.S. non-life group is subject to a Tax Sharing Agreement with its parent, FNF, with which it files a consolidated federal income tax return. The Company’s non-life group Tax Sharing Agreement allows for reimbursement of company tax benefits absorbed by FNF. If, during the year ended December 31, 2023, the Company had computed taxes using the separate return method, the pro-forma provision for income taxes would remain unchanged.
The U.S. Federal income tax returns of the Company for years prior to 2018 are no longer subject to examination by the taxing authorities. The Company does not have any unrecognized tax benefits (“UTBs”) at December 31, 2023 or December 31, 2022. In the event the Company has UTBs, interest and penalties related to uncertain tax positions would be recorded as part of income tax expense in the financial statements. The Company regularly assesses the likelihood of additional tax assessments by jurisdiction and, if necessary, adjusts its tax reserves based on new information or developments.
The Inflation Reduction Act of 2022 (the “Inflation Reduction Act”)was signed into law on August 16, 2022. Among other changes, the Inflation Reduction Act introduced a 15% corporate alternative minimum tax (“CAMT”) on adjusted financial statement income and a 1% excise tax on treasury stock repurchases. These provisions were effective January 1, 2023. For purposes of calculating the adjusted financial statement income, the Company is included in the controlled group of FNF, its parent company. Though the Company is subject to the minimum tax, the Company does not expect to be in a perpetual CAMT position. The life companies will join the consolidated tax return group with FNF and file a life/non-life consolidated return once the five-year waiting period has completed in 2026, which should strengthen that position as FNF is not anticipating owing CAMT on its future returns. The Company has elected to consider the effects of CAMT separately in evaluating the need for a valuation allowance. For the year ended December 31, 2023, due to the reasons above, no valuation allowance is needed. For the year ended December 31, 2023, the Company was subject to CAMT, but there is no impact to total tax. A CAMT credit carryforward was created and is expected to be able to be utilized in future years.
The CIT Act of 2023 was passed in Bermuda on December 27, 2023. The CIT will commence on January 1, 2025 and will apply a statutory rate of 15% to the taxable income or loss of Bermuda tax resident entities and permanent establishments. F&G Life Re, a 953(d) company with no or minimal US permanent tax differences, is not expected to owe any Bermuda CIT due to the foreign tax credit. The deferred tax asset recorded for the year ended December 31, 2023 of $24 million has a full valuation allowance. Since the CIT did not have any material impact to the financial statements, the deferred tax asset and offsetting valuation allowance were netted together in the rate reconciliation above.
As a result of the adoption of ASU 2018-12, the changes required resulted in changes to deferred tax for the prior periods. The decrease in the deferred tax asset as of December 31, 2022 due to ASU 2018-12 was $163 million. See Note A - Business and Summary of Significant Accounting Policies for details on the changes required for the new accounting standard.
Note I- Contractholder Funds
The following tables summarize balances of and changes in contractholder funds’ account balances (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 |
| FIA | | Fixed rate annuities | | Universal Life | | FABN (b) | | FHLB (b) |
Balance, beginning of year | $ | 24,766 | | | $ | 9,358 | | | $ | 2,112 | | | $ | 2,613 | | | $ | 1,982 | |
Issuances | 4,722 | | | 5,061 | | | 199 | | | — | | | 1,256 | |
Premiums received | 103 | | | 1 | | | 382 | | | — | | | — | |
Policy charges (a) | (182) | | | — | | | (261) | | | — | | | — | |
Surrenders and withdrawals | (2,005) | | | (1,142) | | | (90) | | | — | | | — | |
Benefit payments | (526) | | | (240) | | | (27) | | | (53) | | | (763) | |
| | | | | | | | | |
Interest credited | 270 | | | 405 | | | 76 | | | 54 | | | 64 | |
Other | 16 | | | — | | | — | | | (1) | | | — | |
Balance, end of year | $ | 27,164 | | | $ | 13,443 | | | $ | 2,391 | | | $ | 2,613 | | | $ | 2,539 | |
Embedded derivative adjustment (c) | 243 | | | — | | | 84 | | | — | | | — | |
Gross Liability, end of period | $ | 27,407 | | | $ | 13,443 | | | $ | 2,475 | | | $ | 2,613 | | | $ | 2,539 | |
Less: Reinsurance | (17) | | | (7,520) | | | (894) | | | — | | | — | |
Net Liability, after Reinsurance | $ | 27,390 | | | $ | 5,923 | | | $ | 1,581 | | | $ | 2,613 | | | $ | 2,539 | |
| | | | | | | | | |
Weighted-average crediting rate | 1.40 | % | | 4.85 | % | | 3.44 | % | | N/A | | N/A |
Net amount at risk (d) | N/A | | N/A | | $ | 60,389 | | | N/A | | N/A |
Cash surrender value (e) | $ | 25,099 | | | $ | 12,505 | | | $ | 1,872 | | | N/A | | N/A |
(a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance.
(b) FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials.
(c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives.
(d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.
(e) These amounts are gross of reinsurance.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
| FIA | | Fixed rate annuities | | Universal Life | | FABN (b) | | FHLB (b) |
Balance, beginning of year | $ | 21,997 | | | $ | 6,367 | | | $ | 1,907 | | | $ | 1,904 | | | $ | 1,543 | |
Issuances | 4,462 | | | 3,758 | | | 167 | | | 700 | | | 1,192 | |
Premiums received | 106 | | | 3 | | | 295 | | | — | | | — | |
Policy charges (a) | (166) | | | (1) | | | (209) | | | — | | | — | |
Surrenders and withdrawals | (1,322) | | | (797) | | | (74) | | | — | | | — | |
Benefit payments | (485) | | | (192) | | | (22) | | | (35) | | | (789) | |
| | | | | | | | | |
Interest credited | 198 | | | 220 | | | 48 | | | 45 | | | 36 | |
Other | (24) | | | — | | | — | | | (1) | | | — | |
Balance, end of year | $ | 24,766 | | | $ | 9,358 | | | $ | 2,112 | | | $ | 2,613 | | | $ | 1,982 | |
Embedded derivative adjustment (c) | (343) | | | — | | | 15 | | | — | | | — | |
Gross Liability, end of period | $ | 24,423 | | | $ | 9,358 | | | $ | 2,127 | | | $ | 2,613 | | | $ | 1,982 | |
Less: Reinsurance | (17) | | | (3,723) | | | (947) | | | — | | | — | |
Net Liability, after Reinsurance | $ | 24,406 | | | $ | 5,635 | | | $ | 1,180 | | | $ | 2,613 | | | $ | 1,982 | |
| | | | | | | | | |
Weighted-average crediting rate | 0.85 | % | | 2.84 | % | | 2.39 | % | | N/A | | N/A |
Net amount at risk (d) | N/A | | N/A | | $ | 53,348 | | | N/A | | N/A |
Cash surrender value (e) | $ | 23,049 | | | $ | 8,744 | | | $ | 1,698 | | | N/A | | N/A |
(a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance.
(b) FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials.
(c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives.
(d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.
(e) These amounts are gross of reinsurance.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2021 |
| FIA | | Fixed rate annuities | | Universal Life | | FABN (b) | | FHLB (b) |
Balance, beginning of year | $ | 18,703 | | | $ | 5,142 | | | $ | 1,696 | | | $ | — | | | $ | 1,203 | |
Issuances | 4,400 | | | 1,743 | | | 114 | | | 1,899 | | | 759 | |
Premiums received | 103 | | | 3 | | | 233 | | | — | | | — | |
Policy charges (a) | (148) | | | (1) | | | (167) | | | — | | | — | |
Surrenders and withdrawals | (1,303) | | | (543) | | | (68) | | | — | | | — | |
Benefit payments | (440) | | | (145) | | | (19) | | | (7) | | | (447) | |
| | | | | | | | | |
Interest credited | 686 | | | 167 | | | 118 | | | 12 | | | 30 | |
Other | (4) | | | 1 | | | — | | | — | | | (2) | |
Balance, end of year | $ | 21,997 | | | $ | 6,367 | | | $ | 1,907 | | | $ | 1,904 | | | $ | 1,543 | |
Embedded derivative adjustment (c) | 603 | | | — | | | 74 | | | — | | | — | |
Gross Liability, end of period | $ | 22,600 | | | $ | 6,367 | | | $ | 1,981 | | | $ | 1,904 | | | $ | 1,543 | |
Less: Reinsurance | (17) | | | (1,692) | | | (984) | | | — | | | — | |
Net Liability, after Reinsurance | $ | 22,583 | | | $ | 4,675 | | | $ | 997 | | | $ | 1,904 | | | $ | 1,543 | |
| | | | | | | | | |
Weighted-average crediting rate | 3.43 | % | | 2.94 | % | | 6.77 | % | | N/A | | N/A |
Net amount at risk (d) | N/A | | N/A | | $ | 41,326 | | | N/A | | N/A |
Cash surrender value (e) | $ | 20,455 | | | $ | 5,992 | | | $ | 1,572 | | | N/A | | N/A |
(a) Contracts included in the contractholder funds are generally charged a premium and/or monthly assessments on the basis of the account balance.
(b) FABN and FHLB are considered funding agreements that are investment contracts which follow the interest method of accounting, and therefore are not subject to ASU 2018-12 disclosure requirements. However, the Company has elected to present the liability for these agreements within the disaggregated roll forward as we believe it will provide meaningful information for users of the financials.
(c) The embedded derivative adjustment reconciles the account balance to the gross GAAP liability and represents the combination of the host contract and the fair value of the embedded derivatives.
(d) For those guarantees of benefits that are payable in the event of death, the net amount at risk is generally defined as the current guaranteed minimum death benefit in excess of the current account balance at the balance sheet date.
(e) These amounts are gross of reinsurance.
The following table reconciles contractholder funds’ account balances to the contractholder funds liability in the Consolidated Balance Sheet (in millions):
| | | | | | | | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
FIA | $ | 27,407 | | | $ | 24,423 | | | $ | 22,600 | |
Fixed rate annuities | 13,443 | | | 9,358 | | | 6,367 | |
Immediate annuities | 311 | | | 332 | | | 352 | |
Universal life | 2,475 | | | 2,127 | | | 1,981 | |
Traditional life | 5 | | | 5 | | | 5 | |
Funding Agreement-FABN | 2,613 | | | 2,613 | | | 1,904 | |
FHLB | 2,539 | | | 1,982 | | | 1,543 | |
PRT | 5 | | | 3 | | | 1 | |
Total | $ | 48,798 | | | $ | 40,843 | | | $ | 34,753 | |
Annually, typically in the third quarter, we review assumptions associated with reserves for policy benefits and product guarantees. During the third quarter of 2023 and for the year ended December 31, 2023, based on increases in interest rates and pricing changes, we updated certain FIA assumptions used to calculate the fair value of the embedded derivative component within contractholder funds and also aligned reserves to actual policyholder
behavior. These changes resulted in an increase in total benefits and other changes in policy reserves of approximately $73 million for the year ended December 31, 2023.
The following tables present the account values by range of guaranteed minimum crediting rates and the related range of difference, in basis points, between rates being credited to policyholders and the respective guaranteed minimums (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2023 |
Range of guaranteed minimum crediting rate | At Guaranteed Minimum | | 1 Basis Point-50 Basis Points Above | | 51 Basis Points-150 Basis Points Above | | Greater Than 150 Basis Points Above | | Total |
FIA | | | | | | | | | |
0.00%-1.50% | $ | 22,392 | | | $ | 1,444 | | | $ | 526 | | | $ | 1,953 | | | $ | 26,315 | |
1.51%-2.50% | 196 | | | 1 | | | 24 | | | 250 | | | 471 | |
Greater than 2.50% | 377 | | | 1 | | | — | | | — | | | 378 | |
Total | $ | 22,965 | | | $ | 1,446 | | | $ | 550 | | | $ | 2,203 | | | $ | 27,164 | |
| | | | | | | | | |
Fixed Rate Annuities | | | | | | | | | |
0.00%-1.50% | $ | 23 | | | $ | 25 | | | $ | 1,532 | | | $ | 10,271 | | | $ | 11,851 | |
1.51%-2.50% | 5 | | | 8 | | | 23 | | | 453 | | | 489 | |
Greater than 2.50% | 893 | | | 2 | | | 4 | | | 204 | | | 1,103 | |
Total | $ | 921 | | | $ | 35 | | | $ | 1,559 | | | $ | 10,928 | | | $ | 13,443 | |
| | | | | | | | | |
Universal Life | | | | | | | | | |
0.00%-1.50% | $ | 1,987 | | | $ | 5 | | | $ | — | | | $ | 21 | | | $ | 2,013 | |
1.51%-2.50% | — | | | — | | | — | | | — | | | — | |
Greater than 2.50% | 361 | | | 16 | | | 1 | | | — | | | 378 | |
Total | $ | 2,348 | | | $ | 21 | | | $ | 1 | | | $ | 21 | | | $ | 2,391 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2022 |
Range of guaranteed minimum crediting rate | At Guaranteed Minimum | | 1 Basis Point-50 Basis Points Above | | 51 Basis Points-150 Basis Points Above | | Greater Than 150 Basis Points Above | | Total |
FIA | | | | | | | | | |
0.00%-1.50% | $ | 22,848 | | | $ | 801 | | | $ | 410 | | | $ | 151 | | | $ | 24,210 | |
1.51%-2.50% | 162 | | | — | | | 1 | | | — | | | 163 | |
Greater than 2.50% | 390 | | | — | | | 3 | | | — | | | 393 | |
Total | $ | 23,400 | | | $ | 801 | | | $ | 414 | | | $ | 151 | | | $ | 24,766 | |
| | | | | | | | | |
Fixed Rate Annuities | | | | | | | | | |
0.00%-1.50% | $ | 10 | | | $ | 32 | | | $ | 1,871 | | | $ | 6,379 | | | $ | 8,292 | |
1.51%-2.50% | 9 | | | 14 | | | 30 | | | 1 | | | 54 | |
Greater than 2.50% | 997 | | | 4 | | | 4 | | | 7 | | | 1,012 | |
Total | $ | 1,016 | | | $ | 50 | | | $ | 1,905 | | | $ | 6,387 | | | $ | 9,358 | |
| | | | | | | | | |
Universal Life | | | | | | | | | |
0.00%-1.50% | $ | 1,701 | | | $ | 3 | | | $ | — | | | $ | 17 | | | $ | 1,721 | |
1.51%-2.50% | — | | | — | | | — | | | — | | | — | |
Greater than 2.50% | 346 | | | 44 | | | 1 | | | — | | | 391 | |
Total | $ | 2,047 | | | $ | 47 | | | $ | 1 | | | $ | 17 | | | $ | 2,112 | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| December 31, 2021 |
Range of guaranteed minimum crediting rate | At Guaranteed Minimum | | 1 Basis Point-50 Basis Points Above | | 51 Basis Points-150 Basis Points Above | | Greater Than 150 Basis Points Above | | Total |
FIA | | | | | | | | | |
0.00%-1.50% | $ | 20,162 | | | $ | 803 | | | $ | 388 | | | $ | — | | | $ | 21,353 | |
1.51%-2.50% | 171 | | | 11 | | | 25 | | | — | | | 207 | |
Greater than 2.50% | 431 | | | 3 | | | 3 | | | — | | | 437 | |
Total | $ | 20,764 | | | $ | 817 | | | $ | 416 | | | $ | — | | | $ | 21,997 | |
| | | | | | | | | |
Fixed Rate Annuities | | | | | | | | | |
0.00%-1.50% | $ | 2 | | | $ | 28 | | | $ | 1,928 | | | $ | 3,219 | | | $ | 5,177 | |
1.51%-2.50% | 9 | | | 15 | | | 37 | | | 1 | | | 62 | |
Greater than 2.50% | 954 | | | 142 | | | 25 | | | 7 | | | 1,128 | |
Total | $ | 965 | | | $ | 185 | | | $ | 1,990 | | | $ | 3,227 | | | $ | 6,367 | |
| | | | | | | | | |
Universal Life | | | | | | | | | |
0.00%-1.50% | $ | 1,486 | | | $ | 2 | | | $ | — | | | $ | 13 | | | $ | 1,501 | |
1.51%-2.50% | — | | | — | | | — | | | — | | | — | |
Greater than 2.50% | 359 | | | 46 | | | 1 | | | — | | | 406 | |
Total | $ | 1,845 | | | $ | 48 | | | $ | 1 | | | $ | 13 | | | $ | 1,907 | |
Note J - Future Policy Benefits
The following table summarizes balances and changes in the present value of expected net premiums and the present value of the expected FPB for nonparticipating traditional contracts (in millions):
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
Expected net premiums | | | | | | |
Balance, beginning of year | | $ | 797 | | | $ | 1,020 | | | $ | 1,152 | |
Beginning balance at original discount rate | | 974 | | | 1,045 | | | 1,131 | |
| | | | | | |
Effect of actual variances from expected experience | | (1) | | | 33 | | | 25 | |
Balance adjusted for variances from expectation | | $ | 973 | | | $ | 1,078 | | | $ | 1,156 | |
| | | | | | |
Interest accrual | | 19 | | | 20 | | | 22 | |
Net premiums collected | | (118) | | | (124) | | | (133) | |
| | | | | | |
Ending Balance at original discount rate | | $ | 874 | | | $ | 974 | | | $ | 1,045 | |
Effect of changes in discount rate assumptions | | (152) | | | (177) | | | (25) | |
Balance, end of year | | $ | 722 | | | $ | 797 | | | $ | 1,020 | |
| | | | | | |
Expected FPB | | | | | | |
Balance, beginning of year | | $ | 2,151 | | | $ | 2,772 | | | $ | 3,105 | |
Beginning balance at original discount rate | | 2,665 | | | 2,806 | | | 2,995 | |
| | | | | | |
Effect of actual variances from expected experience | | (24) | | | 13 | | | (14) | |
Balance adjusted for variances from expectation | | $ | 2,641 | | | $ | 2,819 | | | $ | 2,981 | |
| | | | | | |
Interest accrual | | 56 | | | 59 | | | 62 | |
Benefits payments | | (205) | | | (213) | | | (237) | |
| | | | | | |
Ending Balance at original discount rate | | $ | 2,492 | | | $ | 2,665 | | | $ | 2,806 | |
Effect of changes in discount rate assumptions | | (421) | | | (514) | | | (34) | |
Balance, end of year | | $ | 2,071 | | | $ | 2,151 | | | $ | 2,772 | |
| | | | | | |
Net liability for future policy benefits | | $ | 1,349 | | | $ | 1,354 | | | $ | 1,752 | |
Less: Reinsurance recoverable | | 413 | | | 612 | | | 749 | |
Net liability for future policy benefits, after reinsurance recoverable | | $ | 936 | | | $ | 742 | | | $ | 1,003 | |
| | | | | | |
Weighted-average duration of liability for future policyholder benefits (years) | | 7.36 | | 7.58 | | 8.54 |
The following tables summarize balances and changes in the present value of the expected FPB for limited-payment contracts (in millions):
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
| | PRT |
Balance, beginning of year | | $ | 2,165 | | | $ | 1,148 | | | $ | — | |
Beginning balance at original discount rate | | 2,475 | | | 1,151 | | | — | |
Effect of changes in cash flow assumptions | | (9) | | | (20) | | | — | |
Effect of actual variances from expected experience | | (7) | | | 2 | | | — | |
Balance adjusted for variances from expectation | | $ | 2,459 | | | $ | 1,133 | | | $ | — | |
Issuances | | 2,041 | | | 1,418 | | | 1,155 | |
Interest accrual | | 109 | | | 50 | | | 2 | |
Benefits payments | | (258) | | | (126) | | | (6) | |
| | | | | | |
Ending Balance at original discount rate | | $ | 4,351 | | | $ | 2,475 | | | $ | 1,151 | |
Effect of changes in discount rate assumptions | | (162) | | | (310) | | | (3) | |
Balance, end of year | | $ | 4,189 | | | $ | 2,165 | | | $ | 1,148 | |
| | | | | | |
Net liability for future policy benefits | | $ | 4,189 | | | $ | 2,165 | | | $ | 1,148 | |
Less: Reinsurance recoverable | | — | | | — | | | — | |
Net liability for future policy benefits, after reinsurance recoverable | | $ | 4,189 | | | $ | 2,165 | | | $ | 1,148 | |
| | | | | | |
Weighted-average duration of liability for future policyholder benefits (years) | | 8.23 | | 8.09 | | 8.75 |
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
| | Immediate annuities |
Balance, beginning of year | | $ | 1,429 | | | $ | 1,954 | | | $ | 2,153 | |
Beginning balance at original discount rate | | 1,858 | | | 1,935 | | | 2,040 | |
Effect of changes in cash flow assumptions | | — | | | — | | | — | |
Effect of actual variances from expected experience | | (15) | | | (26) | | | (47) | |
Balance adjusted for variances from expectation | | $ | 1,843 | | | $ | 1,909 | | | $ | 1,993 | |
Issuances | | 22 | | | 26 | | | 18 | |
Interest accrual | | 51 | | | 60 | | | 60 | |
Benefits payments | | (128) | | | (137) | | | (136) | |
| | | | | | |
Ending Balance at original discount rate | | $ | 1,788 | | | $ | 1,858 | | | $ | 1,935 | |
Effect of changes in discount rate assumptions | | (373) | | | (429) | | | 19 | |
Balance, end of year | | $ | 1,415 | | | $ | 1,429 | | | $ | 1,954 | |
| | | | | | |
Net liability for future policy benefits | | $ | 1,415 | | | $ | 1,429 | | | $ | 1,954 | |
Less: Reinsurance recoverable | | 116 | | | 118 | | | 145 | |
Net liability for future policy benefits, after reinsurance recoverable | | $ | 1,299 | | | $ | 1,311 | | | $ | 1,809 | |
| | | | | | |
Weighted-average duration of liability for future policyholder benefits (years) | | 12.47 | | 11.76 | | 13.61 |
The following tables summarize balances and changes in the liability for DPL for limited-payment contracts (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
| | Immediate annuities | | PRT | | Immediate annuities | | PRT | | Immediate annuities | | PRT |
Balance, beginning of year | | $ | 69 | | | $ | 4 | | | $ | 57 | | | $ | 7 | | | $ | 22 | | | $ | — | |
Effect of modeling changes | | 4 | | | — | | | — | | | — | | | — | | | — | |
Effect of changes in cash flow assumptions | | — | | | 1 | | | — | | | (2) | | | — | | | — | |
Effect of actual variances from expected experience | | 16 | | | 5 | | | 16 | | | — | | | 39 | | | — | |
Balance adjusted for variances from expectation | | 89 | | | 10 | | | 73 | | | 5 | | | 61 | | | — | |
Issuances | | 3 | | | — | | | 1 | | | — | | | — | | | 7 | |
Interest accrual | | 2 | | | 1 | | | 2 | | | — | | | 2 | | | — | |
Amortization | | (7) | | | (1) | | | (7) | | | (1) | | | (6) | | | — | |
Balance, end of year | | $ | 87 | | | $ | 10 | | | $ | 69 | | | $ | 4 | | | $ | 57 | | | $ | 7 | |
The following table reconciles the net FPB to the FPB in the Consolidated Balance Sheets (in millions). The DPL for Immediate Annuities and PRT is presented together with the FPB in the Consolidated Balance Sheets and has been included as a reconciling item in the table below:
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
Traditional Life | | $ | 1,349 | | | $ | 1,354 | | | $ | 1,752 | |
Immediate annuities | | 1,415 | | | 1,429 | | | 1,954 | |
PRT | | 4,189 | | | 2,165 | | | 1,148 | |
Immediate annuities DPL | | 87 | | | 69 | | | 57 | |
PRT DPL | | 10 | | | 4 | | | 7 | |
Total | | $ | 7,050 | | | $ | 5,021 | | | $ | 4,918 | |
The following table provides the amount of undiscounted and discounted expected gross premiums and expected future benefits and expenses for nonparticipating traditional and limited-payment contracts (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Undiscounted | | Discounted |
| | December 31, 2023 | | December 31, 2022 | | December 31, 2023 | | December 31, 2022 |
Traditional Life | | | | | | | | |
Expected future benefit payments | | $ | 2,935 | | | $ | 3,132 | | | $ | 2,075 | | | $ | 2,640 | |
Expected future gross premiums | | 1,082 | | | 1,209 | | | 789 | | | 1,043 | |
Immediate annuities | | | | | | | | |
Expected future benefit payments | | $ | 3,291 | | | $ | 3,434 | | | $ | 1,413 | | | $ | 1,858 | |
Expected future gross premiums | | — | | | — | | | — | | | — | |
PRT | | | | | | | | |
Expected future benefit payments | | $ | 6,709 | | | $ | 3,569 | | | $ | 4,350 | | | $ | 2,472 | |
Expected future gross premiums | | — | | | — | | | — | | | — | |
The following table summarizes the amount of revenue and interest related to nonparticipating traditional and limited-payment contracts recognized in the Consolidated Statements of Operations (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | Gross Premiums (a) | | Interest Expense (b) |
| | December 31, 2023 | | December 31, 2022 | | December 31, 2021 | | December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
Traditional Life | | $ | 123 | | | $ | 137 | | | $ | 152 | | | $ | 37 | | | $ | 39 | | | $ | 40 | |
Immediate annuities | | 24 | | | 23 | | | 16 | | | 51 | | | 60 | | | 60 | |
PRT | | 1,964 | | | 1,362 | | | 1,146 | | | 109 | | | 50 | | | 2 | |
Total | | $ | 2,111 | | | $ | 1,522 | | | $ | 1,314 | | | $ | 197 | | | $ | 149 | | | $ | 102 | |
(a) Included in Life insurance premiums and other fees on the Consolidated Statements of Operations.
(b) Included in Benefits and other changes in policy reserves (remeasurement gains (losses) (a)) on the Consolidated Statements of Operations.
The following table presents the weighted-average interest rate:
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2023 | | December 31, 2022 | | December 31, 2021 |
Traditional Life | | | | | | |
Interest accretion rate | | 2.33 | % | | 2.32 | % | | 2.29 | % |
Current discount rate | | 5.03 | % | | 5.37 | % | | 2.41 | % |
Immediate annuities | | | | | | |
Interest accretion rate | | 3.14 | % | | 3.07 | % | | 3.04 | % |
Current discount rate | | 4.98 | % | | 5.21 | % | | 3.07 | % |
PRT | | | | | | |
Interest accretion rate | | 4.61 | % | | 3.20 | % | | 1.20 | % |
Current discount rate | | 5.03 | % | | 5.40 | % | | 2.79 | % |
The following tables summarize the actual experience and expected experience for mortality and lapses of the FPB:
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2023 |
| | Traditional Life | | Immediate annuities | | PRT |
Mortality | | | | | | |
Actual experience | | 1.7 | % | | 3.2 | % | | 3.2 | % |
Expected experience | | 1.4 | % | | 1.8 | % | | 2.3 | % |
Lapses | | | | | | |
Actual experience | | — | % | | — | % | | — | % |
Expected experience | | 0.3 | % | | — | % | | — | % |
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2022 |
| | Traditional Life | | Immediate annuities | | PRT |
Mortality | | | | | | |
Actual experience | | 1.5 | % | | 3.0 | % | | 1.9 | % |
Expected experience | | 1.3 | % | | 1.9 | % | | 2.5 | % |
Lapses | | | | | | |
Actual experience | | — | % | | — | % | | — | % |
Expected experience | | 0.3 | % | | — | % | | — | % |
| | | | | | | | | | | | | | | | | | | | |
| | December 31, 2021 |
| | Traditional Life | | Immediate annuities | | PRT |
Mortality | | | | | | |
Actual experience | | 1.7 | % | | 4.2 | % | | — | % |
Expected experience | | 1.3 | % | | 2.0 | % | | — | % |
Lapses | | | | | | |
Actual experience | | 0.1 | % | | — | % | | — | % |
Expected experience | | 0.3 | % | | — | % | | — | % |
The following table provides additional information for periods in which a cohort has an NPR > 100% (and therefore capped at 100%) (dollars in millions):
| | | | | | | | | | | | | | | | | | |
| | | | December 31, 2022 |
| | | | | | Cohort X | | Description (a) |
Net Premium Ratio before capping | | | | | | 100 | % | | Term with ROP Non-NY Cohort |
Reserves before NP Ratio capping | | | | | | $ | 1,172 | | | Term with ROP Non-NY Cohort |
Reserves after NP Ratio capping | | | | | | $ | 1,173 | | | Term with ROP Non-NY Cohort |
Loss Expense | | | | | | — | | | Term with ROP Non-NY Cohort |
(a) Return of Premium (“ROP”)
F&G realized actual-to-expected experience variances and made changes to assumptions during the years ended December 31, 2023 and 2022 as follows:
Traditional life
Significant assumption inputs to the calculation of the FPB for traditional life include mortality, lapses (including lapses due to nonpayment of premium and surrenders for cash surrender value), and discount rates (both accretion and current). We review the cash flow assumptions annually, typically in the third quarter. In 2023, F&G undertook a review of all significant assumptions and revised the lapse assumption, resulting in a slight decrease to the FPB. There have been no other significant changes.
Market data that underlies current discount rates was updated in 2023 from that utilized in 2022, resulting in decreased discount rates that drove a material increase to the FPB.
In 2022, F&G similarly undertook a review in the third quarter of the significant cash flow assumptions and did not make any changes to mortality or lapses.
Market data that underlies current discount rates was updated from 2021 and increased significantly year-over-year, resulting in a material decrease to the FPB. Impacts to expected net premiums and expected FPBs due to discount rate changes in 2022 can be observed in the FPB roll forward tables at December 31, 2022.
Immediate annuities (life contingent)
Significant assumption inputs to the calculation of the FPB for immediate annuities (life contingent) include mortality and discount rates (both accretion and current). We review the cash flow assumptions annually, typically in the third quarter. In 2023, F&G undertook a review of the significant cash flow assumptions and did not make any changes to mortality. Market data that underlies current discount rates was updated in 2023 from that utilized in 2022, resulting in decreased discount rates that drove a material increase to the FPB.
In 2022, F&G similarly undertook a review of the significant cash flow assumptions and did not make any changes to those assumptions. Market data that underlies current discount rates was updated from 2021 and increased significantly year-over-year, resulting in a material decrease to the FPB. Impacts to expected FPBs due to assumption changes in 2022 can be observed in the FPB roll forward tables at December 31, 2022.
PRT (life contingent)
Significant assumption inputs to the calculation of the FPB for PRT (life contingent) include mortality and discount rates (both accretion and current). We review the cash flow assumptions annually, typically in the third quarter. In 2023, F&G undertook a review of the significant cash flow assumptions and did not make any changes to mortality. Market data that underlies current discount rates was updated in 2023 from that utilized in 2022 resulting in decreased discount rates that drove a material increase to the FPB.
In 2022, F&G similarly undertook a review of the significant cash flow assumption and did not make any changes to mortality. Market data that underlies current discount rates was updated from 2021 and increased significantly year-over-year, resulting in a material decrease to the FPB. Impacts to expected FPBs due to assumption changes in 2022 can be observed in the FPB roll forward tables at December 31, 2022.
Premium deficiency testing
F&G conducts annual premium deficiency testing for its long-duration contracts except for the FPB for nonparticipating traditional and limited-payment contracts. F&G also conducts annual premium deficiency testing for the VOBA of all long-duration contracts. Premium deficiency testing is performed by reviewing assumptions used to calculate the insurance liabilities and determining whether the sum of the existing contract liabilities and the present value of future gross premiums is sufficient to cover the present value of future benefits to be paid to or on behalf of policyholders and settlement costs and recover unamortized present value of future profits. Anticipated investment income, based on F&G’s experience, is considered when performing premium deficiency testing for long-duration contracts. During 2023 and 2022, F&G was not required to establish any additional liabilities as a result of premium deficiency testing.
Note K - Accounts Payable and Accrued liabilities
As of December 31, 2023 and 2022, the total URL balance of $270 million and $166 million, respectively, is included in Accounts payable and accrued liabilities on the Consolidated Balance Sheets. The following table presents a reconciliation of Accounts payable and accrued liabilities to the Consolidated Balance Sheets as of December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | |
| December 31, |
| 2023 | | 2022 |
Salaries and incentives | $ | 99 | | | $ | 72 | |
Accrued benefits | 60 | | | 58 | |
URL | 270 | | | 166 | |
Trade accounts payable | 297 | | | 114 | |
Liability for policy and contract claims | 92 | | | 109 | |
Retained asset account | 81 | | | 117 | |
Remittances and items not allocated | 284 | | | 225 | |
Option collateral liabilities | 588 | | | 178 | |
Lease liability | 11 | | | 13 | |
Investment purchases payable | 21 | | | 4 | |
Other accrued liabilities | 208 | | | 204 | |
Accounts payable and accrued liabilities | $ | 2,011 | | | $ | 1,260 | |
The following tables roll forward URL for the years ended December 31, 2023 and 2022 (in millions):
| | | | | | | | | | | | | | | |
| Universal Life | | | | | | Total |
Balance at January 1, 2023 | $ | 166 | | | | | | | $ | 166 | |
Capitalization | 119 | | | | | | | 119 | |
Amortization | (15) | | | | | | | (15) | |
Balance at December 31, 2023 | $ | 270 | | | | | | | $ | 270 | |
| | | | | | | |
| Universal Life | | | | | | Total |
Balance at January 1, 2022 | $ | 87 | | | | | | | $ | 87 | |
Capitalization | 89 | | | | | | | 89 | |
Amortization | (10) | | | | | | | (10) | |
Balance at December 31, 2022 | $ | 166 | | | | | | | $ | 166 | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
| | | | | | | |
For IUL the cash flow assumptions used to amortize URL reflect the Company’s best estimates for policyholder behavior. We review cash flow assumptions annually, generally in the third quarter. In 2023, F&G undertook a review of all significant assumptions, and there were changes to IUL assumptions involving surrender rates and premium persistency. In 2022, F&G undertook a review of all significant assumptions, and there were no changes with a significant impact.
Note L - Notes Payable
Notes payable consists of the following:
| | | | | | | | | | | |
| December 31, 2023 | | December 31, 2022 |
| (In millions) |
7.95% F&G Notes, net of $9 of deferred issuance costs at December 31, 2023 | $ | 336 | | | $ | — | |
7.40% F&G Notes, net of $5 of deferred issuance costs at December 31, 2023 | 495 | | | — | |
5.50% F&G Notes, net of $11 and $19 of purchase premium at December 31, 2023 and 2022, respectively | 561 | | | 567 | |
Revolving Credit Facility - Short-term, net of deferred issuance costs of $3 and $3 at December 31, 2023 and 2022, respectively | 362 | | | 547 | |
Total | $ | 1,754 | | | $ | 1,114 | |
7.95% F&G Notes - On December 6, 2023, F&G issued $345 million of its 7.95% Senior Notes due 2053. The 7.95% F&G Notes were issued at par, net of deferred issuance costs of approximately $9 million. The 7.95% F&G Notes are senior unsecured, unsubordinated obligations of F&G and are guaranteed by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. The 7.95% F&G Notes mature on December 15, 2053, and become callable on or after December 15, 2028. Interest is payable quarterly at a fixed rate of 7.95%, and, if the 7.95% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. F&G used a portion of the net proceeds from the offering to repay borrowings under its revolving credit facility as discussed below and for general corporate purposes, including the support of organic growth opportunities.
7.40% F&G Notes - On January 13, 2023, F&G issued $500 million of its 7.40% F&G Notes due 2028. The 7.40% F&G Notes were issued at par, net of deferred issuance costs of approximately $6 million. The 7.40% F&G Notes are senior, unsecured unsubordinated obligations of F&G and are fully and unconditionally guaranteed on an unsecured, unsubordinated basis by each of F&G’s subsidiaries that are guarantors of F&G’s obligations under its existing credit agreement. The 7.40% F&G Notes mature on January 13, 2028, and become callable on or after December 13, 2027. Interest is payable semi-annually at a fixed rate of 7.40%, and if, the 7.40% F&G Notes are downgraded, the interest rate payable is subject to adjustment from time to time per the terms of the indenture. F&G used the net proceeds from the offering for general corporate purposes, including to support the growth of assets under management and for F&G's future liquidity requirements.
5.50% F&G Notes - On April 20, 2018, Fidelity & Guaranty Life Holdings, Inc. (“FGLH”), our indirect wholly
owned subsidiary, completed a debt offering of $550 million aggregate principal amount of 5.50% senior notes due May 1, 2025 at 99.5% of face value for proceeds of $547 million. As a result of the FNF acquisition, a premium of $39 million was established for these notes and is being amortized over the remaining life of the debt through 2025. In conjunction with the acquisition, FNF became a guarantor of FGLH’s obligations under the 5.50% F&G Notes and agreed to fully and unconditionally guarantee the F&G 5.50% Notes, on a joint and several basis.
Revolving Credit Facility - On November 22, 2022, we entered into a Credit agreement (the “Credit Agreement”) with certain lenders (the “Lenders”) and Bank of America, N.A. as administrative agent, swing line lender and an issuing bank, pursuant to which the Lenders have made available an unsecured revolving credit facility in an aggregate principal amount of $550 million to be used for working capital and general corporate purposes. On February 21, 2023, we entered into an amendment with the Lenders to increase the available aggregate principal amount of the Credit Agreement by $115 million to $665 million
The Credit Agreement matures the earlier to occur of November 22, 2025 or 91 days prior to May 1, 2025, the stated maturity date of the 5.50% F&G Notes, unless the principal amount of the 5.50% F&G Notes is 150 million or less at such time, the 5.50% F&G Notes have been redeemed or defeased in full, and any refinancing indebtedness incurred in connection therewith matures at least 91 days after the date that is 3 years from the Effective Date or certain other conditions are met. As the revolving loans under the Credit Agreement mature in less than one year, the amounts outstanding under the Credit Agreement are considered short-term.
Revolving loans under the Credit Agreement generally bear interest at a variable rate based on either (i) the base rate (which is the highest of (a) one-half of one percent in excess of the federal funds rate, (b) the Administrative Agent’s “prime rate”, or (c) the sum of one percent plus Term The Secured Overnight Financing Rate (“SOFR”) plus a margin of between 30.0 and 80.0 basis points depending on the non-credit-enhanced, senior unsecured long-term debt ratings of F&G or (ii) Term SOFR plus a margin of between 130.0 and 180.0 basis points depending on the non-credit-enhanced, senior unsecured long-term debt ratings of F&G. In addition, we pay a facility fee of between 20.0 and 45.0 basis points on the entire facility, also depending on the non-credit-enhanced, senior unsecured long-term debt ratings, which is payable quarterly in arrears. The average variable interest rate on the revolver was 7.11% and 6.07% for the years ended December 31, 2023 and December 31, 2022, respectively.
As of December 31, 2023, and 2022, $365 million and $550 million, respectively, of gross principal balance, was outstanding on the revolving credit facility. Net partial revolver paydowns of $185 million were made during the year ended December 31, 2023. As of December 31, 2023, we had $300 million of remaining borrowing availability.
Refer to Note A - Business and Summary of Significant Accounting Policies, Recent Developments for a discussion of a revolver amendment and extension completed on February 16, 2024.
FNF Credit Facility - On December 29, 2020, we entered into a revolving note agreement with FNF for up to $200 million capacity (the "FNF Credit Facility") to be used for working capital and other general corporate purposes. No amounts were outstanding under this revolving note agreement as of December 31, 2023 or December 31, 2022.
Covenants - The Credit Agreement and the indentures governing the 7.95% F&G Notes, the 7.40% F&G Notes and the 5.50% F&G Notes impose certain operating and financial restrictions, including financial covenants, on F&G. As of December 31, 2023, we were in compliance with all covenants.
Interest Expense - Amortization of deferred issuance costs and purchase premiums are recognized as a component of interest expense. Interest expense on F&G’s outstanding notes payable for the years ended December 31, 2023, 2022 and 2021 was as follows (in millions):
| | | | | | | | | | | | | | | | | |
| Year ended December 31, |
| 2023 | | 2022 | | 2021 |
7.95% F&G Notes | $ | 1 | | | $ | — | | | $ | — | |
7.40% F&G Notes | 37 | | | — | | | — | |
5.50% F&G Notes | 22 | | | 22 | | | 26 | |
Revolving Credit Facility | 37 | | | 1 | | | — | |
FNF Promissory Note (a) | — | | | 6 | | | 3 | |
Total | $ | 97 | | | $ | 29 | | | $ | 29 | |
(a) In June 2022, the $400 million FNF Promissory Note was exchanged for F&G common stock, and the note was retired.
Maturities - Gross principal maturities of notes payable at December 31, 2023 are as follows (in millions):
| | | | | |
| |
2024 | $ | 365 | |
2025 | 550 | |
2026 | — | |
2027 | — | |
2028 | 500 | |
Thereafter | 345 | |
Total | $ | 1,760 | |
Note M - Supplemental Cash Flow Information
The following supplemental cash flow information is provided with respect to certain cash payment and non-cash investing and financing activities (in millions).
| | | | | | | | | | | | | | | | | |
| Year ended December 31, |
| 2023 | | 2022 | | 2021 |
| | | | | |
Cash paid for: | | | | | |
Interest paid | $ | 84 | | | $ | 34 | | | $ | 30 | |
Income taxes (refunded) paid | 4 | | | (72) | | | 44 | |
Deferred sales inducements | 168 | | | 87 | | | 90 | |
Non-cash investing and financing activities: | | | | | |
Investments received from pension risk transfer premiums | 464 | | | — | | | 316 | |
Change in proceeds of sales of investments available for sale receivable in period | 34 | | | 115 | | | (160) | |
Change in purchases of investments available for sale payable in period | 20 | | | (10) | | | 2 | |
Note N - Commitments and Contingencies
Legal and Regulatory Contingencies
In the ordinary course of business, we are involved in various pending and threatened litigation matters related to our operations, some of which include claims for punitive or exemplary damages. Like other companies, our ordinary course litigation includes a number of class action and purported class action lawsuits, which make allegations related to aspects of our operations. We believe that no actions, other than the matters discussed below, if any, depart from customary litigation incidental to our business.
We review lawsuits and other legal and regulatory matters (collectively “legal proceedings”) on an ongoing basis when making accrual and disclosure decisions. When assessing reasonably possible and probable outcomes, management bases its decision on its assessment of the ultimate outcome assuming all appeals have been exhausted. For legal proceedings in which it has been determined that a loss is both probable and reasonably estimable, a liability based on known facts and that represents our best estimate has been recorded. Our accrual for legal and regulatory matters was insignificant as of December 31, 2023 and 2022. We do not consider (i) the amounts we have currently recorded for all legal proceedings in which it has been determined that a loss is both probable and reasonably estimable and (ii) reasonably possible losses for all pending legal proceedings to be material to our
financial statements either individually or in the aggregate. Actual losses may materially differ from the amounts recorded and the ultimate outcome of our pending legal proceedings is generally not yet determinable. While some of these matters could be material to our operating results or cash flows for any particular period if an unfavorable outcome results, at present we do not believe that the ultimate resolution of currently pending legal proceedings, either individually or in the aggregate, will have a material adverse effect on our financial condition.
In August 2020, a lawsuit styled, In the Matter of FGL Holdings, was filed in the Grand Court of the Cayman Islands related to FNF's acquisition of F&G where dissenting shareholders, Kingfishers LP, Kingstown 1740 Fund LP, Kingstown Partners II LP, Kingstown Partners Master Ltd., and Ktown LP, asserted statutory appraisal rights relative to their ownership of 12,000,000 shares of F&G stock. They sought a judicial determination of the fair value of their shares of F&G stock as of the date of valuation under the law of the Cayman Islands, together with interest and legal costs. On October 5, 2022, the Grand Court of the Cayman Islands decided in favor of F&G. The dissenting shareholders failed to appeal the fair value order, and its appeal period expired on October 19, 2022. On April 19, 2023, the Grand Court of the Cayman Islands determined that the dissenting shareholders should pay F&G's Cayman Islands legal expenses and discovery costs relating to the lawsuit, by way of interim payment of $4 million with the balance to be determined after assessment. We are attempting to collect reimbursement of our expenses in this lawsuit.
F&G is a defendant in two putative class action lawsuits related to the alleged compromise of certain of F&G’s customers’ personal information resulting from an alleged vulnerability in the MOVEit file transfer software. F&G’s vendor, Pension Benefit Information, LLC (“PBI”), used the MOVEit software in the course of providing audit and address research services to F&G and many other corporate customers. Miller v. F&G, No. 4:23-cv-00326 (“Miller”), was filed against F&G in the Southern District of Iowa on August 31, 2023. Miller alleges that he is a F&G customer whose information was impacted in the MOVEit incident and brings common law tort and implied contract claims. F&G has yet to be served in Miller. Plaintiff seeks injunctive relief and damages. Cooper v. Progress Software Corp., No. 1:23-cv-12067 (“Cooper”), was filed against F&G and five other defendants in the District of Massachusetts on September 7, 2023. F&G was served on September 15, 2023. Cooper also alleges that he is an F&G customer and brings similar common law tort claims and alleges claims as a purported third-party beneficiary of an alleged contract. Plaintiff seeks declaratory and injunctive relief and damages. At this time, F&G does not believe the incident or resulting lawsuits will have a material impact on its business, operations, or financial results.
Well over 150 similar lawsuits have been filed against other entities impacted by the MOVEit incident including a number of such lawsuits related to PBI’s use of MOVEit. On October 4, 2023, the U.S. Judicial Panel on Multidistrict Litigation (JPML) created a multidistrict litigation (“MDL”) pursuant to 28 U.S.C. § 1407 to handle all litigation brought by individuals whose information was potentially compromised in connection with the alleged MOVEit vulnerability. The JPML assigned the MDL to Judge Allison Burroughs of the U.S. District Court for the District of Massachusetts. Both Miller and Cooper have been transferred to Judge Burroughs in the MDL. Following creation of the MDL, Judge Burroughs conducted an initial case management conference on November 30, 2023 and appointed lead plaintiffs’ counsel on January 19, 2024. Judge Burroughs is currently considering the parties’ case management schedule proposals submitted on February 16, 2024. Judge Burroughs is then likely to issue a Case Management Order with additional processes and a preliminary schedule as a next step in the consolidated litigations.
From time to time we receive inquiries and requests for information from state insurance departments, attorneys general and other regulatory agencies about various matters relating to our business. Sometimes these take the form of civil investigative demands or subpoenas. We cooperate with all such inquiries, and we have responded to or are currently responding to inquiries from multiple governmental agencies. From time to time, we are assessed fines for violations of regulations or other matters or enter into settlements with such authorities, which may require us to pay fines or claims or take other actions. We do not anticipate such fines and settlements, either individually or in the aggregate, will have a material adverse effect on our financial condition.
Commitments
We have unfunded commitments as of December 31, 2023 based upon the timing of when investments and agreements are executed or signed compared to when the actual investments and agreements are funded or closed. Some investments require that funding occur over a period of months or years. A summary of unfunded commitments by commitment type as of December 31, 2023 is included below (in millions):
| | | | | | | |
| December 31, 2023 | | |
Commitment Type | | | |
Unconsolidated VIEs: | | | |
Limited partnerships | $ | 1,735 | | | |
Whole loans | 600 | | | |
Fixed maturity securities, ABS | 244 | | | |
Direct Lending | 667 | | | |
Other fixed maturity securities, AFS | 14 | | | |
Commercial mortgage loans | 72 | | | |
| | | |
Other assets | 421 | | | |
Other invested assets | 15 | | | |
| | | |
Total | $ | 3,768 | | | |
See Note A - Business and Summary of Significant Accounting Policies, for discussion of funding agreements that have been issued pursuant to the FABN Program as well as to the FHLB that are included in Contractholder funds.
The Company leases office space under operating leases. The largest leases expire in 2030. Rent expense and minimum rental commitments under all leases are immaterial.
F&G has a reinsurance agreement with Kubera to cede certain FIA statutory reserves on a coinsurance funds withheld basis, net of applicable existing reinsurance. To enhance Kubera's ability to pay its obligations under the amended reinsurance agreement, effective October 31, 2021, F&G entered into a Variable Note Purchase Agreement (the “NPA”), whereby F&G agreed to fund a note to Kubera to be used to ultimately settle with F&G, with principal increases up to a maximum amount of $300 million, to the extent a potential funding shortfall (treaty assets are less than the total funding requirement) is projected relative to the business ceded to Kubera from F&G as part of the amended reinsurance agreement. The potential funding shortfall will be determined quarterly and, among other items, is impacted by the market value of the assets in the funds withheld account related to the reinsurance agreement and Kubera's capital as calculated on a Bermuda regulatory basis. The NPA matures on November 30, 2071. Based on the current level of the treaty assets and projections that these policies will be profitable over the lifetime of the agreement, we do not expect significant fundings to occur under the NPA. As of December 31, 2023 and 2022, the amount funded under the NPA was insignificant.
Note O - Insurance Subsidiary Financial Information and Regulatory Matters
Our U.S. insurance subsidiaries, FGL Insurance, FGL NY Insurance, Raven Re and Corbeau Re file financial statements with state insurance regulatory authorities and, with the exception of Raven Re, with the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect VOBA, DAC, and DSI, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items.
Our non-U.S. insurance subsidiaries, F&G Life Re Ltd (Bermuda) and F&G Cayman Re Ltd (“F&G Cayman Re”), file financial statements with their respective regulators.
U.S. Companies
Our principal insurance subsidiaries' statutory (SAP and GAAP) financial statements are based on a December 31 year end. Statutory net income and statutory capital and surplus of our wholly owned U.S. regulated insurance subsidiaries were as follows (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| Subsidiary (state of domicile) (a) |
| FGL Insurance (IA) | | FGL NY Insurance (NY) | | Raven Re (VT) | | Corbeau Re (VT) |
Statutory Net income (loss): | | | | | | | |
Year ended December 31, 2023 | $ | (462) | | | $ | 5 | | | $ | 60 | | | $ | (644) | |
Year ended December 31, 2022 | (243) | | | (15) | | | (111) | | | — | |
Year ended December 31, 2021 | 351 | | | 4 | | | 3 | | | — | |
Statutory Capital and Surplus: | | | | | | | |
December 31, 2023 | $ | 2,009 | | | $ | 86 | | | $ | 140 | | | $ | 171 | |
December 31, 2022 | 1,877 | | | 82 | | | 121 | | | — | |
| | | | | | | |
(a)FGL NY Insurance, Raven Re and Corbeau Re are subsidiaries of FGL Insurance, and the columns should not be added together. Corbeau Re was incorporated on September 1, 2023.
Regulation - U.S. Companies
FGL Insurance, FGL NY Insurance, Raven Re's and Corbeau Re’s respective statutory capital and surplus satisfy the applicable minimum regulatory requirements.
In order to enhance the regulation of insurers’ solvency, the NAIC adopted a model law to implement RBC requirements for life, health and property and casualty insurance companies. All states have adopted the NAIC’s model law or a substantially similar law. RBC is used to evaluate the adequacy of capital and surplus maintained by an insurance company in relation to risks associated with: (i) asset risk, (ii) insurance risk, (iii) interest rate risk, and (iv) business risk. As of the most recent annual statutory financial statements filed with insurance regulators, the RBC ratios for FGL Insurance and FGL NY Insurance each exceeded the minimum RBC requirements.
Dividends
The insurance laws of Iowa and New York regulate the amount of dividends that may be paid in any year by FGL Insurance and FGL NY Insurance, respectively.
Pursuant to Iowa insurance law, ordinary dividends are payments, together with all other such payments within the preceding twelve months, that do not exceed the greater of (i) 10% of FGL Insurance’s statutory surplus as regards policyholders as of December 31 of the preceding year; or (ii) the net gain from operations of FGL Insurance (excluding realized capital gains) for the 12-month period ending December 31 of the preceding year.
Dividends in excess of FGL Insurance’s ordinary dividend capacity are referred to as extraordinary and require prior approval of the Iowa Insurance Commissioner. FGL Insurance may only pay dividends out of statutory earned surplus. FGL Insurance did not pay extraordinary dividends to FGAL for the years ended December 31, 2023 and 2022, and paid extraordinary dividends of $38 million during the year ended December 31, 2021.
Each year, FGL NY Insurance may pay a certain limited amount of ordinary dividends or other distributions without being required to obtain the prior consent of or the New York State Department of Financial Services (“NYDFS”). However, to pay any dividends or distributions (including the payment of any dividends or distributions for which prior consent is not required), FGL NY Insurance must provide advance written notice to the NYDFS.
FGL NY Insurance has historically not paid dividends.
Prescribed and permitted practices
FGL Insurance - FGL Insurance applies Iowa-prescribed accounting practices prescribed by 191 Iowa Administrative Code 97, “Accounting for Certain Derivative Instruments Used to Hedge the Growth in Interest Credited for Indexed Insurance Products and Accounting for the Indexed Insurance Products Reserve”, for its FIA products, and as of October 1, 2022, IUL products. Under these alternative accounting practices, the call option derivative instruments that hedge the growth in interest credited on index products are accounted for at amortized cost with the corresponding amortization recorded as a decrease to net investment income and indexed annuity reserves are calculated based on Standard Valuation Law and Actuarial Guideline XXXV assuming the market value of the call options associated with the current index term is zero regardless of the observable market value for such options. This resulted in a $178 million increase and a $152 million decrease to statutory capital and surplus at December 31, 2023 and 2022, respectively.
In addition, based on a permitted practice received from the Iowa Insurance Division, FGL Insurance carries one of its limited partnership interests which qualifies for accounting under SSAP No. 48, “Investments in Joint Ventures, Partnerships and Limited Liability Companies”, on a net asset value per share basis. This is a departure from SSAP No. 48 which requires such investments to be carried based on the investees underlying U.S. GAAP equity (prior to any impairment considerations). This resulted in increases to statutory capital and surplus of $16 million and $13 million at December 31, 2023 and 2022, respectively.
FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset, which increased Raven Re’s statutory capital and surplus by $200 million at December 31, 2023 and 2022. In addition, FGL Insurance’s statutory carrying value of Corbeau Re reflects the effect of permitted practices Corbeau Re received to treat the excess of loss as an admitted asset, which increased Corbeau Re’s statutory capital and surplus by $765 million at December 31, 2023.
Raven Re - Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance and also has approval to include as an admitted asset the value of a letter of credit serving as collateral for reinsurance credit taken by FGL Insurance. Without such permitted statutory accounting practices, Raven Re’s statutory capital and surplus (deficit) would be $(89) million and $(107) million as of December 31, 2023 and 2022, respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent (refer to discussion of letter of credit in Note E- Reinsurance). FGL Insurance’s statutory carrying value of Raven Re was $140 million and $121 million at December 31, 2023 and 2022, respectively.
Corbeau Re - Corbeau Re has four permitted practices pursuant to Vermont Statute, Title 8, Chapter 141 – (8 V.S.A. § 6048k(a)(2), whereby the Vermont Department authorizes the Company to (i) account for the amount equal to the excess of loss amount (“XOL Asset”) as an asset on its statutory financial statements; (ii) calculate the reserves with respect to the Retirement Pro Contracts in accordance with the following reserving methodology: the reserves are calculated as the present value of reinsured benefits when account value equals zero less the present value of reinsurance premiums from the winning integrated stream, floored at zero and capped as necessary to keep the net statutory reserve at the net cash surrender value. For benefits associated with all other contracts (“the GMWB Riders”), the reserves are calculated as the statutory reserves for the entire contract (i.e., the base contracts plus the GMWB Riders) minus the statutory reserves for the base contracts only (“Reserve Calculation Permitted Practice”); (iii) calculate its company action level risk-based capital as defined in Section 8301(13)(A) and, calculated using the risk-based capital factors and formulas prescribed by the NAIC, applying a factor of 0.62% to the XOL Asset Value; and (iv) annually perform a total company solvency analysis in lieu of cash flow testing and actuarial opinion and memorandum under Section 2010-2 of the Vermont Administrative Code. Without such permitted statutory accounting practices, the Company’s statutory capital and surplus (deficit) would be $(594) million as of December 31, 2023, and its risk-based capital would fall below the minimum regulatory requirements. FGL Insurance’s statutory carrying value of Corbeau Re was $171 million at December 31, 2023
FGL NY Insurance - As of December 31, 2023 and 2022, FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices.
Non-U.S. Companies
Net income and capital and surplus of our wholly owned Bermuda and Cayman Islands regulated insurance subsidiaries under U.S. GAAP were as follows (in millions):
| | | | | | | | | | | |
| Subsidiary (country of domicile) |
| F&G Cayman Re (Cayman Islands) | | F&G Life Re (Bermuda) |
Statutory Net income (loss): | | | |
Year ended December 31, 2023 | $ | 384 | | | $ | 151 | |
Year ended December 31, 2022 | (299) | | | (339) | |
Year ended December 31, 2021 | 99 | | | 94 | |
Statutory Capital and Surplus (Deficit): | | | |
December 31, 2023 | $ | 114 | | | $ | 11 | |
December 31, 2022 | (126) | | | (138) | |
| | | |
Regulation - Bermuda
F&G Life Re is a Bermuda exempted company incorporated under the Companies Act 1981, as amended (the “Bermuda Companies Act”) and registered as a Class E insurer under the Insurance Act 1978, as amended, and its related regulations (the “Bermuda Insurance Act”). F&G Life Re is regulated by the Bermuda Monetary Authority (“BMA”).
Effective January 1, 2015, Bermuda was placed on the NAIC’s List of Qualified Jurisdictions, which makes Bermuda-domiciled reinsurers that meet certain criteria to qualify as a certified reinsurer eligible for reduced reinsurance collateral requirements under the NAIC’s Credit for Reinsurance Model Law and Regulations as adopted by various states. F&G Life Re has not applied for a determination to be designated as a certified reinsurer in any state.
Bermuda has been awarded full equivalence for commercial insurers under Europe’s Solvency II regime applicable to insurance companies, which regime came into effect on January 1, 2016.
Effective January 1, 2020, Bermuda was granted NAIC Reciprocal Jurisdiction status, which makes Bermuda domiciled reinsurers that satisfy certain conditions eligible to be designated as a reciprocal jurisdiction reinsurer. Under the NAIC’s Credit for Reinsurance Model Law and Regulations which has been adopted by all states, a ceding insurer may take credit for reinsurance ceded to a reciprocal jurisdiction reinsurer without posting collateral. F&G Life Re has not applied for a determination to be designated a reciprocal jurisdiction reinsurer in any state.
All insurers are required to implement corporate governance policies and processes as the BMA considers appropriate given the nature, size, complexity and risk profile of the insurer and all insurers, on an annual basis, are required to deliver a declaration to the BMA confirming whether or not they meet the minimum criteria for registration under the Insurance Act.
All insurers are required to comply with the Bermuda Insurance Code of Conduct, which is a codification of best practices for insurers provided by the BMA, and to submit annually to the BMA with its statutory financial return a declaration of compliance confirming it complies with the Bermuda Insurance Code of Conduct.
The BMA utilizes a risk-based approach when it comes to licensing and supervising insurance and reinsurance companies. As part of the BMA’s risk-based system, an assessment of the inherent risks within each particular class of insurer or reinsurer is used to determine the limitations and specific requirements that may be imposed. Thereafter the BMA keeps its analysis of relative risk within individual institutions under review on an ongoing basis, including through the scrutiny of audited financial statements, and, as appropriate, meeting with senior management during onsite visits.
The Bermuda Insurance Act imposes on Bermuda insurance companies solvency and liquidity standards, as well as auditing and reporting requirements. Certain significant aspects of the Bermuda insurance regulatory framework are set forth below.
Minimum Solvency Margin. The Bermuda Insurance Act provides that the value of the assets of an insurer must exceed the value of its liabilities by an amount greater than its prescribed minimum solvency margin.
The minimum solvency margin that must be maintained by a Class E insurer is the greater of: (i) $8,000,000; (ii) 2% of first $500,000,000 of assets plus 1.5% of assets above $500,000,000; and (iii) 25% of that insurer’s enhanced capital requirement (“ECR”). An insurer may file an application under the Bermuda Insurance Act to waive the aforementioned requirements.
ECR and Bermuda Solvency Capital Requirements (“BSCR”). Class E insurers are required to maintain available capital and surplus at a level equal to or in excess of the applicable ECR, which is established by reference to either the applicable BSCR model or an approved internal capital model. Furthermore, to enable the BMA to better assess the quality of the insurer’s capital resources, a Class E insurer is required to disclose the makeup of its capital in accordance with its 3-tiered capital system. An insurer may file an application under the Bermuda Insurance Act to have the aforementioned ECR requirements waived.
Restrictions on Dividends and Distributions. In addition to the requirements under the Bermuda Companies Act (as discussed below), the Bermuda Insurance Act limits the maximum amount of annual dividends and distributions that may be paid or distributed by F&G Life Re without prior regulatory approval.
F&G Life Re is prohibited from declaring or paying a dividend if it fails to meet its minimum solvency margin, or ECR, or if the declaration or payment of such dividend would cause such breach. If F&G Life Re were to fail to meet its minimum solvency margin on the last day of any financial year, it would be prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA.
In addition, as a Class E insurer, F&G Life Re must not declare or pay a dividend to any person other than a policyholder unless the value of the assets of such insurer, as certified by the insurer’s approved actuary, exceeds its liabilities (as so certified) by the greater of its margin of solvency or ECR. In the event a dividend complies with the above, F&G Life Re must ensure the amount of any such dividend does not exceed that excess.
Furthermore, as a Class E insurer, F&G Life Re must not declare or pay a dividend in any financial year which would exceed 25% of its total capital and statutory surplus, as set out in its previous year’s financial statements, unless at least seven days before payment of such dividend F&G Life Re files with the BMA an affidavit signed by at least two directors of F&G Life Re and its principal representative under the Bermuda Insurance Act stating that, in the opinion of those signing, declaration of such dividend has not caused the insurer to fail to meet its relevant margins.
The Bermuda Companies Act also limits F&G Life Re’s ability to pay dividends and make distributions to its shareholders. F&G Life Re is not permitted to declare or pay a dividend, or make a distribution out of its contributed surplus, if it is, or would after the payment be, unable to pay its liabilities as they become due or if the realizable value of its assets would be less than its liabilities.
Reduction of Capital. F&G Life Re may not reduce its total statutory capital by 15% or more, as set out in its previous year’s financial statements, unless it has received the prior approval of the BMA. Total statutory capital consists of the insurer’s paid in share capital, its contributed surplus (sometimes called additional paid in capital) and any other fixed capital designated by the BMA as statutory capital.
Regulation - Cayman Islands
F&G Cayman Re is a Cayman Islands exempted company incorporated under the Companies Act, as amended (2023 Revision) (the “Cayman Islands Companies Act”) and licensed as a Class D insurer in the Cayman Islands under the Insurance Act, 2010 as amended and its related regulation (the “Cayman Islands Insurance Act”). F&G Cayman Re is regulated by the Cayman Islands Monetary Authority (“CIMA”).
The Cayman Islands Insurance Act provides that no person may carry on an insurance business in or from within the Cayman Islands unless licensed under the Cayman Islands Insurance Act. CIMA has broad discretion in its consideration of whether to grant a license and must act in the public interest. CIMA is required by the Cayman Islands Insurance Act to determine whether an applicant is a fit and proper body to be engaged in insurance business. A licensed insurer must comply with the terms of its license and such other conditions as CIMA may impose at any time. In addition, the Cayman Islands Insurance Act requires CIMA approval of increases in control or dispositions of control of an insurance company.
All insurers are required to implement corporate governance policies as CIMA considers appropriate given the nature, size, complexity and risk profile of the insurer. All insurers are also required to comply with the CIMA's Rules and Statements of Guidance as applicable to insurers which is a codification of best practices provided by CIMA, and to submit annually to CIMA audited financial statements and a declaration of compliance confirming it complies with the Cayman Islands Insurance Act.
CIMA utilizes a risk-based approach to licensing and supervising insurers and to determining limitations and/or specific requirements. CIMA reviews on an ongoing basis, an insurer’s audited financial statements, actuarial valuation report and, as appropriate, meeting with senior management during onsite visits.
The Cayman Islands Insurance Act and regulations promulgated thereunder impose solvency and liquidity standards on Cayman Islands insurance companies, as well as auditing and reporting requirements.
Capital Requirements. The Cayman Islands Insurance Act provides that an insurer must maintain a minimum capital requirement based on its license class. For a Class D insurer, the minimum capital requirement is $50,000,000. In addition, an insurer must maintain a minimum margin of solvency at a level equal to or in excess of the total prescribed capital requirement which is established by reference to either the applicable prescribed capital requirements based on license class or an internal capital model approved by CIMA. Notwithstanding the minimum capital requirements, CIMA may set an enhanced prescribed capital requirement in respect of any insurer. CIMA may also, for class B, C and D insurers, exclude from the calculations assets that it deems inappropriate.
As a regulated insurance company, F&G Cayman Re is subject to the supervision of CIMA and CIMA may at any time direct F&G Cayman Re, in relation to a policy, a line of business or the entire business, to cease or refrain from committing an act or pursing a course of conduct and to perform such acts as in the opinion of CIMA are necessary to remedy or ameliorate the situation.
The laws and regulations of the Cayman Islands require that, among other things, F&G Cayman Re maintain minimum levels of statutory capital, surplus and liquidity, meet solvency standards, submit to periodic examinations of its financial condition and restrict payments of dividends and reductions of capital. Statutes, regulations and policies that F&G Cayman Re is subject to may also restrict the ability of F&G Cayman Re to write insurance and reinsurance policies, make certain investments and distribute funds. Any failure to meet the applicable requirements or minimum statutory capital requirements could subject it to further examination or corrective action by CIMA, including restrictions on dividend payments, limitations on our writing of additional business or engaging in finance activities, supervision or liquidation.
The prescribed and permitted statutory accounting practices have no impact on our audited Consolidated Financial Statements, which are prepared in accordance with GAAP.
Note P - ASU 2018-12 Transition
F&G adopted ASU 2018-12 on January 1, 2023 with a transition date of January 1, 2021, which is the earliest period presented in the annual December 31, 2023 Consolidated Financial Statements. We elected to adopt ASU 2018-12 using the full retrospective transition method and balances for FPB, DAC and balances amortized on a basis consistent with DAC (VOBA, DSI, and URL), and MRBs were adjusted to conform to ASU 2018-12 starting as of the FNF Acquisition Date. No hindsight was used for the full retrospective adoption of MRBs. As a result of adoption, the Company recorded a cumulative-effect adjustment, which increased opening 2021 retained earnings by $75 million, net of tax.
The following table summarizes the balance of and changes in the FPB on January 1, 2021 due to adoption of ASU 2018-12 (in millions):
| | | | | | | | | | | | | | | | | |
| Immediate annuities | | Traditional Life | | Total (3) |
Balance, December 31, 2020 | $ | 1,861 | | | $ | 2,144 | | | $ | 4,005 | |
| | | | | |
| | | | | |
Cumulative effect of retrospective adoption (1) | 201 | | | (279) | | | (78) | |
Effect of remeasurement of liability at current discount rate (2) | 113 | | | 88 | | | 201 | |
Balance, January 1, 2021 | $ | 2,175 | | | $ | 1,953 | | | $ | 4,128 | |
Less: Reinsurance Recoverable | 322 | | | 793 | | | 1,115 | |
Balance, January 1, 2021, net of reinsurance | $ | 1,853 | | | $ | 1,160 | | | $ | 3,013 | |
| | | | | |
(1) Adjustments for the cumulative effect of adoption of the new measurement guidance under the full retrospective method for contract issue years from the FNF Acquisition Date through December 31, 2020, net of the effects of any change in the DPL. |
(2) The remeasurement of the liability at the current discount rate is reflected as an adjustment to opening AOCI upon the adoption of ASU 2018-12. |
(3) PRT was not written as of the transition date, January 1, 2021, and as a result is not presented in the transition adjustment roll forward. |
The following table summarizes the balance of and changes in VOBA on January 1, 2021 due to adoption of ASU 2018-12 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| FIA | | Fixed rate annuities | | Immediate annuities | | Universal Life | | Traditional Life | | Total |
Balance, December 31, 2020 | $ | 1,208 | | | $ | 15 | | | $ | 86 | | | $ | 139 | | | $ | 18 | | | $ | 1,466 | |
Adjustment for reversal of AOCI adjustments (1) | 208 | | | 24 | | | — | | | 29 | | | (29) | | | 232 | |
Cumulative effect of retrospective adoption (2) | (14) | | | 7 | | | (5) | | | (9) | | | (1) | | | (22) | |
Transition opening balance adjustment (3) | 69 | | | 2 | | | 145 | | | 5 | | | 43 | | | 264 | |
Balance, January 1, 2021 | $ | 1,471 | | | $ | 48 | | | $ | 226 | | | $ | 164 | | | $ | 31 | | | $ | 1,940 | |
| | | | | | | | | | | |
(1) Prior period "shadow" adjustments in AOCI have been reversed upon the adoption of ASU 2018-12 from opening AOCI. |
(2) Adjustments for the cumulative effect of adoption of the simplified amortization methodology under the full retrospective method from the FNF Acquisition Date through December 31, 2020. |
(3) Adjustments for the change in VOBA due to the full retrospective adjustment of carrying amounts of acquired contracts as of the FNF Acquisition Date due to the adoption of ASU 2018-12. |
The following table summarizes the balance of and changes in DAC on January 1, 2021 due to adoption of ASU 2018-12 (in millions):
| | | | | | | | | | | | | | | | | | | | | | | |
| FIA | | Fixed rate annuities | | Universal Life | | Total |
Balance, December 31, 2020 | $ | 167 | | | $ | 14 | | | $ | 41 | | | $ | 222 | |
Adjustment for reversal of AOCI adjustments (1) | 15 | | | 2 | | | 8 | | | 25 | |
Cumulative effect of retrospective adoption (2) | (1) | | | — | | | (1) | | | (2) | |
Balance, January 1, 2021 | $ | 181 | | | $ | 16 | | | $ | 48 | | | $ | 245 | |
| | | | | | | |
(1) Prior period "shadow" adjustments in AOCI have been reversed upon the adoption of ASU 2018-12 from opening AOCI. |
(2) Adjustments for the cumulative effect of adoption of the simplified amortization methodology under the full retrospective method for contract issue years from the FNF Acquisition Date through December 31, 2020. |
The following table summarizes the balance of and changes in DSI on January 1, 2021 due to adoption of ASU 2018-12 (in millions):
| | | | | | | | | | | | | | | |
| FIA | | | | | | Total |
Balance, December 31, 2020 | $ | 36 | | | | | | | $ | 36 | |
Adjustment for reversal of AOCI adjustments (1) | 5 | | | | | | | 5 | |
Cumulative effect of retrospective adoption (2) | 4 | | | | | | | 4 | |
Balance, January 1, 2021 | $ | 45 | | | | | | | $ | 45 | |
| | | | | | | |
(1) Prior period "shadow" adjustments in AOCI have been reversed upon the adoption of ASU 2018-12 from opening AOCI. |
(2) Adjustments for the cumulative effect of adoption of the simplified amortization methodology under the full retrospective method for contract issue years from the FNF Acquisition Date through December 31, 2020. |
The following table summarizes the balance of and changes in URL on January 1, 2021 due to adoption of ASU 2018-12 (in millions):
| | | | | | | | | | | | | | | |
| | | | | Universal Life | | Total |
Balance, December 31, 2020 | | | | | $ | 2 | | | $ | 2 | |
Adjustment for reversal of AOCI adjustments (1) | | | | | 25 | | | 25 | |
Cumulative effect of retrospective adoption (2) | | | | | 2 | | | 2 | |
Balance, January 1, 2021 | | | | | $ | 29 | | | $ | 29 | |
| | | | | | | |
(1) Prior period "shadow" adjustments in AOCI have been reversed upon the adoption of ASU 2018-12 from opening AOCI. |
(2) Adjustments for the cumulative effect of adoption of the simplified amortization methodology under the full retrospective method for contract issue years from the FNF Acquisition Date through December 31, 2020. |
The following table summarizes the balance of and changes in the asset and liability position of MRBs on January 1, 2021 due to adoption of ASU 2018-12 (in millions):
| | | | | | | | | | | | | | | | | |
| FIA | | Fixed rate annuities | | Total |
Balance, December 31, 2020 - Carrying amount of MRBs under prior guidance (1) | $ | 531 | | | $ | — | | | $ | 531 | |
Adjustment for reversal of AOCI adjustments (2) | (116) | | | — | | | (116) | |
Cumulative effect of the changes in the instrument-specific credit risk between the original contract issuance date and the transition date (3) | 159 | | | — | | | 159 | |
Remaining cumulative difference (exclusive of the instrument specific credit risk change) between December 31, 2020 carrying amount and fair value measurement for the MRBs (4) | (96) | | | 1 | | | (95) | |
Balance, January 1, 2021 - Market risk benefits at fair value | $ | 478 | | | $ | 1 | | | $ | 479 | |
Less: Reinsurance Recoverable | — | | | — | | | — | |
Balance, January 1, 2021, net of reinsurance | $ | 478 | | | $ | 1 | | | $ | 479 | |
| | | | | |
(1) The pre-adoption balance as of December 31, 2020 balance for MRBs represents the contract features that meet the definition of an MRB under ASU 2018-12 and the related carrying amount of those features prior to the ASU. Those contract features were previously accounted for at fair value as a derivative or embedded derivative under ASC 815 or as an additional liability for annuitization benefits or death or other insurance benefits under ASC 944. |
(2) Prior period "shadow" adjustments in AOCI have been reversed upon the adoption of ASU 2018-12 from opening AOCI. |
(3) The cumulative effective of the change in instrument-specific credit risk between the FNF Acquisition Date or, if later, the original contract issuance date and the transition date to ASU 2018-12, which is recorded as an adjustment to opening AOCI. |
(4) The cumulative difference (exclusive of instrument-specific credit risk change) between the pre-adoption carrying amount and the fair value measurement for MRBs is recorded as an adjustment to opening retained earnings. |
The following table presents the effect of transition adjustments on Equity on January 1, 2021 due to the adoption of ASU 2018-12 (in millions):
| | | | | | | | | | | |
| January 1, 2021 |
| Retained Earnings | | AOCI |
Contractholder funds | $ | 101 | | | $ | 115 | |
MRB | 30 | | | (160) | |
FPB | (14) | | | (159) | |
VOBA | (21) | | | 233 | |
DAC | (1) | | | 5 | |
Increase to Equity, gross of tax | $ | 95 | | | $ | 34 | |
Tax impact | 20 | | 9 |
Increase to Equity, net of tax | $ | 75 | | | $ | 25 | |
For MRBs, the transition adjustment reflected within the Consolidated Statements of Comprehensive Earnings relates to the cumulative effect of changes in the instrument-specific credit risk between contract issue date and transition date. The remaining difference between the fair value and carrying amount of the MRBs at transition, excluding the amounts recorded in the Consolidated Statements of Comprehensive Earnings, was recorded as an adjustment to Retained Earnings as of the transition date.
For the FPB, the net transition adjustment is primarily related to the difference in the discount rate used pre-transition and the discount rate at January 1, 2021, partially offset by the removal of provisions for adverse deviation from the cash flow assumptions used in the FPB calculation. At transition, we did not identify any instances, at the cohort level, where net premiums exceeded gross premiums.
Before the adoption of ASU 2018-12, VOBA was amortized consistent with DAC, which was amortized over the lives of the policies in relation to the expected emergence of estimated gross profits (“EGPs”). Based on our historical practice of using consistent amortization methods for VOBA and DAC, we elected to change the amortization method for VOBA associated with fixed rate annuities, FIAs, and IUL/Universal Life (“UL”) products to maintain consistency with the amortization method for DAC. At transition, VOBA associated with these product types is amortized on a constant level basis for the grouped contracts over the expected term of the related contracts to approximate straight-line amortization. Additionally, at transition, shadow adjustments previously recorded in the Consolidated Statements of Comprehensive Earnings, consistent with the historic amortization of DAC, have been removed.
For DAC, DSI and URL, we removed shadow adjustments previously recorded in the Consolidated Statements of Comprehensive Earnings for the impact of unrealized gains and losses that were included in the pre-transition expected gross profits amortization calculation as of the transition date.
Note Q - Related Party Transactions
The Company has determined that related parties would fall into the following categories; (i) affiliates of the entity, (ii) entities for which investments in their equity securities would be required to be accounted for by the equity method by the investing entity, (iii) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management, (iv) principal owners (>10% equity stake) of the entity and members of their immediate families, (v) management (including FNF’s Board of Directors, CEO, and other persons responsible for achieving the objectives of the entity and who have the authority to establish policies and make decisions) of the entity and other members of their immediate families, (vi) other parties with which the entity may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests (vii) other parties that can significantly influence management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate business, (viii) attorney in fact of a reciprocal reporting entity or any affiliate of the attorney in fact, and (ix) a U.S. manager of a U.S. branch or any affiliate of the U.S. manager of a U.S. branch.
The Company has determined that FNF as well as FNF's directors and officers (along with their immediate family members) are related parties.
FNF
Separation Agreement
F&G has entered into the Separation Agreement with FNF to provide for, among other things, the principal corporate transactions required to effect the separation and distribution, certain conditions to the separation and distribution and provisions governing our relationship with FNF with respect to and resulting from the separation and distribution. Refer to “Risk Factors - Risks Related to the Separation and Distribution and our Status as a subsidiary of FNF” in this Annual Report on Form 10-K for additional information on the separation.
Notes Payable
For a description of our financing arrangements with FNF see Note L - Notes Payable to the Consolidated Financial Statements included in this Annual Report on Form 10-K.
Governance
Because FNF owns approximately 85% of the shares of outstanding F&G common stock, we are a controlled company within the meaning of the corporate governance standards of the NYSE. A controlled company does not need its board of directors to have a majority of independent directors or to form an independent compensation committee or nominating and corporate governance committee. Refer to “Risk Factors - Risks Related to the Separation and Distribution and our Status as a subsidiary of FNF” in this Annual Report on Form 10-K for additional information on management and governance.
FNF $250 million Preferred Stock Investment
On January 12, 2024 we completed a $250 million preferred stock investment from FNF. F&G will use net proceeds from the investment to support the growth of its assets under management. Under the terms of the agreement, FNF agreed to invest $250 million in exchange for 5,000,000 shares of F&G’s 6.875% Series A Mandatory Convertible Preferred Stock, par value $.001 per share, liquidation preference of $50.00 per share (the “FNF Preferred Stock”). Unless earlier converted at the option of the holder, each outstanding share of the FNF Preferred Stock will automatically convert into shares of F&G common stock on January 15, 2027.
Tax Sharing Agreement
Refer to Note H - Income Taxes for a discussion of the tax matters agreement between FNF and the Company.
Stock Split, Increase to Authorized shares and Exchange Agreement with FNF
On June 24, 2022, the following actions previously approved by the F&G board of directors became effective: (i) a stock split in a ratio of 105,000 for 1. FNF, as the sole shareholder, received, in the form of a dividend, 104,999 additional shares of common stock for each share of common stock held. Earnings per share has been retrospectively adjusted to reflect as if the split occurred as of June 1, 2020 in accordance with GAAP; (ii) an increase in the number of authorized shares of common stock from one thousand (1,000) to five hundred million (500,000,000); (iii) an exchange agreement with FNF pursuant to which F&G transferred shares of its common stock to FNF in exchange for the $400 million FNF Promissory Note, after which the note was retired. There was no gain or loss recorded with respect to the exchange agreement. For the years ended December 31, 2023 and 2022, interest expense on the FNF Promissory Note was $0 and approximately $6 million, respectively.
Corporate Services Agreement
FNF has entered into a Corporate Services Agreement with F&G, which we refer to as the Corporate Services Agreement. Pursuant to such agreement, FNF will provide F&G with certain corporate services, including internal audit services, litigation and dispute management services, compliance services, corporate and transactional support services, SEC & reporting services, insurance and risk management services, human resources support services and real estate services. The Corporate Services Agreement terminates after the date upon which all corporate services or
transition assistance have been terminated or upon the mutual agreement of the parties. F&G may terminate corporate services by providing 90 days written notice to FNF.
Reverse Corporate Services Agreement
F&G has entered into a Reverse Corporate Services Agreement with FNF. Pursuant to such agreement, F&G will provide FNF with certain services, including employee services. The Reverse Corporate Services Agreement terminates after the date upon which all corporate services or transition assistance has been terminated or upon the mutual agreement of the parties. FNF may terminate corporate services by providing 90 days written notice to F&G.
Shared Services
For the three-year period ended December 31, 2023, FNF provided certain operational support services for F&G including tax, insurance, legal, risk management, information technology, employee benefits and accounting. Expenses incurred by F&G for all services were insignificant for the years ended December 31, 2023, 2022 and 2021.
Owned Distribution Investments
In 2023, we purchased a 30% minority ownership stake in Quility, a 40% minority ownership stake in DCMT, and a 49% minority ownership stake in Syncis. Refer to FN A - Business and Summary of Significant Accounting Policies - Owned Distribution Investments for more information regarding these investments.
We also have a 30% minority ownership stake in Freedom Equity Group (“FEG”). FEG is a Network Marketing Group that focuses on cultural markets including Mexican-American, Hmong, Laotian, Filipino, Burmese, Congolese-American, Samoan, African-American, Thai and Vietnamese.
We have elected the fair value option to account for these investments and have included them in Investments in unconsolidated affiliates on the accompanying Consolidated Balance Sheets.
For the years ended December 31, 2023 and 2022, we expensed approximately $154 million and $74 million in commissions on sales through our funded owned distribution investments and their affiliates. Acquisition expenses are deferred and amortized in Depreciation and amortization on the accompanying Consolidated Statements of Operations.
Refer to Note A - Business and Summary of Significant Accounting Policies - Recent Developments, for discussion of a recent investment we made in Roar Joint Venture, LLC.
Specialty Lending Company LLC (“Specialty Lending”)
The Company has a 10% ownership stake in Specialty Lending with a 50% voting interest. Specialty Lending is a specialty finance company focused on consumer credit. Specialty Lending is accounted for using the equity method of accounting and is included in Investments in unconsolidated affiliates on the accompanying Consolidated Balance Sheets.
Note R - Employee Benefit Plans
FNF Stock Purchase Plan
During the years ended December 31, 2022 and 2021, our eligible employees could voluntarily participate in FNF's employee stock purchase plan (“ESPP”) sponsored by FNF. Pursuant to the ESPP, employees may contribute an amount between 3% and 15% of their base salary and certain commissions. Company matching contributions are funded one year after employee contributions are made pursuant to the ESPP. We provided FNF an insignificant amount with respect to our matching contributions to the ESPP in the years ended December 31, 2023, 2022 and 2021. Effective January 1, 2023, our employees were no longer eligible to participate in the ESPP.
F&G Stock Purchase Plan
On January 1, 2023, the Company adopted an Employee Stock Purchase Plan (“F&G ESPP”), enabling employees to purchase the Company stock in an amount between 3% and 15% of their base salary and certain commissions. Based on employee contributions the company will match either 33.3% or 50% one year after initial employee contributions are made pursuant to the F&G ESPP. Our matching expense related to the F&G ESPP was immaterial for the year ended December 31, 2023.
401(k) Plan
During the three-year period ended December 31, 2023, we have offered our employees the opportunity to participate in our 401(k) plan (the “401(k) Plan”), a qualified voluntary contributory savings plan that is available to substantially all of our employees. Eligible employees may contribute up to 75% of their pre-tax annual compensation, up to the amount allowed pursuant to the Internal Revenue Code. We make an employer match on the 401(k) Plan of $1.00 on each $1.00 contributed up to the first 5% of eligible earnings contributed to the 401(k) Plan by employees. The employer match recorded in personnel costs in the Consolidated Statement of Operations was $7 million, $5 million, $3 million in for the years ended December 31, 2023, 2022 and 2021, respectively, and was credited based on the participant's individual investment elections in the 401(k) Plan.
Stock-Based Compensation
We account for stock-based compensation plans in accordance with GAAP on share-based payments, which requires that compensation cost relating to share-based payments be recognized in the consolidated financial statements based on the fair value of each award. Using the fair value method of accounting, compensation cost is measured based on the fair value of the award at the grant date and recognized over the service period. Total compensation costs recorded in personnel costs in the Consolidated Statement of Operations for the years ended December 31, 2023, 2022, and 2021 were $23 million, $12 million and $9 million, respectively.
2022 F&G Omnibus Incentive Plan
On December 1, 2022, we established the F&G Annuities & Life, Inc. 2022 Omnibus Incentive Plan (the “2022 F&G Omnibus Plan”), authorizing the issuance of up to 6 million shares of F&G common stock, subject to the terms of the 2022 F&G Omnibus Plan. The 2022 F&G Omnibus Plan provides for the grant of stock options, stock appreciation rights, restricted stock, restricted stock units and performance shares, performance units, other cash and stock-based awards and dividend equivalents. As of December 31, 2023, there were 1,784,142 shares of restricted stock outstanding under the 2022 F&G Omnibus Plan. Awards granted are approved by the Compensation Committee of the Board of Directors. Awards vest over a 3-year period and have a performance restriction that must be met for shares awarded to vest. If the performance restriction is not satisfied during the measurement period, all of the shares that do not satisfy the performance criteria will be forfeited to the Company for no consideration.
F&G restricted stock transactions under the 2022 F&G Omnibus Plan during the years ended December 31, 2023 and 2022 are as follows:
| | | | | | | | | | | |
| Shares | | Weighted Average Grant Date Fair Value |
Balance, January 1, 2023 | 1,409,904 | | | $ | 21.80 | |
Granted | 876,736 | | | 40.28 | |
Canceled | (48,900) | | | 21.80 | |
Vested | (453,598) | | | 21.80 | |
Balance, December 31, 2023 | 1,784,142 | | | $ | 30.88 | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | |
| | | | | | | | | | | |
| Shares | | Weighted Average Grant Date Fair Value |
Balance, January 1, 2022 | — | | | $ | — | |
Granted | 1,411,369 | | | 21.80 | |
Canceled | (1,465) | | | 21.80 | |
Vested | — | | | — | |
Balance, December 31, 2022 | 1,409,904 | | | $ | 21.80 | |
Fair value of restricted stock awards and units is based on the grant date value of the underlying stock derived from quoted market prices. The total fair value of restricted stock awards granted in the years ended December 31, 2023 and December 31, 2022 was $35 million and $31 million, respectively. There were 453,598 and 0 restricted stock awards which vested in the years ended December 31, 2023 and 2022. Net earnings (loss) reflects stock-based compensation expense amounts of $19 million and $1 million for the years ended December 31, 2023 and 2022, respectively, which are recorded in personnel costs in the Consolidated Statement of Operations.
For the period ended December 31, 2023, the total unrecognized compensation costs related to non-vested restricted stock grants pursuant to the 2022 F&G Omnibus Plan are $45 million, which is expected to be recognized in pre-tax income over a weighted average period of 2.67 years.
FGL Incentive Plan and 2020 F&G Omnibus Incentive Plan
We have outstanding restricted stock grants and stock options under the FGL Holdings 2017 Omnibus Incentive Plan, as amended and restated (the “2020 F&G Omnibus Plan”), which was assumed by FNF. The outstanding awards and options are settled by issuance of FNF common stock. All of the outstanding options are vested and expire at various dates through August 2026. As of December 31, 2023, there were 181,479 shares of restricted stock and 643,623 stock options outstanding under the 2020 F&G Omnibus Plan.
Stock option transactions under the 2020 F&G Omnibus Plan for the three-year period ended December 31, 2023, are as follows:
| | | | | | | | | | | | | | | | | |
| Options | | Weighted Average Exercise Price | | Exercisable |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
Balance, December 31, 2020 | 2,002,690 | | | $ | 36.14 | | | 1,021,671 | |
| | | | | |
Exercised | (474,754) | | | 36.68 | | | |
Canceled | — | | | — | | | |
Balance, December 31, 2021 | 1,527,936 | | | 35.97 | | | 1,072,584 | |
Granted | — | | | — | | | |
Exercised | (352,614) | | | 38.79 | | | |
Canceled | (2,715) | | | 28.00 | | | |
Balance, December 31, 2022 | 1,172,607 | | | 35.15 | | | 1,172,607 | |
Granted | — | | | — | | | — | |
Exercised | (502,414) | | | 30.31 | | | — | |
Canceled | (26,570) | | | 38.07 | | | — | |
Balance, December 31, 2023 | 643,623 | | | $ | 38.80 | | | 643,623 | |
The following table summarizes information related to stock options outstanding and exercisable as of December 31, 2023:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| Options Outstanding | | Options Exercisable |
Range of Exercise Prices | Number of Options | | Weighted Average Remaining Contractual Life | | Weighted Average Exercise Price | | Intrinsic Value | | Number of Options | | Weighted Average Remaining Contractual Life | | Weighted Average Exercise Price | | Intrinsic Value |
| | | (In years) | | | | (In millions) | | | | (In years) | | | | (In millions) |
| | | | | | | | | | | | | | | |
$0.00 - $28.00 | 17,409 | | | 2.60 | | $ | 28.00 | | | $ | 1 | | | 17,409 | | | 2.60 | | $ | 28.00 | | | $ | 1 | |
$28.00 - $39.10 | 626,214 | | | 1.76 | | 39.10 | | | 7 | | | 626,214 | | | 1.76 | | 39.10 | | | 7 | |
| | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | |
| 643,623 | | | | | | | $ | 8 | | | 643,623 | | | | | | | $ | 8 | |
Option awards are measured at fair value on the grant date using the Black Scholes Option Pricing Model. The intrinsic value of options exercised in the year ended December 31, 2023 was $8 million and was insignificant for the years ended December 31, 2022 and December 31, 2021.
Restricted stock transactions under the 2020 F&G Omnibus Plan for the three-year period ended December 31, 2023, are as follows:
| | | | | | | | | | | |
| Shares | | Weighted Average Grant Date Fair Value |
Balance, December 31, 2020 | 449,870 | | | $ | 34.11 | |
Granted | 311,081 | | | 48.28 | |
Canceled | (12,437) | | | 33.40 | |
Vested | (29,873) | | | 34.59 | |
Balance, December 31, 2021 | 718,641 | | | 40.24 | |
Granted | — | | | — | |
Canceled | (78,551) | | | 37.79 | |
Vested | (138,542) | | | 34.11 | |
Balance, December 31, 2022 | 501,548 | | | 42.31 | |
Granted | — | | | — | |
Canceled | (15,965) | | | 45.63 | |
Vested | (304,104) | | | 42.87 | |
Balance, December 31, 2023 | 181,479 | | | $ | 41.08 | |
The total fair value of restricted stock awards granted in the years ended December 31, 2023, 2022 and 2021 was $0, $0 and $15 million, respectively. The total fair value of restricted stock awards, which vested in the years ended December 31, 2023, 2022, and 2021 was $13 million, $5 million and $1 million, respectively. Net earnings (loss) reflects stock-based compensation expense amounts of $3 million, $12 million and $9 million for the years ended December 31, 2023, 2022 and 2021, respectively, which are included in personnel costs in the Consolidated Statement of Operations.
At December 31, 2023, the total unrecognized compensation cost related to restricted stock grants pursuant to the FGL Incentive Plan and the 2020 F&G Omnibus Plan is $1 million, all of which is expected to be recognized in pre-tax income in 2024.
Non-Qualified Deferred Compensation Plan
We have established the F&G Annuities & Life, Inc. Deferred Compensation Plan (the “Deferred Compensation Plan”), which allows eligible employees and directors to make voluntary contributions to the Deferred Compensation Plan. Employer contributions to the Deferred Compensation Plan are discretionary. For the year ended December 31, 2023, we did not make any discretionary contributions. At December 31, 2023 and 2022, the total liability for the Deferred Compensation Plan was $11 million and $12 million, respectively.
Note S - Earnings Per Share
The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands):
| | | | | | | | | | | | | | | | | |
| Year Ended December 31, |
| 2023 | | 2022 | | 2021 |
| | | | | |
| | | | | |
Net earnings (loss) from continuing operations | $ | (58) | | | $ | 635 | | | $ | 1,232 | |
Net earnings (loss) from discontinued operations | — | | | — | | | 8 | |
Net earnings (loss) | $ | (58) | | | $ | 635 | | | $ | 1,240 | |
| | | | | |
| | | | | |
| | | | | |
Weighted-average common shares outstanding - basic | 124 | | | 115 | | | 105 | |
Dilutive effect of unvested restricted stock | — | | | — | | | — | |
Dilutive effect of stock options | — | | | — | | | — | |
Weighted-average shares outstanding - diluted | 124 | | | 115 | | | 105 | |
| | | | | |
Net earnings (loss) per common share: | | | | | |
Basic - continuing | $ | (0.47) | | | $ | 5.52 | | | $ | 11.73 | |
Basic - discontinued operations | — | | | — | | | 0.08 | |
Basic - net | $ | (0.47) | | | $ | 5.52 | | | $ | 11.81 | |
| | | | | |
Diluted - continuing | (0.47) | | | $ | 5.52 | | | $ | 11.73 | |
Diluted - discontinued operations | — | | | — | | | 0.08 | |
Diluted - net | $ | (0.47) | | | $ | 5.52 | | | $ | 11.81 | |
Under applicable accounting guidance, companies in a loss position are required to use basic weighted average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our net loss for the year ended December 31, 2023, we were required to use basic weighted-average common shares outstanding in the calculation of diluted loss per share, as the inclusion of 593 thousand restricted shares would have been antidilutive to the calculation. If we had not incurred a net loss for the year ended December 31, 2023, dilutive potential common shares would have been 125 million.
Restricted stock, options or other instruments, which provide the ability to acquire shares of our common stock that are antidilutive are excluded from the computation of diluted earnings per share. For the years ended December 31, 2023 and 2022, the diluted earnings per share calculation excluded the weighted average effect of 111 thousand and 120 thousand restricted stock units, respectively, issued under the 2022 F&G Omnibus Plan due to their antidilutive effect. For the year ended December 31, 2021, the Company did not have any share-based plans involving the issuance of the Company's equity and, therefore, no impact to the diluted earnings per share calculation.
On June 24, 2022, the following actions previously approved by the F&G board of directors became effective: (i) a stock split in a ratio of 105,000 for 1. Earnings per share has been retrospectively adjusted to reflect as if the split occurred as of June 1, 2020 in accordance with GAAP; (ii) a resolution to enter an exchange agreement with FNF pursuant to which F&G transferred shares of its common stock to FNF in exchange for the $400 million FNF Promissory Note, after which the note was retired.
Note T - Recent Accounting Pronouncements
Adopted Pronouncements
In August 2018, the FASB issued ASU 2018-12, as clarified and amended by ASU 2019-09, Financial Services-Insurance: Effective Date and ASU 2020-11, Financial Services-Insurance: Effective Date and Early Application, effective for fiscal years beginning after December 15, 2022 including interim periods within those fiscal years. This update introduced the following requirements: assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being
recognized in the statement of operations; the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in AOCI; MRBs associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value recognized in earnings, except for the change attributable to instrument-specific credit risk which is recognized in AOCI; deferred acquisition costs are no longer required to be amortized in proportion to premiums, gross profits, or gross margins; instead, those balances must be amortized on a constant level basis over the expected term of the related contracts; deferred acquisition costs must be written off for unexpected contract terminations; and disaggregated roll forwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, MRBs, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed. We adopted this standard, which required the new guidance be applied as of the beginning of the earliest period that will be presented in our annual December 31, 2023 Consolidated Financial Statements or January 1, 2021, referred to as the transition date, and elected the full retrospective transition method. As a result of adoption, the Company recorded a cumulative-effect adjustment, which increased opening 2021 retained earnings by $75 million, net of tax. Refer to Note P - Transition for more information.
In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848. The amendments in this update defer the sunset provision within Topic 848 that provides a temporary, optional expedient and exception for contracts affected by reference rate reform by not applying certain modification accounting requirements and instead accounting for the modified contract as a continuation of the existing contract. This guidance eases the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting through December 31, 2024. We adopted this standard upon issuance and this standard had no impact on our Consolidated Financial Statements and related disclosures to date.
Pronouncements Not Yet Adopted
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this update improve reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expense categories that are regularly provided to the chief operating decision maker (“CODM”) and included in each reported measure of a segment’s profit or loss. In addition, the amendments enhance interim disclosure requirements that are currently required annually, clarify circumstances in which an entity can disclose multiple segment measures of profit or loss, and contain other disclosure requirements. Additionally, the amendments require that entities with a single reportable segment must now provide all the disclosures previously required under Topic 280. The amendments in this update are incremental to the current requirements of Topic 280 and do not change how a public entity identifies its operating segments, aggregates those operating segments, or applies the quantitative thresholds to determine its reportable segments. The enhanced segment disclosure requirements apply retrospectively to all prior periods presented in the financial statements. The significant segment expense and other segment item amounts disclosed in prior periods shall be based on the significant segment expense categories identified and disclosed in the period of adoption. The amendments in this update are effective for all public entities for fiscal years beginning after December 15, 2023, and interim periods beginning after December 15, 2024. Early adoption is permitted, and the updates must be applied retrospectively to all periods presented in the financial statements. We do not currently expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. The amendments in this update enhance the transparency of the income tax disclosures by expanding on the disclosures required annually. The amendments require entities to disclose in their rate reconciliation table additional categories of information about federal, state, and foreign income taxes, in addition to providing details about the reconciling items in some categories if above a quantitative threshold. Additionally, the amendments require annual disclosure of income taxes paid (net of refunds received) disaggregated by jurisdiction based on a quantitative threshold. The amendments in this update are effective for public business entities for annual periods beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. The amendments should be applied on a prospective basis, and retrospective application is permitted. We do not currently expect to early adopt this standard and are in the process of assessing its impact on our disclosures upon adoption.